A01AA |
Caries prophylactic agents
|
Agents prophylactiques des caries
|
WHO |
Active |
2021-06-14 14:58:44 |
A01AA01 |
sodium fluoride
|
Fluorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AA02 |
sodium monofluorophosphate
|
monofluorophosphate de sodium
|
WHO |
Active |
2023-01-25 11:26:57 |
A01AA03 |
olaflur
|
olaflur
|
WHO |
Active |
2023-01-25 11:27:42 |
A01AA04 |
stannous fluoride
|
Fluorure d'étain
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AA30 |
combinations
|
associations
|
WHO |
Active |
2023-01-25 11:28:25 |
A01AA51 |
sodium fluoride, combinations
|
fluorure de sodium, associations
|
WHO |
Active |
2023-01-25 11:29:09 |
A01AB |
Antiinfectives and antiseptics for local oral treatment
|
Anti-infectieux et antiseptiques pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB02 |
hydrogen peroxide
|
Peroxyde d'hydrogène
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB03 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB04 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB05 |
polynoxylin
|
polynoxylin
|
WHO |
Active |
2023-01-25 11:29:50 |
A01AB06 |
domiphen
|
domiphen
|
WHO |
Active |
2023-01-25 11:30:33 |
A01AB07 |
oxyquinoline
|
Oxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB08 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB09 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB10 |
natamycin
|
natamycine
|
WHO |
Active |
2023-01-25 11:31:16 |
A01AB12 |
hexetidine
|
hexétidine
|
WHO |
Active |
2023-01-25 11:31:58 |
A01AB13 |
tetracycline
|
tétracycline
|
WHO |
Active |
2023-01-25 11:32:42 |
A01AB14 |
benzoxonium chloride
|
chlorure de benzoxonium
|
WHO |
Active |
2023-01-25 11:33:23 |
A01AB15 |
tibezonium iodide
|
iodure de tibezonium
|
WHO |
Active |
2023-01-25 11:34:06 |
A01AB16 |
mepartricin
|
mépartricine
|
WHO |
Active |
2023-01-25 11:34:48 |
A01AB17 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB18 |
clotrimazole
|
Clotrimazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB19 |
sodium perborate
|
perborate de sodium
|
WHO |
Active |
2023-01-25 11:59:27 |
A01AB21 |
chlortetracycline
|
Chlortétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB22 |
doxycycline
|
Doxycycline
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AB23 |
minocycline
|
Minocycline
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AC |
Corticosteroids for local oral treatment
|
Corticostéroïdes pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AC01 |
triamcinolone
|
triamcinolone
|
WHO |
Active |
2023-01-25 12:00:09 |
A01AC02 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AC03 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AC54 |
prednisolone, combinations
|
prednisolone, associations
|
WHO |
Active |
2023-01-25 12:00:51 |
A01AD |
Other agents for local oral treatment
|
Autres agents pour un traitement local oral
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AD01 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AD02 |
benzydamine
|
benzydamine
|
WHO |
Active |
2023-01-25 12:01:35 |
A01AD05 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
A01AD06 |
adrenalone
|
adrénalone
|
WHO |
Active |
2023-01-25 12:02:17 |
A01AD07 |
amlexanox
|
amlexanox
|
WHO |
Active |
2023-01-25 12:03:00 |
A01AD08 |
becaplermin
|
bécaplermine
|
WHO |
Active |
2023-01-25 12:03:43 |
A02AA |
Magnesium compounds
|
Dérivés du magnésium
|
WHO |
Active |
2024-05-17 08:23:52 |
A02AA01 |
magnesium carbonate
|
Carbonate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AA02 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AA03 |
magnesium peroxide
|
peroxyde de magnésium
|
WHO |
Active |
2023-01-25 12:04:28 |
A02AA04 |
magnesium hydroxide
|
Hydroxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AA05 |
magnesium silicate
|
silicate de magnésium
|
WHO |
Active |
2023-01-25 12:05:12 |
A02AA10 |
combinations
|
associations
|
WHO |
Active |
2023-01-25 12:05:56 |
A02AB |
Aluminium compounds
|
Dérivés de l'aluminium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AB01 |
aluminium hydroxide
|
hydroxyde d'aluminium
|
WHO |
Active |
2023-01-25 12:06:41 |
A02AB02 |
algeldrate
|
algeldrate
|
WHO |
Active |
2023-01-25 12:07:26 |
A02AB03 |
aluminium phosphate
|
phosphate d'aluminium
|
WHO |
Active |
2023-01-25 12:08:08 |
A02AB04 |
dihydroxialumini sodium carbonate
|
carbonate sodique dihydroxialuminique
|
WHO |
Active |
2023-01-27 09:29:04 |
A02AB05 |
aluminium acetoacetate
|
acétoacétate d'aluminium
|
WHO |
Active |
2023-01-27 09:29:49 |
A02AB06 |
aloglutamol
|
aloglutamol
|
WHO |
Active |
2023-01-27 09:30:30 |
A02AB07 |
aluminium glycinate
|
glycinate d'aluminium
|
WHO |
Active |
2023-01-27 09:31:14 |
A02AB10 |
combinations
|
associations
|
WHO |
Active |
2023-01-27 09:31:55 |
A02AC |
Calcium compounds
|
Dérivés du calcium
|
WHO |
Active |
2024-05-17 10:54:30 |
A02AC01 |
calcium carbonate
|
Carbonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AC02 |
calcium silicate
|
silicate de calcium
|
WHO |
Active |
2023-01-27 09:32:38 |
A02AC10 |
combinations
|
associations
|
WHO |
Active |
2023-01-27 09:33:19 |
A02AD |
Combinations and complexes of aluminium, calcium and magnesium compounds
|
Associations et dérivés complexes d'aluminium, de calcium et de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AD01 |
ordinary salt combinations
|
associations ordinaires de sels
|
WHO |
Active |
2023-01-27 09:34:01 |
A02AD02 |
magaldrate
|
magaldrate
|
WHO |
Active |
2023-01-27 09:34:43 |
A02AD03 |
almagate
|
almagate
|
WHO |
Active |
2023-01-27 09:35:27 |
A02AD04 |
hydrotalcite
|
hydrotalcite
|
WHO |
Active |
2023-01-27 09:36:09 |
A02AD05 |
almasilate
|
almasilate
|
WHO |
Active |
2023-01-27 09:36:52 |
A02AF |
Antacids with antiflatulents
|
Antacides et antiflatulents
|
WHO |
Active |
2021-06-09 15:34:07 |
A02AF01 |
magaldrate and antiflatulents
|
magaldrate et antiflatulents
|
WHO |
Active |
2024-05-17 08:24:34 |
A02AF02 |
ordinary salt combinations and antiflatulents
|
associations ordinaires de sels et antiflatulents
|
WHO |
Active |
2024-05-17 08:25:17 |
A02BA |
H2-receptor antagonists
|
Antihistaminiques anti-H2
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BA01 |
cimetidine
|
Cimétidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BA02 |
ranitidine
|
Rantidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BA03 |
famotidine
|
Famotidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BA04 |
nizatidine
|
Nizatidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BA05 |
niperotidine
|
nipérotidine
|
WHO |
Active |
2023-01-27 09:39:01 |
A02BA06 |
roxatidine
|
roxatidine
|
WHO |
Active |
2023-01-27 09:39:46 |
A02BA07 |
ranitidine bismuth citrate
|
ranitidine bismuth citrate
|
WHO |
Active |
2023-01-27 09:40:28 |
A02BA08 |
lafutidine
|
lafutidine
|
WHO |
Active |
2023-01-27 09:41:09 |
A02BA51 |
cimetidine, combinations
|
cimétidine, associations
|
WHO |
Active |
2023-01-27 09:41:53 |
A02BA53 |
famotidine, combinations
|
famotidine, associations
|
WHO |
Active |
2023-01-27 09:42:35 |
A02BB |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BB01 |
misoprostol
|
Misoprostol
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BB02 |
enprostil
|
enprostil
|
WHO |
Active |
2023-01-27 09:43:20 |
A02BC |
Proton pump inhibitors
|
Inhibiteurs de la pompe à protons
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC01 |
omeprazole
|
Oméprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC02 |
pantoprazole
|
Pantoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC03 |
lansoprazole
|
Lansoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC04 |
rabeprazole
|
rabéprazole
|
WHO |
Active |
2023-01-27 09:44:02 |
A02BC05 |
esomeprazole
|
Ésoméprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC06 |
dexlansoprazole
|
Dexlansoprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC07 |
dexrabeprazole
|
dexrabéprazole
|
WHO |
Active |
2023-01-27 09:44:43 |
A02BC08 |
vonoprazan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BC53 |
lansoprazole, combinations
|
lansoprazole, associations
|
WHO |
Active |
2023-01-27 09:45:25 |
A02BC54 |
rabeprazole, combinations
|
rabéprazole, associations
|
WHO |
Active |
2023-01-27 09:46:06 |
A02BD |
Combinations for eradication of Helicobacter pylori
|
Associations pour l'éradication du Helicobacter pylori
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BD01 |
omeprazole, amoxicillin and metronidazole
|
oméprazole, amoxicilline et métronidazole
|
WHO |
Active |
2024-05-17 08:25:59 |
A02BD02 |
lansoprazole, tetracycline and metronidazole
|
lansoprazole, tétracycline et métronidazole
|
WHO |
Active |
2024-05-17 08:26:42 |
A02BD03 |
lansoprazole, amoxicillin and metronidazole
|
lansoprazole, amoxicilline et métronidazole
|
WHO |
Active |
2024-05-17 08:27:25 |
A02BD04 |
pantoprazole, amoxicillin and clarithromycin
|
pantoprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2024-05-17 08:28:07 |
A02BD05 |
omeprazole, amoxicillin and clarithromycin
|
oméprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2024-05-17 08:28:51 |
A02BD06 |
esomeprazole, amoxicillin and clarithromycin
|
ésoméprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2024-05-17 08:29:32 |
A02BD07 |
lansoprazole, amoxicillin and clarithromycin
|
lansoprazole, amoxicilline et clarithromycine
|
WHO |
Active |
2023-01-27 11:45:45 |
A02BD08 |
bismuth subcitrate, tetracycline and metronidazole
|
subcitrate de bismuth, tétracycline et métronidazole
|
WHO |
Active |
2023-01-27 11:46:27 |
A02BD09 |
lansoprazole, clarithromycin and tinidazole
|
lansoprazole, clarithromycine et tinidazole
|
WHO |
Active |
2023-01-27 11:47:09 |
A02BD10 |
lansoprazole, amoxicillin and levofloxacin
|
lansoprazole, amoxicilline et lévofloxacine
|
WHO |
Active |
2024-05-17 08:30:15 |
A02BD11 |
pantoprazole, amoxicillin, clarithromycin and metronidazole
|
pantoprazole, amoxicilline, clarithromycine et métronidazole
|
WHO |
Active |
2023-01-27 11:48:36 |
A02BD12 |
rabeprazole, amoxicillin and clarithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BD13 |
rabeprazole, amoxicillin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BD14 |
vonoprazan, amoxicillin and clarithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BD15 |
vonoprazan, amoxicillin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BX |
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
Autres médicaments en cas d'ulcère peptique et de reflux gastro-œsophageal (en anglais : GORD)
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BX01 |
carbenoxolone
|
carbénoxolone
|
WHO |
Active |
2023-01-27 11:49:18 |
A02BX02 |
sucralfate
|
Sucralfate
|
WHO |
Active |
2021-06-09 15:34:07 |
A02BX03 |
pirenzepine
|
pirenzépine
|
WHO |
Active |
2023-01-27 11:50:01 |
A02BX04 |
methiosulfonium chloride
|
chlorure de méthiosulfonium
|
WHO |
Active |
2024-05-17 08:30:58 |
A02BX05 |
bismuth subcitrate
|
sous-citrate de bismuth
|
WHO |
Active |
2023-01-27 11:51:25 |
A02BX06 |
proglumide
|
proglumide (en)
|
WHO |
Active |
2024-05-17 08:31:41 |
A02BX07 |
gefarnate
|
gefarnate
|
WHO |
Active |
2023-01-27 11:52:49 |
A02BX08 |
sulglicotide
|
sulglicotide
|
WHO |
Active |
2023-01-27 11:53:32 |
A02BX09 |
acetoxolone
|
acétoxolone
|
WHO |
Active |
2023-01-27 11:54:15 |
A02BX10 |
zolimidine
|
zolimidine
|
WHO |
Active |
2023-01-27 11:54:58 |
A02BX11 |
troxipide
|
troxipide
|
WHO |
Active |
2023-01-27 11:55:41 |
A02BX12 |
bismuth subnitrate
|
sous-nitrate de bismuth
|
WHO |
Active |
2023-01-27 11:56:24 |
A02BX13 |
alginic acid
|
acide alginique
|
WHO |
Active |
2023-01-27 11:57:07 |
A02BX14 |
rebamipide
|
rébamipide
|
WHO |
Active |
2023-01-27 11:57:48 |
A02BX51 |
carbenoxolone, combinations excl. psycholeptics
|
carbénoxolone, associations sans psycholeptiques
|
WHO |
Active |
2023-01-27 11:58:31 |
A02BX77 |
gefarnate, combinations with psycholeptics
|
gefarnate, associations impliquant des psycholeptiques
|
WHO |
Active |
2023-01-31 13:10:43 |
A03AA |
Synthetic anticholinergics, esters with tertiary amino group
|
Anticholinergiques synthétiques, esters d'amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AA01 |
oxyphencyclimine
|
oxyphencyclimine
|
WHO |
Active |
2023-01-31 13:11:28 |
A03AA03 |
camylofin
|
camylofine
|
WHO |
Active |
2023-01-31 13:12:12 |
A03AA04 |
mebeverine
|
mébévérine
|
WHO |
Active |
2023-01-31 13:12:56 |
A03AA05 |
trimebutine
|
trimébutine
|
WHO |
Active |
2023-01-31 13:13:40 |
A03AA06 |
rociverine
|
rocivérine
|
WHO |
Active |
2023-01-31 13:14:22 |
A03AA07 |
dicycloverine
|
dicyclovérine
|
WHO |
Active |
2023-01-31 13:15:06 |
A03AA08 |
dihexyverine
|
dihexyvérine
|
WHO |
Active |
2023-01-31 13:15:48 |
A03AA09 |
difemerine
|
difemerine
|
WHO |
Active |
2023-01-31 13:16:32 |
A03AA30 |
piperidolate
|
pipéridolate
|
WHO |
Active |
2023-01-31 13:17:15 |
A03AB |
Synthetic anticholinergics, quaternary ammonium compounds
|
Anticholinergiques synthétiques, ammoniums quaternaires
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AB01 |
benzilone
|
benzilone
|
WHO |
Active |
2023-01-31 13:18:00 |
A03AB02 |
glycopyrronium bromide
|
Bromure de Glycopyrronium
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AB03 |
oxyphenonium
|
oxyphenonium
|
WHO |
Active |
2023-01-31 13:18:42 |
A03AB04 |
penthienate
|
penthiénate
|
WHO |
Active |
2023-01-31 13:19:24 |
A03AB05 |
propantheline
|
propanthéline
|
WHO |
Active |
2023-01-31 13:20:05 |
A03AB06 |
otilonium bromide
|
bromure d'otilonium
|
WHO |
Active |
2023-01-31 13:20:48 |
A03AB07 |
methantheline
|
méthanthéline
|
WHO |
Active |
2023-01-31 13:21:30 |
A03AB08 |
tridihexethyl
|
tridihexéthyl
|
WHO |
Active |
2023-01-31 13:22:12 |
A03AB09 |
isopropamide
|
isopropamide
|
WHO |
Active |
2023-01-31 13:22:54 |
A03AB10 |
hexocyclium
|
hexocyclium
|
WHO |
Active |
2023-01-31 13:23:38 |
A03AB11 |
poldine
|
poldine
|
WHO |
Active |
2023-01-31 13:24:21 |
A03AB12 |
mepenzolate
|
mépenzolate
|
WHO |
Active |
2023-01-31 13:25:03 |
A03AB13 |
bevonium
|
bévonium
|
WHO |
Active |
2023-01-31 13:25:47 |
A03AB14 |
pipenzolate
|
pipenzolate
|
WHO |
Active |
2023-01-31 13:26:31 |
A03AB15 |
diphemanil
|
diphémanil
|
WHO |
Active |
2023-01-31 13:27:15 |
A03AB17 |
tiemonium iodide
|
iodure de tiémonium
|
WHO |
Active |
2023-01-31 13:27:59 |
A03AB18 |
prifinium bromide
|
bromure de prifinium
|
WHO |
Active |
2023-01-31 17:15:11 |
A03AB19 |
timepidium bromide
|
bromure de timépidium
|
WHO |
Active |
2023-01-31 17:15:53 |
A03AB21 |
fenpiverinium
|
fenpivérinium
|
WHO |
Active |
2023-01-31 17:16:38 |
A03AB53 |
oxyphenonium, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AC |
Synthetic antispasmodics, amides with tertiary amines
|
Antispasmodiques de synthèse, amides d'amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AC04 |
nicofetamide
|
nicofétamide
|
WHO |
Active |
2023-01-31 17:17:20 |
A03AC05 |
tiropramide
|
tiropramide
|
WHO |
Active |
2023-01-31 17:18:03 |
A03AD |
Papaverine and derivatives
|
Papavérine et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AD01 |
papaverine
|
papavérine
|
WHO |
Active |
2023-01-31 17:18:49 |
A03AD02 |
drotaverine
|
drotavérine
|
WHO |
Active |
2023-01-31 17:19:32 |
A03AD30 |
moxaverine
|
moxavérine
|
WHO |
Active |
2023-01-31 17:20:18 |
A03AE |
Serotonin receptor antagonists
|
Substances agissant sur les récepteurs de la sérotonine
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AE01 |
alosetron
|
alosétron
|
WHO |
Active |
2023-01-31 17:21:02 |
A03AE03 |
cilansetron
|
cilansétron
|
WHO |
Active |
2023-01-31 17:21:45 |
A03AX |
Other drugs for functional gastrointestinal disorders
|
Autres médicaments en cas de troubles fonctionnels du côlon
|
WHO |
Active |
2021-06-09 15:34:07 |
A03AX01 |
fenpiprane
|
fenpiprane
|
WHO |
Active |
2023-01-31 17:22:28 |
A03AX02 |
diisopromine
|
diisopromine
|
WHO |
Active |
2023-01-31 17:23:11 |
A03AX03 |
chlorbenzoxamine
|
chlorbenzoxamine
|
WHO |
Active |
2023-01-31 17:23:53 |
A03AX04 |
pinaverium
|
pinaverium
|
WHO |
Active |
2023-01-31 17:24:37 |
A03AX05 |
fenoverine
|
fenoverine
|
WHO |
Active |
2023-01-31 17:25:19 |
A03AX06 |
idanpramine
|
idanpramine
|
WHO |
Active |
2023-01-31 17:26:00 |
A03AX07 |
proxazole
|
proxazole
|
WHO |
Active |
2023-01-31 17:26:44 |
A03AX08 |
alverine
|
alvérine
|
WHO |
Active |
2023-01-31 17:27:27 |
A03AX09 |
trepibutone
|
trepibutone
|
WHO |
Active |
2023-01-31 17:28:10 |
A03AX10 |
isometheptene
|
isometheptene
|
WHO |
Active |
2023-01-31 17:28:53 |
A03AX11 |
caroverine
|
caroverine
|
WHO |
Active |
2023-01-31 17:29:38 |
A03AX12 |
phloroglucinol
|
phloroglucinol
|
WHO |
Active |
2023-01-31 17:30:21 |
A03AX13 |
silicones
|
silicones
|
WHO |
Active |
2023-01-31 17:31:05 |
A03AX14 |
valethamate
|
valéthamate
|
WHO |
Active |
2023-01-31 17:31:50 |
A03AX30 |
trimethyldiphenylpropylamine
|
triméthyldiphenylpropylamine
|
WHO |
Active |
2023-01-31 17:32:35 |
A03AX58 |
alverine, combinations
|
alvérine, assocations
|
WHO |
Active |
2023-02-01 09:47:23 |
A03BA |
Belladonna alkaloids, tertiary amines
|
Alcaloïdes de la belladone, amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
A03BA01 |
atropine
|
atropine
|
WHO |
Active |
2023-02-01 09:48:08 |
A03BA03 |
hyoscyamine
|
hyoscyamine
|
WHO |
Active |
2023-02-01 09:48:50 |
A03BA04 |
belladonna total alkaloids
|
alcaloïdes totaux de la belladone
|
WHO |
Active |
2023-02-01 09:49:33 |
A03BB |
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
Alcaloïdes de la belladone, semisynthétiques, ammoniums quaternaires
|
WHO |
Active |
2021-06-09 15:34:07 |
A03BB01 |
butylscopolamine
|
butylscopolamine
|
WHO |
Active |
2023-02-01 09:50:16 |
A03BB02 |
methylatropine
|
méthylatropine
|
WHO |
Active |
2023-02-01 09:50:58 |
A03BB03 |
methylscopolamine
|
méthylscopolamine
|
WHO |
Active |
2023-02-01 09:51:42 |
A03BB04 |
fentonium
|
fentonium
|
WHO |
Active |
2023-02-01 09:52:26 |
A03BB05 |
cimetropium bromide
|
bromure de cimétropium
|
WHO |
Active |
2023-02-01 09:53:08 |
A03BB06 |
homatropine methylbromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A03CA |
Synthetic anticholinergic agents in combination with psycholeptics
|
Anticholinergiques de synthèse associés à des psycholeptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A03CA01 |
isopropamide and psycholeptics
|
isopropamide et psycholeptiques
|
WHO |
Active |
2024-05-17 08:32:22 |
A03CA02 |
clidinium and psycholeptics
|
clidinium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:33:06 |
A03CA03 |
oxyphencyclimine and psycholeptics
|
oxyphencyclimine et psycholeptiques
|
WHO |
Active |
2024-05-17 08:33:47 |
A03CA04 |
otilonium bromide and psycholeptics
|
bromure d'otilonium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:34:32 |
A03CA05 |
glycopyrronium bromide and psycholeptics
|
glycopyrronium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:35:14 |
A03CA06 |
bevonium and psycholeptics
|
bevonium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:35:57 |
A03CA07 |
ambutonium and psycholeptics
|
ambutonium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:36:39 |
A03CA09 |
pipenzolate and psycholeptics
|
pipenzolate et psycholeptiques
|
WHO |
Active |
2024-05-17 08:37:23 |
A03CA30 |
emepronium and psycholeptics
|
emepronium et psycholeptiques
|
WHO |
Active |
2024-05-17 08:38:05 |
A03CA34 |
propantheline and psycholeptics
|
propanthéline et psycholeptiques
|
WHO |
Active |
2024-05-17 08:38:47 |
A03CB |
Belladonna and derivatives in combination with psycholeptics
|
Belladone et dérivés associés à des psycholeptiques
|
WHO |
Active |
2024-05-17 08:39:29 |
A03CB01 |
methylscopolamine and psycholeptics
|
méthylscopolamine et psycholeptiques
|
WHO |
Active |
2024-05-17 11:00:11 |
A03CB02 |
belladonna total alkaloids and psycholeptics
|
alcaloïdes totaux de la belladone et psycholeptiques
|
WHO |
Active |
2023-02-01 10:01:41 |
A03CB03 |
atropine and psycholeptics
|
atropine et psycholeptiques
|
WHO |
Active |
2024-05-17 08:40:11 |
A03CB04 |
homatropine methylbromide and psycholeptics
|
méthylhomatropine et psycholeptiques
|
WHO |
Active |
2024-05-17 08:40:54 |
A03CB31 |
hyoscyamine and psycholeptics
|
hyoscyamine et psycholeptiques
|
WHO |
Active |
2024-05-17 08:41:36 |
A03DA |
Synthetic anticholinergic agents in combination with analgesics
|
Anticholinergiques de synthèse associés à des analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A03DA02 |
pitofenone and analgesics
|
pitofenone et analgésiques
|
WHO |
Active |
2024-05-17 08:42:19 |
A03DA04 |
ciclonium and analgesics
|
ciclonium et analgésiques
|
WHO |
Active |
2024-05-17 08:43:03 |
A03DA05 |
camylofin and analgesics
|
camylofin et analgésiques
|
WHO |
Active |
2024-05-17 08:43:46 |
A03DA06 |
trospium and analgesics
|
trospium et analgésiques
|
WHO |
Active |
2024-05-17 08:44:28 |
A03DA07 |
tiemonium iodide and analgesics
|
iodure de tiémonium et analgésiques
|
WHO |
Active |
2024-05-17 08:45:10 |
A03DB |
Belladonna and derivatives in combination with analgesics
|
Belladone et dérivés associés à des analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A03DB04 |
butylscopolamine and analgesics
|
butylscopolamine et analgésiques
|
WHO |
Active |
2024-05-17 08:45:52 |
A03FA |
Propulsives
|
Propulsifs
|
WHO |
Active |
2021-06-09 15:34:07 |
A03FA01 |
metoclopramide
|
métoclopramide
|
WHO |
Active |
2023-02-03 11:10:16 |
A03FA02 |
cisapride
|
cisapride
|
WHO |
Active |
2023-02-03 11:11:00 |
A03FA03 |
domperidone
|
Dompéridone
|
WHO |
Active |
2021-06-09 15:34:07 |
A03FA04 |
bromopride
|
bromopride
|
WHO |
Active |
2023-02-03 11:11:44 |
A03FA05 |
alizapride
|
alizapride
|
WHO |
Active |
2023-02-03 11:12:26 |
A03FA06 |
clebopride
|
clébopride
|
WHO |
Active |
2023-02-03 11:13:10 |
A03FA07 |
itopride
|
itropride
|
WHO |
Active |
2023-02-03 11:13:53 |
A03FA08 |
cinitapride
|
cinitapride
|
WHO |
Active |
2023-02-03 11:14:35 |
A03FA09 |
mosapride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AA |
Serotonin (5HT3) antagonists
|
antagonistes de la sérotonine (Antagonistes 5HT3)
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AA01 |
ondansetron
|
Ondansétron
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AA02 |
granisetron
|
Granisétron
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AA03 |
tropisetron
|
tropisetron
|
WHO |
Active |
2023-02-03 11:15:23 |
A04AA04 |
dolasetron
|
dolasétron
|
WHO |
Active |
2023-02-03 11:16:05 |
A04AA05 |
palonosetron
|
Palonosétron
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AA55 |
palonosetron, combinations
|
palonosétron, associations
|
WHO |
Active |
2023-02-03 11:16:48 |
A04AD |
Other antiemetics
|
Autres antiémétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AD01 |
scopolamine
|
scopolamine
|
WHO |
Active |
2023-02-03 11:17:32 |
A04AD02 |
cerium oxalate
|
oxalate de cérium
|
WHO |
Active |
2023-02-03 11:18:15 |
A04AD04 |
chlorobutanol
|
Chlorobutanol
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AD05 |
metopimazine
|
métopimazine
|
WHO |
Active |
2023-02-03 11:19:00 |
A04AD10 |
dronabinol
|
mronabinol
|
WHO |
Active |
2023-02-03 11:19:43 |
A04AD11 |
nabilone
|
Nabilone
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AD12 |
aprepitant
|
Aprépitant
|
WHO |
Active |
2021-06-09 15:34:07 |
A04AD13 |
casopitant
|
casopitant
|
WHO |
Active |
2023-02-03 11:20:27 |
A04AD14 |
rolapitant
|
rolapitant
|
WHO |
Active |
2023-02-03 11:21:13 |
A04AD51 |
scopolamine, combinations
|
scopolamine, associations
|
WHO |
Active |
2023-02-03 11:21:57 |
A04AD54 |
chlorobutanol, combinations
|
chlorobutanol, associations
|
WHO |
Active |
2023-02-03 11:22:40 |
A05AA |
Bile acids and derivatives
|
Acides biliaires et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
A05AA01 |
chenodeoxycholic acid
|
acide chénodésoxycholique
|
WHO |
Active |
2023-02-03 11:23:22 |
A05AA02 |
ursodeoxycholic acid
|
acide ursodésoxycholique
|
WHO |
Active |
2023-02-03 11:24:05 |
A05AA03 |
cholic acid
|
acide cholique
|
WHO |
Active |
2023-02-03 12:36:51 |
A05AA04 |
obeticholic acid
|
Acide obéticholique
|
WHO |
Active |
2021-06-09 15:34:07 |
A05AB |
Preparations for biliary tract therapy
|
Préparations pour le traitement du conduit biliaire
|
WHO |
Active |
2021-06-09 15:34:07 |
A05AB01 |
nicotinyl methylamide
|
nicotinyl méthylamide
|
WHO |
Active |
2023-02-03 12:37:34 |
A05AX |
Other drugs for bile therapy
|
Autres médicaments pour le traitement de la bile
|
WHO |
Active |
2021-06-09 15:34:07 |
A05AX01 |
piprozolin
|
piprozoline
|
WHO |
Active |
2023-02-03 14:06:00 |
A05AX02 |
hymecromone
|
hymécromone
|
WHO |
Active |
2023-02-03 14:06:41 |
A05AX03 |
cyclobutyrol
|
cyclobutyrol
|
WHO |
Active |
2023-02-03 14:07:24 |
A05BA |
Liver therapy
|
Traitement du foie
|
WHO |
Active |
2021-06-09 15:34:07 |
A05BA01 |
arginine glutamate
|
arginine glutamate
|
WHO |
Active |
2023-02-03 14:08:07 |
A05BA03 |
silymarin
|
silymarine
|
WHO |
Active |
2023-02-03 14:08:49 |
A05BA04 |
citiolone
|
citiolone
|
WHO |
Active |
2023-02-03 14:09:32 |
A05BA05 |
epomediol
|
épomédiol
|
WHO |
Active |
2023-02-03 14:10:15 |
A05BA06 |
ornithine oxoglurate
|
ornithine oxoglurate
|
WHO |
Active |
2023-02-03 14:10:58 |
A05BA07 |
tidiacic arginine
|
arginine tidiacique
|
WHO |
Active |
2023-02-03 14:11:42 |
A05BA08 |
glycyrrhizic acid
|
acide glycyrrhizique (glycyrrhizine)
|
WHO |
Active |
2024-05-17 08:46:34 |
A06AA |
Softeners, emollients
|
émollients
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AA01 |
liquid paraffin
|
paraffine liquide
|
WHO |
Active |
2023-02-03 14:13:08 |
A06AA02 |
docusate sodium
|
Docusate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AA51 |
liquid paraffin, combinations
|
associations à base de paraffine liquide
|
WHO |
Active |
2024-05-17 08:47:18 |
A06AB |
Contact laxatives
|
laxatifs de contact
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AB01 |
oxyphenisatine
|
oxyphénisatine
|
WHO |
Active |
2023-02-03 14:14:33 |
A06AB02 |
bisacodyl
|
Bisacodyl
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AB03 |
dantron
|
dantrone
|
WHO |
Active |
2023-02-03 14:15:15 |
A06AB04 |
phenolphthalein
|
phénolphtaléine
|
WHO |
Active |
2023-02-03 14:15:59 |
A06AB05 |
castor oil
|
huile de ricin
|
WHO |
Active |
2023-02-03 14:16:41 |
A06AB06 |
senna glycosides
|
glycosides du Senna
|
WHO |
Active |
2023-02-03 14:17:26 |
A06AB07 |
cascara
|
cascara
|
WHO |
Active |
2023-02-03 14:18:11 |
A06AB08 |
sodium picosulfate
|
Picosulfate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AB09 |
bisoxatin
|
bisoxatine
|
WHO |
Active |
2023-02-03 14:18:55 |
A06AB20 |
contact laxatives in combination
|
laxatifs de contact en association
|
WHO |
Active |
2023-02-03 14:19:40 |
A06AB30 |
contact laxatives in combination with belladonna alkaloids
|
laxatifs de contact en association avec de la belladone alcaloïde
|
WHO |
Active |
2024-05-17 08:47:59 |
A06AB52 |
bisacodyl, combinations
|
bisacodyl, associations
|
WHO |
Active |
2023-02-03 14:21:04 |
A06AB53 |
dantron, combinations
|
dantrone, associations
|
WHO |
Active |
2023-02-03 14:21:49 |
A06AB56 |
senna glycosides, combinations
|
senna glycosides, associations
|
WHO |
Active |
2023-02-03 14:22:33 |
A06AB57 |
cascara, combinations
|
cascara, associations
|
WHO |
Active |
2023-02-03 14:23:15 |
A06AB58 |
sodium picosulfate, combinations
|
picosulfate de sodium, associations
|
WHO |
Active |
2023-02-03 14:23:58 |
A06AC |
Bulk-forming laxatives
|
Laxatifs de lest
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AC01 |
ispaghula (psylla seeds)
|
ispaghula (semences de Psylla)
|
WHO |
Active |
2024-05-17 08:48:42 |
A06AC02 |
ethulose
|
éthulose
|
WHO |
Active |
2023-02-03 14:25:24 |
A06AC03 |
sterculia
|
sterculia
|
WHO |
Active |
2023-02-03 14:26:06 |
A06AC05 |
linseed
|
semence de lin
|
WHO |
Active |
2023-02-03 14:26:49 |
A06AC06 |
methylcellulose
|
Méthylcellulose
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AC07 |
triticum (wheat fibre)
|
triticum (fibre)
|
WHO |
Active |
2024-05-17 08:49:26 |
A06AC08 |
polycarbophil calcium
|
polycarbophil calcium
|
WHO |
Active |
2023-02-03 14:28:15 |
A06AC51 |
ispaghula, combinations
|
ispaghul, associations
|
WHO |
Active |
2023-02-03 14:28:58 |
A06AC53 |
sterculia, combinations
|
sterculia, associations
|
WHO |
Active |
2023-02-03 14:29:40 |
A06AC55 |
linseed, combinations
|
semence de lin, associations
|
WHO |
Active |
2023-02-03 14:30:22 |
A06AD |
Osmotically acting laxatives
|
laxatifs osmotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD01 |
magnesium carbonate
|
Carbonate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD02 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD03 |
magnesium peroxide
|
peroxyde de magnésium
|
WHO |
Active |
2023-02-03 14:31:06 |
A06AD04 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD10 |
mineral salts in combination
|
sels minéraux en association
|
WHO |
Active |
2023-02-03 14:31:49 |
A06AD11 |
lactulose
|
Lactulose
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD12 |
lactitol
|
lactitol
|
WHO |
Active |
2023-02-03 14:32:31 |
A06AD13 |
sodium sulfate
|
Sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD15 |
macrogol
|
Macrogol
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD16 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD17 |
sodium phosphate
|
phosphate trisodique
|
WHO |
Active |
2023-02-03 14:33:13 |
A06AD18 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AD19 |
magnesium citrate
|
citrate de magnésium
|
WHO |
Active |
2023-02-03 14:33:56 |
A06AD21 |
sodium tartrate
|
tartrate de sodium
|
WHO |
Active |
2023-02-03 14:34:39 |
A06AD61 |
lactulose, combinations
|
lactulose, associations
|
WHO |
Active |
2023-02-03 14:35:21 |
A06AD65 |
macrogol, combinations
|
macrogol, associations
|
WHO |
Active |
2023-02-03 14:36:03 |
A06AG |
Enemas
|
Lavements
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AG01 |
sodium phosphate
|
phosphate trisodique
|
WHO |
Active |
2023-02-03 14:36:46 |
A06AG02 |
bisacodyl
|
Bisacodyl
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AG03 |
dantron, incl. combinations
|
dantrone, y compris les associations
|
WHO |
Active |
2023-02-03 14:37:29 |
A06AG04 |
glycerol
|
glycérol
|
WHO |
Active |
2023-02-03 14:38:11 |
A06AG07 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AG10 |
docusate sodium, incl. combinations
|
docusate de sodium, y compris les associations
|
WHO |
Active |
2023-02-03 14:38:52 |
A06AG11 |
sodium lauryl sulfoacetate, incl. combinations
|
sodium lauryl sulfoacetate, y compris les associations
|
WHO |
Active |
2023-02-03 14:39:34 |
A06AG20 |
combinations
|
associations
|
WHO |
Active |
2023-02-03 14:40:17 |
A06AH |
Peripheral opioid receptor antagonists
|
Antagonistes de récepteurs opioïdes périphériques
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AH01 |
methylnaltrexone bromide
|
Bromure de méthylnaltrexone
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AH02 |
alvimopan
|
alvimopan
|
WHO |
Active |
2023-02-03 14:41:00 |
A06AH03 |
naloxegol
|
Naloxégol
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AH04 |
naloxone
|
Naloxone
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AX |
Other drugs for constipation
|
Autres laxatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AX01 |
glycerol
|
glycérol
|
WHO |
Active |
2023-02-03 14:41:45 |
A06AX02 |
carbon dioxide producing drugs
|
médicaments producteurs de dioxyde de carbone
|
WHO |
Active |
2024-05-17 08:50:09 |
A06AX03 |
lubiprostone
|
lubiprostone
|
WHO |
Active |
2023-02-03 14:43:10 |
A06AX04 |
linaclotide
|
Linaclotide
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AX05 |
prucalopride
|
Prucalopride
|
WHO |
Active |
2021-06-09 15:34:07 |
A06AX06 |
tegaserod
|
tégasérod
|
WHO |
Active |
2023-02-03 14:43:53 |
A06AX07 |
plecanatide
|
Plécanatide
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA01 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA02 |
nystatin
|
Nystatine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA03 |
natamycin
|
natamycine
|
WHO |
Active |
2023-02-03 14:44:35 |
A07AA04 |
streptomycin
|
Streptomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA05 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA06 |
paromomycin
|
Paromomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA07 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA08 |
kanamycin
|
kanamycine
|
WHO |
Active |
2023-02-03 14:45:17 |
A07AA09 |
vancomycin
|
Vancomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA10 |
colistin
|
Colistine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA11 |
rifaximin
|
RIFAXIMINE
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA12 |
fidaxomicin
|
Fidaxomicine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA13 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AA51 |
neomycin, combinations
|
néomycine, associations
|
WHO |
Active |
2023-02-03 14:46:00 |
A07AA54 |
streptomycin, combinations
|
streptomycine, associations
|
WHO |
Active |
2023-02-03 14:46:41 |
A07AB |
Sulfonamides
|
Sulfamidés
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AB02 |
phthalylsulfathiazole
|
phtalylsulfathiazole
|
WHO |
Active |
2023-02-03 14:47:23 |
A07AB03 |
sulfaguanidine
|
Sulfaguanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AB04 |
succinylsulfathiazole
|
Succinylsulfathiazol
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AC |
Imidazole derivatives
|
Dérivés de l'imidazole
|
WHO |
Active |
2021-10-25 19:07:10 |
A07AC01 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AX |
Other intestinal antiinfectives
|
Autres antiseptiques intestinaux
|
WHO |
Active |
2021-06-09 15:34:07 |
A07AX01 |
broxyquinoline
|
broxyquinoline
|
WHO |
Active |
2023-02-03 14:48:06 |
A07AX02 |
acetarsol
|
acétarsol
|
WHO |
Active |
2023-02-03 14:48:50 |
A07AX03 |
nifuroxazide
|
nifuroxazide
|
WHO |
Active |
2023-02-03 14:49:33 |
A07AX04 |
nifurzide
|
nifurzide
|
WHO |
Active |
2023-02-03 14:50:16 |
A07BA |
Charcoal preparations
|
Préparations à base de charbon activé
|
WHO |
Active |
2021-06-09 15:34:07 |
A07BA01 |
medicinal charcoal
|
charbon médicinal
|
WHO |
Active |
2023-02-03 14:51:00 |
A07BA51 |
medicinal charcoal, combinations
|
charbon médicinal, associations
|
WHO |
Active |
2023-02-03 14:51:42 |
A07BC |
Other intestinal adsorbents
|
Autres absorbants intestinaux
|
WHO |
Active |
2021-06-09 15:34:07 |
A07BC01 |
pectin
|
Pectine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07BC02 |
kaolin
|
Kaolin
|
WHO |
Active |
2021-06-09 15:34:07 |
A07BC03 |
crospovidone
|
crospovidone
|
WHO |
Active |
2023-02-03 14:52:24 |
A07BC04 |
attapulgite
|
attapulgite
|
WHO |
Active |
2023-02-03 14:53:07 |
A07BC05 |
diosmectite
|
diosmectite
|
WHO |
Active |
2023-02-03 14:53:50 |
A07BC30 |
combinations
|
associations
|
WHO |
Active |
2023-02-03 14:54:34 |
A07BC54 |
attapulgite, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA |
Antipropulsives
|
Antipropulsivants
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA01 |
diphenoxylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA02 |
opium
|
Opium
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA03 |
loperamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA04 |
difenoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA05 |
loperamide oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA06 |
eluxadoline
|
ELUXADOLINE
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA52 |
morphine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07DA53 |
loperamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA |
Corticosteroids acting locally
|
Corticostéroïdes locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA01 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA02 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA03 |
prednisone
|
Prednisone
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA04 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA05 |
tixocortol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA06 |
budesonide
|
Budésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EA07 |
beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EB |
Antiallergic agents, excl. corticosteroids
|
Antiallergiques, à l'exclusion des corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EB01 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EC |
Aminosalicylic acid and similar agents
|
Acide aminosalicylique et agents apparenté
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EC01 |
sulfasalazine
|
Sulfasalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EC02 |
mesalazine
|
Mésalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EC03 |
olsalazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07EC04 |
balsalazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07FA |
Antidiarrheal microorganisms
|
Micro-organismes antidiarrhéiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A07FA01 |
lactic acid producing organisms
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07FA02 |
saccharomyces boulardii
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07FA51 |
lactic acid producing organisms, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA |
Other antidiarrheals
|
Autres antidiarrhéiques
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA01 |
albumin tannate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA02 |
ceratonia
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA04 |
racecadotril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA06 |
crofelemer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A07XA51 |
albumin tannate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA |
Centrally acting antiobesity products
|
Produits antiobésité d'action centrale
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA01 |
phentermine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA02 |
fenfluramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA03 |
amfepramone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA04 |
dexfenfluramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA05 |
mazindol
|
Mazindol
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA06 |
etilamfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA07 |
cathine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA08 |
clobenzorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA09 |
mefenorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA10 |
sibutramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA11 |
lorcaserin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA56 |
ephedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AA62 |
bupropion and naltrexone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AB |
Peripherally acting antiobesity products
|
Produits antiobésité d'action périphérique
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AB01 |
orlistat
|
Orlistat
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AX |
Other antiobesity drugs
|
Autres médicaments anti obésité
|
WHO |
Active |
2021-06-09 15:34:07 |
A08AX01 |
rimonabant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA |
Enzyme preparations
|
Enzyme - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA01 |
diastase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA02 |
multienzymes (lipase, protease etc.)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA03 |
pepsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AA04 |
tilactase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB |
Acid preparations
|
Acide - préparations
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB01 |
glutamic acid hydrochloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB02 |
betaine hydrochloride
|
Chlorhydrate de bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB03 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AB04 |
citric acid
|
Acide citrique
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AC |
Enzyme and acid preparations, combinations
|
Enzyme et acide - préparations en combinaiso
|
WHO |
Active |
2021-10-25 19:07:13 |
A09AC01 |
pepsin and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A09AC02 |
multienzymes and acid preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB |
Insulins and analogues for injection, fast-acting
|
Insulines et analogues pour injection, à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB06 |
insulin glulisine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AB30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC |
Insulins and analogues for injection, intermediate-acting
|
Insulines et analogues pour injection, à action intermédiaire
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD |
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
|
Insulines et analogues pour injection, à action intermédiaire ou longue combinées avec insulines à action rapide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD04 |
insulin lispro
|
Insuline lispro
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD05 |
insulin aspart
|
Insuline asparte
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD06 |
insulin degludec and insulin aspart
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AD30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE |
Insulins and analogues for injection, long-acting
|
Insulines et analogues pour injection, à action lent
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE02 |
insulin (beef)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE03 |
insulin (pork)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE04 |
insulin glargine
|
Insuline glargine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE05 |
insulin detemir
|
Insuline détemir
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE06 |
insulin degludec
|
Insuline dégludec
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE54 |
insulin glargine and lixisenatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AE56 |
insulin degludec and liraglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AF |
Insulins and analogues for inhalation
|
Insulines et analogues pour inhalation
|
WHO |
Active |
2021-06-09 15:34:07 |
A10AF01 |
insulin (human)
|
Insuline (humaine)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA |
Biguanides
|
Biguanides
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA01 |
phenformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA02 |
metformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BA03 |
buformin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB |
Sulfonylureas
|
Sulfonylurées
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB01 |
glibenclamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB02 |
chlorpropamide
|
Chlorpropamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB03 |
tolbutamide
|
Tolbutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB04 |
glibornuride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB05 |
tolazamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB06 |
carbutamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB07 |
glipizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB08 |
gliquidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB09 |
gliclazide
|
Gliclazide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB10 |
metahexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB11 |
glisoxepide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB12 |
glimepiride
|
Glimépiride
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BB31 |
acetohexamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BC |
Sulfonamides (heterocyclic)
|
Sulfonamides (hétérocycliques)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BC01 |
glymidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD |
Combinations of oral blood glucose lowering drugs
|
Associations de médicaments oraux réduisant la glycémie
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD01 |
phenformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD02 |
metformin and sulfonylureas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD03 |
metformin and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD04 |
glimepiride and rosiglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD05 |
metformin and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD06 |
glimepiride and pioglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD07 |
metformin and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD08 |
metformin and vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD09 |
pioglitazone and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD10 |
metformin and saxagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD11 |
metformin and linagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD12 |
pioglitazone and sitagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD13 |
metformin and alogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD14 |
metformin and repaglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD15 |
metformin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD16 |
metformin and canagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD17 |
metformin and acarbose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD18 |
metformin and gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD19 |
linagliptin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD20 |
metformin and empagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD21 |
saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD22 |
metformin and evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD23 |
metformin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD24 |
sitagliptin and ertugliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BD25 |
metformin, saxagliptin and dapagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF |
Alpha glucosidase inhibitors
|
Inhibteurs d'alpha-glycosidase
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF01 |
acarbose
|
Acarbose
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF02 |
miglitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BF03 |
voglibose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG |
Thiazolidinediones
|
Thiazolidinédiones
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG01 |
troglitazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG02 |
rosiglitazone
|
Rosiglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BG03 |
pioglitazone
|
Pioglitazone
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH |
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Inhibiteurs de la dipeptidyl peptidase-4 (DPP-4
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH01 |
sitagliptin
|
Sitagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH02 |
vildagliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH03 |
saxagliptin
|
Saxagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH04 |
alogliptin
|
Alogliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH05 |
linagliptin
|
Linagliptine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH06 |
gemigliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH07 |
evogliptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH51 |
sitagliptin and simvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BH52 |
gemigliptin and rosuvastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ |
Glucagon-like peptide-1 (GLP-1) analogues
|
Analogues du Glucagon-like peptide-1 (GLP-1)
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ01 |
exenatide
|
Exénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ02 |
liraglutide
|
Liraglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ03 |
lixisenatide
|
Lixisénatide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ04 |
albiglutide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ05 |
dulaglutide
|
Dulaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BJ06 |
semaglutide
|
Sémaglutide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK |
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
|
Inhibiteurs du cotransporteur sodium-glucose de type 2
|
WHO |
Active |
2023-02-24 14:56:32 |
A10BK01 |
dapagliflozin
|
Dapagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK02 |
canagliflozin
|
Canagliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK03 |
empagliflozin
|
EMPAGLIFLOZINE
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK04 |
ertugliflozin
|
Ertugliflozine
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK05 |
ipragliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BK06 |
sotagliflozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX |
Other blood glucose lowering drugs, excl. insulins
|
Autres médicament réduisant la glycémie, autres que les insulines
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX01 |
guar gum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX02 |
repaglinide
|
Répaglinide
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX03 |
nateglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX05 |
pramlintide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX06 |
benfluorex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10BX08 |
mitiglinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A10XA |
Aldose reductase inhibitors
|
Inhibiteurs d'aldose réductase
|
WHO |
Active |
2021-06-09 15:34:07 |
A10XA01 |
tolrestat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA |
Multivitamins with minerals
|
Multivitamines et minéraux
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA01 |
multivitamins and iron
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA02 |
multivitamins and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA03 |
multivitamins and other minerals, incl. combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11AA04 |
multivitamins and trace elements
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA |
Vitamin A, plain
|
Vitamine A, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA01 |
retinol (vit A)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CA02 |
betacarotene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC |
Vitamin D and analogues
|
Vitamine D et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC01 |
ergocalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC02 |
dihydrotachysterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC03 |
alfacalcidol
|
Alfacalcidol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC04 |
calcitriol
|
Calcitriol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC05 |
colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC06 |
calcifediol
|
Calcifédiol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11CC55 |
colecalciferol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA |
Vitamin B1, plain
|
Vitamine B1, non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA01 |
thiamine (vit B1)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA02 |
sulbutiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11DA03 |
benfotiamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GA |
Ascorbic acid (vitamin C), plain
|
Acide ascorbique (vitamine C), non associée
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GA01 |
ascorbic acid (vit C)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GB |
Ascorbic acid (vitamin C), combinations
|
Acide ascorbique (vitamine C), associations
|
WHO |
Active |
2021-06-09 15:34:07 |
A11GB01 |
ascorbic acid (vit C) and calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA |
Other plain vitamin preparations
|
Autres préparations à base de vitamines seules
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA01 |
nicotinamide
|
Nicotinamide
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA02 |
pyridoxine (vit B6)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA03 |
tocopherol (vit E)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA04 |
riboflavin (vit B2)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA05 |
biotin
|
Biotine
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA06 |
pyridoxal phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA07 |
inositol
|
Inositol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA08 |
tocofersolan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA30 |
dexpanthenol
|
Dexpanthénol
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA31 |
calcium pantothenate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A11HA32 |
pantethine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA |
Calcium
|
Calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA01 |
calcium phosphate
|
Phosphate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA02 |
calcium glubionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA03 |
calcium gluconate
|
Gluconate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA04 |
calcium carbonate
|
Carbonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA05 |
calcium lactate
|
Lactate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA06 |
calcium lactate gluconate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA08 |
calcium glycerylphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA10 |
calcium glucoheptonate
|
Glucoheptonate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA11 |
calcium pangamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA13 |
calcium citrate
|
Citrate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA20 |
calcium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12AA30 |
calcium laevulate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA |
Potassium
|
Potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA02 |
potassium citrate
|
Citrate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA03 |
potassium hydrogentartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA04 |
potassium hydrogencarbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA05 |
potassium gluconate
|
Gluconate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA30 |
potassium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12BA51 |
potassium chloride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA |
Sodium
|
Sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CA02 |
sodium sulfate
|
Sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB |
Zinc
|
Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB01 |
zinc sulfate
|
Sulfate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CB02 |
zinc gluconate
|
Gluconate de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC |
Magnesium
|
Magnésium
|
WHO |
Active |
2021-10-25 19:07:15 |
A12CC01 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC02 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC03 |
magnesium gluconate
|
Gluconate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC04 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC05 |
magnesium aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC06 |
magnesium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC07 |
magnesium levulinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC08 |
magnesium pidolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC09 |
magnesium orotate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC10 |
magnesium oxide
|
Oxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CC30 |
magnesium (different salts in combination)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD |
Fluoride
|
Fluorure
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD01 |
sodium fluoride
|
Fluorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD02 |
sodium monofluorophosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CD51 |
fluoride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE |
Selenium
|
Sélénium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE01 |
sodium selenate
|
Sélénate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A12CE02 |
sodium selenite
|
Sélénite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA |
Androstan derivatives
|
Dérivés de l'androstane
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA01 |
androstanolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA02 |
stanozolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA03 |
metandienone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA04 |
metenolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA05 |
oxymetholone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA06 |
quinbolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA07 |
prasterone
|
Prastérone
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA08 |
oxandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AA09 |
norethandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB |
Estren derivatives
|
Dérivés de l'estrane
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB01 |
nandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB02 |
ethylestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A14AB03 |
oxabolone cipionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA |
Amino acids and derivatives
|
Acides aminés et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA01 |
levocarnitine
|
Lévocarnitine
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA02 |
ademetionine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA03 |
glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA04 |
mercaptamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA05 |
carglumic acid
|
Acide carglumique
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA06 |
betaine
|
Bétaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AA07 |
metreleptin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB01 |
alglucerase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB02 |
imiglucerase
|
Imiglucérase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB03 |
agalsidase alfa
|
Agalsidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB04 |
agalsidase beta
|
Agalsidase bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB05 |
laronidase
|
Laronidase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB06 |
sacrosidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB07 |
alglucosidase alfa
|
Alglucosidase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB08 |
galsulfase
|
Galsulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB09 |
idursulfase
|
Idursulfase
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB10 |
velaglucerase alfa
|
Vélaglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB11 |
taliglucerase alfa
|
Taliglucérase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB12 |
elosulfase alfa
|
Élosulfase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB13 |
asfotase alfa
|
ASFOTASE ALFA
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB14 |
sebelipase alfa
|
Sébélipase alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB15 |
velmanase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB16 |
idursulfase beta
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB17 |
cerliponase alfa
|
Cerliponase Alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB18 |
vestronidase alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AB19 |
pegvaliase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX |
Various alimentary tract and metabolism products
|
Produits divers pour le tube digestif et le métabolisme
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX01 |
thioctic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX02 |
anethole trithione
|
Anéthole trithione
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX03 |
sodium phenylbutyrate
|
Phénylbutyrate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX04 |
nitisinone
|
Nitisinone
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX05 |
zinc acetate
|
Acétate de Zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX06 |
miglustat
|
Miglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX07 |
sapropterin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX08 |
teduglutide
|
TÉDUGLUTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX09 |
glycerol phenylbutyrate
|
Phénylbutyrate de glycérol
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX10 |
eliglustat
|
Éliglustat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX11 |
sodium benzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX12 |
trientine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX13 |
uridine triacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX14 |
migalastat
|
Migalastat
|
WHO |
Active |
2021-06-09 15:34:07 |
A16AX15 |
telotristat
|
Télotristat
|
WHO |
Active |
2024-11-15 11:30:48 |
B01AA |
Vitamin K antagonists
|
Antivitamines K
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA01 |
dicoumarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA02 |
phenindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA03 |
warfarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA04 |
phenprocoumon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA07 |
acenocoumarol
|
Acénocoumarol
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA08 |
ethyl biscoumacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA09 |
clorindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA10 |
diphenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA11 |
tioclomarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AA12 |
fluindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB |
Heparin group
|
Groupe de l'héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB01 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB02 |
antithrombin III
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB04 |
dalteparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB05 |
Enoxaparin
|
Enoxaparine
|
WHO |
Active |
2021-10-01 12:48:37 |
B01AB06 |
nadroparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB07 |
parnaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB08 |
reviparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB09 |
danaparoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB10 |
tinzaparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB11 |
sulodexide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB12 |
bemiparin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AB51 |
heparin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC |
Platelet aggregation inhibitors excl. heparin
|
Inhibiteurs de l'agrégation plaquettaire, héparine exclue
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC01 |
ditazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC02 |
cloricromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC03 |
picotamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC04 |
clopidogrel
|
Clopidogrel
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC05 |
ticlopidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC06 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC07 |
dipyridamole
|
Dipyridamole
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC08 |
carbasalate calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC09 |
epoprostenol
|
Époprosténol
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC10 |
indobufen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC11 |
iloprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC13 |
abciximab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC15 |
aloxiprin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC16 |
eptifibatide
|
Eptifibatide
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC17 |
tirofiban
|
Tirofiban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC18 |
triflusal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC19 |
beraprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC21 |
treprostinil
|
Tréprostinil
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC22 |
prasugrel
|
Prasugrel
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC23 |
cilostazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC24 |
ticagrelor
|
Ticagrélor
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC25 |
cangrelor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC26 |
vorapaxar
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC27 |
selexipag
|
Sélexipag
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AC56 |
acetylsalicylic acid, combinations with proton pump inhibitors
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD01 |
streptokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD02 |
alteplase
|
Altéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD03 |
anistreplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD04 |
urokinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD05 |
fibrinolysin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD06 |
brinase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD07 |
reteplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD08 |
saruplase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD09 |
ancrod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD10 |
drotrecogin alfa (activated)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD11 |
tenecteplase
|
Ténectéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AD12 |
protein C
|
Protéine c
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE |
Direct thrombin inhibitors
|
Inhibiteurs directs de la thrombine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE01 |
desirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE02 |
lepirudin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE03 |
argatroban
|
Argatroban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE04 |
melagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE05 |
ximelagatran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE06 |
bivalirudin
|
Bivalirudine
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AE07 |
dabigatran etexilate
|
Dabigatran étexilate
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF |
Direct factor Xa inhibitors
|
Inhibiteurs directs du facteur Xa
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF01 |
rivaroxaban
|
Rivaroxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF02 |
apixaban
|
Apixaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF03 |
edoxaban
|
Édoxaban
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AF04 |
betrixaban
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX |
Other antithrombotic agents
|
Autres antithrombotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX01 |
defibrotide
|
DÉFIBROTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX04 |
dermatan sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX05 |
fondaparinux
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B01AX07 |
caplacizumab
|
Caplacizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA01 |
aminocaproic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA02 |
tranexamic acid
|
Acide tranexamique
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AA03 |
aminomethylbenzoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB |
Proteinase inhibitors
|
Inhibiteurs de protéinases
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB01 |
aprotinin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB02 |
alfa1 antitrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB04 |
camostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02AB05 |
ulinastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA |
Vitamin K
|
Vitamine K
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA01 |
phytomenadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BA02 |
menadione
|
Ménadione
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BB |
Fibrinogen
|
Fibrinogène
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BB01 |
fibrinogen, human
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC |
Local hemostatics
|
Hémostatiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC01 |
absorbable gelatin sponge
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC02 |
oxidized cellulose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC03 |
tetragalacturonic acid hydroxymethylester
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC05 |
adrenalone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC06 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC07 |
collagen
|
Collagène
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC08 |
calcium alginate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC09 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BC30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD |
Blood coagulation factors
|
Facteurs de la coagulation sanguine
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD01 |
coagulation factor IX, II, VII and X in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD02 |
coagulation factor VIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD03 |
factor VIII inhibitor bypassing activity
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD04 |
coagulation factor IX
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD05 |
coagulation factor VII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD06 |
von Willebrand factor and coagulation factor VIII in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD07 |
coagulation factor XIII
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD08 |
coagulation factor VIIa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD10 |
von Willebrand factor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD11 |
catridecacog
|
Catridecacog
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD13 |
coagulation factor X
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD14 |
susoctocog alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BD30 |
thrombin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX |
Other systemic hemostatics
|
Autres hémostatiques systémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX01 |
etamsylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX02 |
carbazochrome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX03 |
batroxobin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX04 |
romiplostim
|
Romiplostim
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX05 |
eltrombopag
|
Eltrombopag
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX06 |
emicizumab
|
Émicizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX07 |
lusutrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX08 |
avatrombopag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B02BX09 |
fostamatinib
|
Fostamatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA |
Iron bivalent, oral preparations
|
Fer bivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA01 |
ferrous glycine sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA03 |
ferrous gluconate
|
Gluconate de fer
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA04 |
ferrous carbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA05 |
ferrous chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA06 |
ferrous succinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA07 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA08 |
ferrous tartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA09 |
ferrous aspartate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA10 |
ferrous ascorbate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA11 |
ferrous iodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AA12 |
ferrous sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB |
Iron trivalent, oral preparations
|
Fer trivalent, préparations orales
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB01 |
ferric sodium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB02 |
saccharated iron oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB03 |
sodium feredetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB04 |
ferric hydroxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB05 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB07 |
chondroitin sulfate-iron complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB08 |
ferric acetyl transferrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB09 |
ferric proteinsuccinylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AB10 |
ferric maltol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD |
Iron in combination with folic acid
|
Fer en association avec l'acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD01 |
ferrous amino acid complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD02 |
ferrous fumarate
|
Fumarate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD03 |
ferrous sulfate
|
Sulfate ferreux
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AD04 |
ferric oxide polymaltose complexes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE |
Iron in other combinations
|
Fer dans d'autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE01 |
iron, vitamin B12 and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE02 |
iron, multivitamins and folic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE03 |
iron and multivitamins
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE04 |
iron, multivitamins and minerals
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03AE10 |
various combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA |
Vitamin B12 (cyanocobalamin and analogues)
|
Vitamine B12 (cyanocobalamine et dérivés)
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA01 |
cyanocobalamin
|
Cyanocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA02 |
cyanocobalamin tannin complex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA03 |
hydroxocobalamin
|
Hydroxocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA04 |
cobamamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA05 |
mecobalamin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA51 |
cyanocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BA53 |
hydroxocobalamin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB |
Folic acid and derivatives
|
Acide folique et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB01 |
folic acid
|
Acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
B03BB51 |
folic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA |
Other antianemic preparations
|
Autres préparations anti-anémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA01 |
erythropoietin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA02 |
darbepoetin alfa
|
Darbépoétine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA03 |
methoxy polyethylene glycol-epoetin beta
|
Méthoxy polyéthylèneglycol-époétine bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA04 |
peginesatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA05 |
roxadustat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B03XA06 |
luspatercept
|
Luspatercept
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA |
Blood substitutes and plasma protein fractions
|
Substituts du sang et fractions protéiques plasmatiques
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA01 |
albumin
|
Albumine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA02 |
other plasma protein fractions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA03 |
fluorocarbon blood substitutes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA05 |
dextran
|
Dextran
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA06 |
gelatin agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA07 |
hydroxyethylstarch
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA08 |
hemoglobin crosfumaril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA09 |
hemoglobin raffimer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AA10 |
hemoglobin glutamer (bovine)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX |
Other blood products
|
Autres dérivés du sang
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX02 |
thrombocytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX03 |
blood plasma
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05AX04 |
stem cells from umbilical cord blood
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA |
Solutions for parenteral nutrition
|
Solutions pour nutrition parentérale
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA01 |
amino acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA02 |
fat emulsions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA03 |
carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA04 |
protein hydrolysates
|
Hydrolysat protéique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB |
Solutions affecting the electrolyte balance
|
Solutions modifiant le bilan électrolytique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB01 |
electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB02 |
electrolytes with carbohydrates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB03 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BB04 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC |
Solutions producing osmotic diuresis
|
Solutions produisant une diurèse osmotique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC01 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05BC02 |
carbamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA |
Antiinfectives
|
Anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA01 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA02 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA03 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA04 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA05 |
taurolidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA06 |
mandelic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA07 |
noxytiolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA08 |
ethacridine lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA09 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB |
Salt solutions
|
Solutions salines
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB01 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB02 |
sodium citrate
|
Citrate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB03 |
magnesium citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB04 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CB10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX |
Other irrigating solutions
|
Autres solutions d'irrigation
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX01 |
glucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX02 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX03 |
glycine
|
Glycine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX04 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
B05CX10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA |
Electrolyte solutions
|
Solutions d'électrolytes
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA01 |
potassium chloride
|
Chlorure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA02 |
sodium bicarbonate
|
Bicarbonate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA03 |
sodium chloride
|
Chlorure de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA04 |
ammonium chloride
|
Chlorure d'ammonium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA05 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA06 |
potassium phosphate, incl. combinations with other potassium salts
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA07 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA08 |
sodium acetate
|
Acétate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA09 |
sodium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA10 |
magnesium phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA11 |
magnesium chloride
|
Chlorure de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA12 |
zinc chloride
|
Chlorure de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA13 |
hydrochloric acid
|
Acide chlorhydrique
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA14 |
sodium glycerophosphate
|
Glycérophosphate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA15 |
potassium lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA16 |
cardioplegia solutions
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA17 |
potassium acetate
|
Acétate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA30 |
combinations of electrolytes
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XA31 |
electrolytes in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB |
Amino acids
|
Acides aminés
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB01 |
arginine hydrochloride
|
Chlorhydrate d'arginine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB02 |
alanyl glutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XB03 |
lysine
|
Lysine
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XX |
Other i.v. solution additives
|
Autres additifs pour solutions intraveineuses
|
WHO |
Active |
2021-06-09 15:34:07 |
B05XX02 |
trometamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA02 |
fibrinolysin and desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA03 |
hyaluronidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA04 |
chymotrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA07 |
trypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA10 |
desoxyribonuclease
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AA55 |
streptokinase, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AB |
Heme products
|
Autres médicaments dérivés de l'hème
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AB01 |
hemin
|
Hémine
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC |
Drugs used in hereditary angioedema
|
Autres médicaments utilisés dans l'angio-œdème héréditaire
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC01 |
C1-inhibitor, plasma derived
|
Inhibiteurs C1, dérivés du plasma
|
WHO |
Active |
2021-10-01 12:48:41 |
B06AC02 |
icatibant
|
ICATIBANT
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC03 |
ecallantide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC04 |
conestat alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AC05 |
lanadelumab
|
Lanadélumab
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AX |
Other hematological agents
|
Not found
|
WHO |
Active |
2021-06-09 15:34:07 |
B06AX01 |
crizanlizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA |
Digitalis glycosides
|
Glycosides de la Digitale
|
WHO |
Active |
2024-05-17 08:50:50 |
C01AA01 |
acetyldigitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA02 |
acetyldigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA03 |
digitalis leaves
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA04 |
digitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA05 |
digoxin
|
Digoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA06 |
lanatoside C
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA07 |
deslanoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA08 |
metildigoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA09 |
gitoformate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AA52 |
acetyldigoxin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB |
Scilla glycosides
|
Glycosides de la scille
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB01 |
proscillaridin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AB51 |
proscillaridin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC |
Strophanthus glycosides
|
Glycosides du Strophantus
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC01 |
g-strophanthin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AC03 |
cymarin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AX |
Other cardiac glycosides
|
Autres glycosides cardiotoniques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01AX02 |
peruvoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA |
Antiarrhythmics, class Ia
|
Antiarythmiques, classe Ia
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA01 |
quinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA02 |
procainamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA03 |
disopyramide
|
Disopyramide
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA04 |
sparteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA05 |
ajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA08 |
prajmaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA12 |
lorajmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA13 |
hydroquinidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA51 |
quinidine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BA71 |
quinidine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB |
Antiarrhythmics, class Ib
|
Antiarythmiques, classe I
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB02 |
mexiletine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB03 |
tocainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BB04 |
aprindine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC |
Antiarrhythmics, class Ic
|
Antiarythmiques, classe
|
WHO |
Active |
2021-06-11 15:22:32 |
C01BC03 |
propafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC04 |
flecainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC07 |
lorcainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC08 |
encainide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BC09 |
ethacizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD |
Antiarrhythmics, class III
|
Antiarythmiques, classe III
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD01 |
amiodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD02 |
bretylium tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD03 |
bunaftine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD04 |
dofetilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD05 |
ibutilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD06 |
tedisamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BD07 |
dronedarone
|
Dronédarone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG |
Other antiarrhythmics, class I and III
|
Autres antiarythmiques de classe I et III
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG01 |
moracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG07 |
cibenzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01BG11 |
vernakalant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA |
Adrenergic and dopaminergic agents
|
Agents adrénergiques et dopaminergique
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA01 |
etilefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA02 |
isoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA03 |
norepinephrine
|
Norépinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA04 |
dopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA05 |
norfenefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA06 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA07 |
dobutamine
|
Dobutamine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA08 |
oxedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA09 |
metaraminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA10 |
methoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA11 |
mephentermine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA12 |
dimetofrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA13 |
prenalterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA14 |
dopexamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA15 |
gepefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA16 |
ibopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA17 |
midodrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA18 |
octopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA19 |
fenoldopam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA21 |
cafedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA22 |
arbutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA23 |
theodrenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA24 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA25 |
amezinium metilsulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA26 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA27 |
droxidopa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE |
Phosphodiesterase inhibitors
|
Inhibiteurs de la phosphodiestéra
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE01 |
amrinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE02 |
milrinone
|
Milrinone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE03 |
enoximone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CE04 |
bucladesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX |
Other cardiac stimulants
|
Autres stimulants cardiaque
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX06 |
angiotensinamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX07 |
xamoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX08 |
levosimendan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01CX09 |
angiotensin II
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA |
Organic nitrates
|
Nitrates organiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA02 |
glyceryl trinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA04 |
methylpropylpropanediol dinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA05 |
pentaerithrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA07 |
propatylnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA08 |
isosorbide dinitrate
|
Dinitrate d'isosorbide
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA09 |
trolnitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA13 |
eritrityl tetranitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA14 |
isosorbide mononitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA20 |
organic nitrates in combination
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA38 |
tenitramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA52 |
glyceryl trinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA55 |
pentaerithrityl tetranitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA58 |
isosorbide dinitrate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DA70 |
organic nitrates in combination with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DB |
Quinolone vasodilators
|
Vasodilateurs à base de quinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DB01 |
flosequinan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX |
Other vasodilators used in cardiac diseases
|
Autres vasodilateurs utilisés dans des maladies cardiaques
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX01 |
itramin tosilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX02 |
prenylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX03 |
oxyfedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX04 |
benziodarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX05 |
carbocromen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX06 |
hexobendine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX07 |
etafenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX08 |
heptaminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX09 |
imolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX10 |
dilazep
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX11 |
trapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX12 |
molsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX13 |
efloxate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX14 |
cinepazet
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX15 |
cloridarol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX16 |
nicorandil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX18 |
linsidomine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX19 |
nesiritide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX21 |
serelaxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX52 |
prenylamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01DX53 |
oxyfedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EA |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EA01 |
alprostadil
|
Alprostadil
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB |
Other cardiac preparations
|
Autres médicaments pour le cœur
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB02 |
camphora
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB03 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB04 |
crataegus glycosides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB05 |
creatinolfosfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB06 |
fosfocreatine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB07 |
fructose 1,6-diphosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB09 |
ubidecarenone
|
Ubidécarénone
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB10 |
adenosine
|
Adénosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB11 |
tiracizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB13 |
acadesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB15 |
trimetazidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB16 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB17 |
ivabradine
|
Ivabradine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB18 |
ranolazine
|
Ranolazine
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB21 |
regadenoson
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB22 |
meldonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C01EB23 |
tiazotic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA |
Rauwolfia alkaloids
|
Alcaloïdes du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA01 |
rescinnamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA02 |
reserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA04 |
rauwolfia alkaloids, whole root
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA05 |
deserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA06 |
methoserpidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA07 |
bietaserpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AA52 |
reserpine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB |
Methyldopa
|
Méthyldopa
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB01 |
methyldopa (levorotatory)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AB02 |
methyldopa (racemic)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC |
Imidazoline receptor agonists
|
Antagonistes des récepteurs de l'imidazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC01 |
clonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC02 |
guanfacine
|
Guanfacine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC04 |
tolonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC05 |
moxonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02AC06 |
rilmenidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BA |
Sulfonium derivatives
|
Dérivés du Sulfonium
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BA01 |
trimetaphan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BB |
Secondary and tertiary amines
|
Amines secondaires et tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C02BB01 |
mecamylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA |
Alpha-adrenoreceptor antagonists
|
Alpha-bloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA01 |
prazosin
|
Prazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA02 |
indoramin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA03 |
trimazosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA04 |
doxazosin
|
Doxazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CA06 |
urapidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC01 |
betanidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC02 |
guanethidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC03 |
guanoxan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC04 |
debrisoquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC05 |
guanoclor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC06 |
guanazodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02CC07 |
guanoxabenz
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DA |
Thiazide derivatives
|
Dérivés du thiazide
|
WHO |
Active |
2024-05-17 08:51:31 |
C02DA01 |
diazoxide
|
Diazoxide
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB |
Hydrazinophthalazine derivatives
|
Dérivés de l'hydrazinophtalazine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB01 |
dihydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB02 |
hydralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB03 |
endralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DB04 |
cadralazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DC |
Pyrimidine derivatives
|
Dérivés de la pyrimidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DC01 |
minoxidil
|
Minoxidil
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DD |
Nitroferricyanide derivatives
|
Dérivés du nitroferricyanure
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DD01 |
nitroprusside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DG |
Guanidine derivatives
|
Dérivés de la guanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02DG01 |
pinacidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KA |
Alkaloids, excl. rauwolfia
|
Alcaloïdes, autres que ceux du Rauwolfia
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KA01 |
veratrum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KB |
Tyrosine hydroxylase inhibitors
|
Inhibiteurs de la tyrosine hydroxylase
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KB01 |
metirosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KC |
MAO inhibitors
|
IMAO, inhibiteurs de la monoamino oxydase
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KC01 |
pargyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KD |
Serotonin antagonists
|
Antagonistes de la sérotonine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KD01 |
ketanserin
|
Kétansérine
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX |
Antihypertensives for pulmonary arterial hypertension
|
Antihypertenseurs pour l'hypertension artérielle pulmonaire
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX01 |
bosentan
|
Bosentan
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX02 |
ambrisentan
|
Ambrisentan
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX03 |
sitaxentan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX04 |
macitentan
|
MACITENTAN
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX05 |
riociguat
|
RIOCIGUAT
|
WHO |
Active |
2021-06-09 15:34:07 |
C02KX52 |
ambrisentan and tadalafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA |
Rauwolfia alkaloids and diuretics in combination
|
Associations d'alcaloïdes du Rauwolfia et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA01 |
reserpine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA02 |
rescinnamine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA03 |
deserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA04 |
methoserpidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA09 |
syrosingopine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA50 |
combination of rauwolfia alkaloids and diuretics incl. other combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA51 |
reserpine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA52 |
rescinnamine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LA71 |
reserpine and diuretics, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LB |
Methyldopa and diuretics in combination
|
Associations de méthyldopa et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LB01 |
methyldopa (levorotatory) and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC |
Imidazoline receptor agonists in combination with diuretics
|
Associations d'antagonistes des récepteurs de l'imidazoline et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC01 |
clonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC05 |
moxonidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LC51 |
clonidine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LE |
Alpha-adrenoreceptor antagonists and diuretics
|
Associations d'alpha-bloquants et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LE01 |
prazosin and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LF |
Guanidine derivatives and diuretics
|
Associations de dérivés de la guanidine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LF01 |
guanethidine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG |
Hydrazinophthalazine derivatives and diuretics
|
Associations de dérivés de la hydrazinophtalazine et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG01 |
dihydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG02 |
hydralazine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LG51 |
dihydralazine and diuretics, combinations with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LL |
MAO inhibitors and diuretics
|
Associations d'IMAO et de diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C02LL01 |
pargyline and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA |
Thiazides, plain
|
Thiazidiques non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA01 |
bendroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA02 |
hydroflumethiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA03 |
hydrochlorothiazide
|
Hydrochlorothiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA04 |
chlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA05 |
polythiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA06 |
trichlormethiazide
|
Trichlorméthiazide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA07 |
cyclopenthiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA08 |
methyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA09 |
cyclothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AA13 |
mebutizide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB |
Thiazides and potassium in combination
|
Thiazidiques et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB01 |
bendroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB02 |
hydroflumethiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB03 |
hydrochlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB04 |
chlorothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB07 |
cyclopenthiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AB09 |
cyclothiazide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AH |
Thiazides, combinations with psycholeptics and/or analgesics
|
Thiazidiques en association avec psycholeptiques et/ou analgésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AH02 |
hydroflumethiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AX |
Thiazides, combinations with other drugs
|
Thiazidiques en association avec d'autres substances
|
WHO |
Active |
2021-06-09 15:34:07 |
C03AX01 |
hydrochlorothiazide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA02 |
quinethazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA03 |
clopamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA04 |
chlortalidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA05 |
mefruside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA07 |
clofenamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA08 |
metolazone
|
Métolazone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA09 |
meticrane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA10 |
xipamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA11 |
indapamide
|
Indapamide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA12 |
clorexolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BA13 |
fenquizone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB03 |
clopamide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BB04 |
chlortalidone and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BC |
Mercurial diuretics
|
Diurétiques mercuriels
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BC01 |
mersalyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BD |
Xanthine derivatives
|
Dérivés xanthiques
|
WHO |
Active |
2021-10-25 19:07:17 |
C03BD01 |
theobromine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03BX |
Other low-ceiling diuretics
|
Autres diurétiques low-ceiling
|
WHO |
Active |
2021-10-25 19:07:19 |
C03BX03 |
cicletanine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA |
Sulfonamides, plain
|
Sulfamides non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA01 |
furosemide
|
Furosémide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA02 |
bumetanide
|
Bumétanide
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA03 |
piretanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CA04 |
torasemide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB |
Sulfonamides and potassium in combination
|
Sulfamides et potassium en association
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB01 |
furosemide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CB02 |
bumetanide and potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC |
Aryloxyacetic acid derivatives
|
Dérivés de l'acide aryloxyacétique
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC01 |
etacrynic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CC02 |
tienilic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CD |
Pyrazolone derivatives
|
Dérivés de la pyrazolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CD01 |
muzolimine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CX |
Other high-ceiling diuretics
|
Autres diurétiques de l'anse
|
WHO |
Active |
2021-06-09 15:34:07 |
C03CX01 |
etozolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA |
Aldosterone antagonists
|
Antagonistes de l'aldostérone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA01 |
spironolactone
|
Spironolactone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA02 |
potassium canrenoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA03 |
canrenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DA04 |
eplerenone
|
Éplérénone
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB |
Other potassium-sparing agents
|
Autres diurétiques épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB01 |
amiloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03DB02 |
triamterene
|
Triamtérène
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA |
Low-ceiling diuretics and potassium-sparing agents
|
Diurétiques low-ceiling et épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA01 |
hydrochlorothiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA02 |
trichlormethiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA03 |
epitizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA04 |
altizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA05 |
mebutizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA06 |
chlortalidone and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA07 |
cyclopenthiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA12 |
metolazone and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA13 |
bendroflumethiazide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EA14 |
butizide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB |
High-ceiling diuretics and potassium-sparing agents
|
Diurétiques de l'anse et épargneurs potassiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB01 |
furosemide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03EB02 |
bumetanide and potassium-sparing agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA |
Vasopressin antagonists
|
Antagonistes de la vasopressine
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA01 |
tolvaptan
|
Tolvaptan
|
WHO |
Active |
2021-06-09 15:34:07 |
C03XA02 |
conivaptan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA |
2-amino-1-phenylethanol derivatives
|
Dérivés du 2-amino-1-phényléthanol
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA01 |
isoxsuprine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA02 |
buphenine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AA31 |
bamethan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB |
Imidazoline derivatives
|
Dérivés de l'imidazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB01 |
phentolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AB02 |
tolazoline
|
Tolazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC |
Nicotinic acid and derivatives
|
Acide nicotinique et ses dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC01 |
nicotinic acid
|
Acide nicotinique
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC02 |
nicotinyl alcohol (pyridylcarbinol)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC03 |
inositol nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AC07 |
ciclonicate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD |
Purine derivatives
|
Dérivés de la purine
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD01 |
pentifylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD02 |
xantinol nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD03 |
pentoxifylline
|
Pentoxifylline
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AD04 |
etofylline nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE |
Ergot alkaloids
|
Alcaloïdes de l'ergot de seigle
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE01 |
ergoloid mesylates
|
Mésylates d'ergoloïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE02 |
nicergoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE04 |
dihydroergocristine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE51 |
ergoloid mesylates, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AE54 |
dihydroergocristine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AF |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AF01 |
kallidinogenase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX |
Other peripheral vasodilators
|
Autres vasodilatateurs périphériques
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX01 |
cyclandelate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX02 |
phenoxybenzamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX07 |
vincamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX10 |
moxisylyte
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX11 |
bencyclane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX17 |
vinburnine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX19 |
suloctidil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX20 |
buflomedil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX21 |
naftidrofuryl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX23 |
butalamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX24 |
visnadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX26 |
cetiedil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX27 |
cinepazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX28 |
ifenprodil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX30 |
azapetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C04AX32 |
fasudil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA |
Corticosteroids
|
Corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA01 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA04 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA05 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA06 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA08 |
fluocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA09 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA10 |
fluocinolone acetonide
|
Acétonide de fluocinolone
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA11 |
fluocinonide
|
Fluocinonide
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AA12 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD |
Local anesthetics
|
Anesthésiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD02 |
tetracaine
|
Tétracaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD03 |
benzocaine
|
Benzocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD04 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD05 |
procaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD06 |
oxetacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AD07 |
pramocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE |
Muscle relaxants
|
Myorelaxants
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE01 |
glyceryl trinitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE02 |
isosorbide dinitrate
|
Dinitrate d'isosorbide
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AE03 |
diltiazem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX |
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
Autres traitements des hémorroïdes et des fissures anales pour usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX01 |
aluminium preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX02 |
bismuth preparations, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX03 |
other preparations, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX04 |
zinc preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05AX05 |
tribenoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA |
Heparins or heparinoids for topical use
|
Héparines ou héparinoïdes pour usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA01 |
organo-heparinoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA02 |
sodium apolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA03 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA04 |
pentosan polysulfate sodium
|
Pentosane de polysulfate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA51 |
heparinoid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BA53 |
heparin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB |
Sclerosing agents for local injection
|
Agents sclérosants pour injection locale
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB01 |
monoethanolamine oleate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB02 |
polidocanol
|
POLIDOCANOL
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB03 |
invert sugar
|
Sucre inverti
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB04 |
sodium tetradecyl sulfate
|
Tétradécyl sulfate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB05 |
phenol
|
Phénol
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BB56 |
glucose, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX |
Other sclerosing agents
|
Autres agents sclérosants
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX01 |
calcium dobesilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05BX51 |
calcium dobesilate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA |
Bioflavonoids
|
Bioflavonoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA01 |
rutoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA02 |
monoxerutin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA03 |
diosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA04 |
troxerutin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA05 |
hidrosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA51 |
rutoside, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA53 |
diosmin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CA54 |
troxerutin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX |
Other capillary stabilizing agents
|
Autres stabilisateurs de capillaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX01 |
tribenoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX02 |
naftazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C05CX03 |
Hippocastani semen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA |
Beta blocking agents, non-selective
|
Bêtabloquants non sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA01 |
alprenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA02 |
oxprenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA03 |
pindolol
|
Pindolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA05 |
propranolol
|
Propranolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA06 |
timolol
|
Timolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA07 |
sotalol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA12 |
nadolol
|
Nadolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA14 |
mepindolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA15 |
carteolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA16 |
tertatolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA17 |
bopindolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA19 |
bupranolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA23 |
penbutolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AA27 |
cloranolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB |
Beta blocking agents, selective
|
Bêtabloquants sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB01 |
practolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB02 |
metoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB03 |
atenolol
|
Aténolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB04 |
acebutolol
|
Acébutolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB05 |
betaxolol
|
Bétaxolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB06 |
bevantolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB07 |
bisoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB08 |
celiprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB09 |
esmolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB10 |
epanolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB11 |
s-atenolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB12 |
nebivolol
|
Nébivolol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB13 |
talinolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AB14 |
landiolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG |
Alpha and beta blocking agents
|
Alpha et bêtabloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG01 |
labetalol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07AG02 |
carvedilol
|
Carvédilol
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA |
Beta blocking agents, non-selective, and thiazides
|
Bêtabloquants non sélectifs et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA02 |
oxprenolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA05 |
propranolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA06 |
timolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA07 |
sotalol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA12 |
nadolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BA68 |
metipranolol and thiazides, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB |
Beta blocking agents, selective, and thiazides
|
Bêtabloquants sélectifs et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB02 |
metoprolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB03 |
atenolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB04 |
acebutolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB06 |
bevantolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB07 |
bisoprolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB12 |
nebivolol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BB52 |
metoprolol and thiazides, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BG |
Alpha and beta blocking agents and thiazides
|
Alpha et bêtabloquants et thiazidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07BG01 |
labetalol and thiazides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA |
Beta blocking agents, non-selective, and other diuretics
|
Bêtabloquants non sélectifs et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA02 |
oxprenolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA03 |
pindolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA17 |
bopindolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CA23 |
penbutolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB |
Beta blocking agents, selective, and other diuretics
|
Bêtabloquants sélectifs et autres diurétiques
|
WHO |
Active |
2021-10-25 19:07:21 |
C07CB02 |
metoprolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB03 |
atenolol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CB53 |
atenolol and other diuretics, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CG |
Alpha and beta blocking agents and other diuretics
|
Alpha et bêtabloquants et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07CG01 |
labetalol and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DA |
Beta blocking agents, non-selective, thiazides and other diuretics
|
Bêtabloquants non sélectifs, thiazidiques et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DA06 |
timolol, thiazides and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DB |
Beta blocking agents, selective, thiazides and other diuretics
|
Bêtabloquants sélectifs, thiazidiques et autres diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C07DB01 |
atenolol, thiazides and other diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB |
Beta blocking agents and calcium channel blockers
|
Bêtabloquants et inhibiteurs du canal de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB02 |
metoprolol and felodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB03 |
atenolol and nifedipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB07 |
bisoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB12 |
nebivolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FB13 |
metoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX |
Beta blocking agents, other combinations
|
Bêtabloquants, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX01 |
propranolol and other combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX02 |
sotalol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX03 |
metoprolol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX04 |
bisoprolol and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX05 |
metoprolol and ivabradine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C07FX06 |
carvedilol and ivabradine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA |
Dihydropyridine derivatives
|
Dérivés de la dihydropyridine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA01 |
amlodipine
|
Amlodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA02 |
felodipine
|
Félodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA03 |
isradipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA04 |
nicardipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA05 |
nifedipine
|
Nifédipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA06 |
nimodipine
|
Nimodipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA07 |
nisoldipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA08 |
nitrendipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA09 |
lacidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA10 |
nilvadipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA11 |
manidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA12 |
barnidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA13 |
lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA14 |
cilnidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA15 |
benidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA16 |
clevidipine
|
Clévidipine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA51 |
amlodipine and celecoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CA55 |
nifedipine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CX |
Other selective calcium channel blockers with mainly vascular effects
|
Autres inhibiteurs calciques sélectifs à effets vasculaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C08CX01 |
mibefradil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA |
Phenylalkylamine derivatives
|
Dérivés de la phénylalkylamin
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA01 |
verapamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA02 |
gallopamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DA51 |
verapamil, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DB |
Benzothiazepine derivatives
|
Dérivés de la benzothiazépine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08DB01 |
diltiazem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA |
Phenylalkylamine derivatives
|
Dérivés de la phénylalkylamine
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA01 |
fendiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EA02 |
bepridil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX |
Other non-selective calcium channel blockers
|
Autres inhibiteurs calciques non sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX01 |
lidoflazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08EX02 |
perhexiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA |
Calcium channel blockers and diuretics
|
Inhibiteur calcique et diurétique
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA01 |
nifedipine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C08GA02 |
amlodipine and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA |
ACE inhibitors, plain
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène, non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA01 |
captopril
|
Captopril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA02 |
enalapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA03 |
lisinopril
|
Lisinopril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA04 |
perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA05 |
ramipril
|
Ramipril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA06 |
quinapril
|
Quinapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA07 |
benazepril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA08 |
cilazapril
|
Cilazapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA09 |
fosinopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA10 |
trandolapril
|
Trandolapril
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA11 |
spirapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA12 |
delapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA13 |
moexipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA14 |
temocapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA15 |
zofenopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09AA16 |
imidapril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA |
ACE inhibitors and diuretics
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène et diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA01 |
captopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA02 |
enalapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA03 |
lisinopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA04 |
perindopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA05 |
ramipril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA06 |
quinapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA07 |
benazepril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA08 |
cilazapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA09 |
fosinopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA12 |
delapril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA13 |
moexipril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BA15 |
zofenopril and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB |
ACE inhibitors and calcium channel blockers
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène et inhibiteurs du canal du calcium
|
WHO |
Active |
2024-05-17 08:52:13 |
C09BB02 |
enalapril and lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB03 |
lisinopril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB04 |
perindopril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB05 |
ramipril and felodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB06 |
enalapril and nitrendipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB07 |
ramipril and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB10 |
trandolapril and verapamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BB12 |
delapril and manidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX |
ACE inhibitors, other combinations
|
Inhibiteurs de l'enzyme de conversion de l'angiotensinogène, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX01 |
perindopril, amlodipine and indapamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX02 |
perindopril and bisoprolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX03 |
ramipril, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09BX04 |
perindopril, bisoprolol and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA |
Angiotensin II receptor blockers (ARBs), plain
|
Antagonistes de l'angiotensine II, non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA01 |
losartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA02 |
eprosartan
|
Éprosartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA03 |
valsartan
|
Valsartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA04 |
irbesartan
|
Irbésartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA05 |
tasosartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA06 |
candesartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA07 |
telmisartan
|
Telmisartan
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA08 |
olmesartan medoxomil
|
Olmésartan médoxomil
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA09 |
azilsartan medoxomil
|
Azilsartan Médoxomil
|
WHO |
Active |
2021-06-09 15:34:07 |
C09CA10 |
fimasartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA |
Angiotensin II receptor blockers (ARBs) and diuretics
|
Antagonistes de l'angiotensine II et diurétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA01 |
losartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA02 |
eprosartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA03 |
valsartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA04 |
irbesartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA06 |
candesartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA07 |
telmisartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA08 |
olmesartan medoxomil and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA09 |
azilsartan medoxomil and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DA10 |
fimasartan and diuretics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB |
Angiotensin II receptor blockers (ARBs) and calcium channel blockers
|
Antagonistes de l'angiotensine II et inhibiteurs du canal de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB01 |
valsartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB02 |
olmesartan medoxomil and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB04 |
telmisartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB05 |
irbesartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB06 |
losartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB07 |
candesartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB08 |
valsartan and lercanidipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DB09 |
fimasartan and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX |
Angiotensin II receptor blockers (ARBs), other combinations
|
Antagonistes de l'angiotensine II, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX01 |
valsartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX02 |
valsartan and aliskiren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX03 |
olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX04 |
valsartan and sacubitril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX05 |
valsartan and nebivolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX06 |
candesartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09DX07 |
irbesartan, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA |
Renin-inhibitors
|
Inhibiteurs de la rénine
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA01 |
remikiren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA02 |
aliskiren
|
Aliskirène
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA52 |
aliskiren and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA53 |
aliskiren and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C09XA54 |
aliskiren, amlodipine and hydrochlorothiazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA |
HMG CoA reductase inhibitors
|
Inhibiteurs de l'HMG-CoA réductase (statines)
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA01 |
simvastatin
|
Simvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA02 |
lovastatin
|
Lovastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA03 |
pravastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA04 |
fluvastatin
|
Fluvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA05 |
atorvastatin
|
Atorvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA06 |
cerivastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA07 |
rosuvastatin
|
Rosuvastatine
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AA08 |
pitavastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB |
Fibrates
|
Fibrates
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB01 |
clofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB02 |
bezafibrate
|
Bézafibrate
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB03 |
aluminium clofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB04 |
gemfibrozil
|
Gemfibrozil
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB05 |
fenofibrate
|
Fénofibrate
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB06 |
simfibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB07 |
ronifibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB08 |
ciprofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB09 |
etofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB10 |
clofibride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AB11 |
choline fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC |
Bile acid sequestrants
|
Séquestrants d'acides biliaires
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC01 |
colestyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC02 |
colestipol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC03 |
colextran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AC04 |
colesevelam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD |
Nicotinic acid and derivatives
|
Acide nicotiniques et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD01 |
niceritrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD02 |
nicotinic acid
|
Acide nicotinique
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD03 |
nicofuranose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD04 |
aluminium nicotinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD05 |
nicotinyl alcohol (pyridylcarbinol)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD06 |
acipimox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AD52 |
nicotinic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX |
Other lipid modifying agents
|
Autres agents réduisant les lipides sériques
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX01 |
dextrothyroxine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX02 |
probucol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX03 |
tiadenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX06 |
omega-3-triglycerides incl. other esters and acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX07 |
magnesium pyridoxal 5-phosphate glutamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX08 |
policosanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX09 |
ezetimibe
|
Ézétimibe
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX10 |
alipogene tiparvovec
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX11 |
mipomersen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX12 |
lomitapide
|
Lomitapide
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX13 |
evolocumab
|
ÉVOLOCUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX14 |
alirocumab
|
Alirocumab
|
WHO |
Active |
2021-06-09 15:34:07 |
C10AX15 |
bempedoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA |
Combinations of various lipid modifying agents
|
Inhibiteurs de l'HMG-CoA réductase en association avec d'autres modificateurs des lipides
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA01 |
lovastatin and nicotinic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA02 |
simvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA03 |
pravastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA04 |
simvastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA05 |
atorvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA06 |
rosuvastatin and ezetimibe
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA07 |
rosuvastatin and omega-3 fatty acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA08 |
atorvastatin and omega-3 fatty acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BA09 |
rosuvastatin and fenofibrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX |
Lipid modifying agents in combination with other drugs
|
Inhibiteurs de l'HMG-CoA réductase, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX01 |
simvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX02 |
pravastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX03 |
atorvastatin and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX04 |
simvastatin, acetylsalicylic acid and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX05 |
rosuvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX06 |
atorvastatin, acetylsalicylic acid and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX07 |
rosuvastatin, amlodipine and lisinopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX08 |
atorvastatin and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX09 |
rosuvastatin and amlodipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX10 |
rosuvastatin and valsartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX11 |
atorvastatin, amlodipine and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX12 |
atorvastatin, acetylsalicylic acid and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX13 |
rosuvastatin, perindopril and indapamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX14 |
rosuvastatin, amlodipine and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX15 |
atorvastatin and perindopril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX16 |
rosuvastatin and fimasartan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
C10BX17 |
rosuvastatin and ramipril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA |
Antibiotics
|
Antibiotiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA01 |
nystatin
|
Nystatine
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA02 |
natamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA03 |
hachimycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA04 |
pecilocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA06 |
mepartricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA07 |
pyrrolnitrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AA08 |
griseofulvin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC |
Imidazole and triazole derivatives
|
Dérivés imidazolés et triazolés à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC01 |
clotrimazole
|
Clotrimazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC02 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC03 |
econazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC04 |
chlormidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC05 |
isoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC06 |
tiabendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC07 |
tioconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC08 |
ketoconazole
|
Kétoconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC09 |
sulconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC10 |
bifonazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC11 |
oxiconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC12 |
fenticonazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC13 |
omoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC14 |
sertaconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC15 |
fluconazole
|
Fluconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC16 |
flutrimazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC17 |
eberconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC18 |
luliconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC19 |
efinaconazole
|
Éfinaconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC20 |
imidazoles/triazoles in combination with corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC52 |
miconazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AC60 |
bifonazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE |
Other antifungals for topical use
|
Autres antifongiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE01 |
bromochlorosalicylanilide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE02 |
methylrosaniline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE04 |
undecylenic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE05 |
polynoxylin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE07 |
chlorphenesin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE08 |
ticlatone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE09 |
sulbentine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE10 |
ethyl hydroxybenzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE11 |
haloprogin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE12 |
salicylic acid
|
Acide salicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE13 |
selenium sulfide
|
Sulfure de sélénium
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE14 |
ciclopirox
|
Ciclopirox
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE15 |
terbinafine
|
Terbinafine
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE16 |
amorolfine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE17 |
dimazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE18 |
tolnaftate
|
Tolnaftate
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE19 |
tolciclate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE21 |
flucytosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE22 |
naftifine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE23 |
butenafine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE24 |
tavaborole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01AE54 |
undecylenic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01BA |
Antifungals for systemic use
|
Antifongiques à usage systémique
|
WHO |
Active |
2021-06-09 15:34:07 |
D01BA01 |
griseofulvin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D01BA02 |
terbinafine
|
Terbinafine
|
WHO |
Active |
2021-06-09 15:34:07 |
D02AE |
Carbamide products
|
Médicaments à base d'urée
|
WHO |
Active |
2021-06-09 15:34:07 |
D02AE01 |
carbamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D02AE51 |
carbamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BA |
Protectives against UV-radiation for topical use
|
Protecteurs contre les rayonnements à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BA01 |
aminobenzoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BA02 |
octinoxate
|
Octinoxate
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BB |
Protectives against UV-radiation for systemic use
|
Protecteurs contre les rayonnements à usage systémique
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BB01 |
betacarotene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D02BB02 |
afamelanotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX |
Other cicatrizants
|
Autres cicatrisants
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX01 |
cadexomer iodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX02 |
dextranomer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX03 |
dexpanthenol
|
Dexpanthénol
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX04 |
calcium pantothenate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX05 |
hyaluronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX06 |
becaplermin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX09 |
crilanomer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX10 |
enoxolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX11 |
sodium chlorite
|
Chlorite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX12 |
trolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX13 |
Betulae cortex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03AX14 |
centella asiatica herba
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03BA |
Proteolytic enzymes
|
Enzymes protéolytiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D03BA01 |
trypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03BA02 |
collagenase
|
Collagénase
|
WHO |
Active |
2021-06-09 15:34:07 |
D03BA03 |
bromelains
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D03BA52 |
collagenase, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA |
Antihistamines for topical use
|
Antihistaminiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA01 |
thonzylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA02 |
mepyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA03 |
thenalidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA04 |
tripelennamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA09 |
chloropyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA10 |
promethazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA12 |
tolpropamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA13 |
dimetindene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA14 |
clemastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA15 |
bamipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA16 |
pheniramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA22 |
isothipendyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA32 |
diphenhydramine
|
Diphénhydramine
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA33 |
diphenhydramine methylbromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AA34 |
chlorphenoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB |
Anesthetics for topical use
|
Anesthésiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB02 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB03 |
oxybuprocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB04 |
benzocaine
|
Benzocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB05 |
quinisocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB06 |
tetracaine
|
Tétracaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AB07 |
pramocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AX |
Other antipruritics
|
Autres antiprurigineux
|
WHO |
Active |
2021-06-09 15:34:07 |
D04AX01 |
doxepin
|
Doxépine
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AC |
Antracen derivatives
|
Dérivés anthracéniques
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AC01 |
dithranol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AC51 |
dithranol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AD |
Psoralens for topical use
|
Psoralènes à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AD01 |
trioxysalen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AD02 |
methoxsalen
|
Méthoxsalène
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX |
Other antipsoriatics for topical use
|
Autres médicaments contre le psoriasis à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX01 |
fumaric acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX02 |
calcipotriol
|
Calcipotriol
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX03 |
calcitriol
|
Calcitriol
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX04 |
tacalcitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX05 |
tazarotene
|
Tazarotène
|
WHO |
Active |
2021-06-09 15:34:07 |
D05AX52 |
calcipotriol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BA |
Psoralens for systemic use
|
Psoralènes à usage systémique
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BA01 |
trioxysalen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BA02 |
methoxsalen
|
Méthoxsalène
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BA03 |
bergapten
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BB |
Retinoids for treatment of psoriasis
|
Rétinoïdes pour le traitement du psoriasis
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BB01 |
etretinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BB02 |
acitretin
|
Acitrétine
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BX |
Other antipsoriatics for systemic use
|
Autres médicaments contre le psoriasis à usage systémique
|
WHO |
Active |
2021-06-09 15:34:07 |
D05BX51 |
fumaric acid derivatives, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AA |
Tetracycline and derivatives
|
Tétracyclines et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AA01 |
demeclocycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AA02 |
chlortetracycline
|
Chlortétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AA03 |
oxytetracycline
|
Oxytétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AA04 |
tetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX |
Other antibiotics for topical use
|
Autres antibiotiques à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX01 |
fusidic acid
|
Acide fusidique
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX02 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX04 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX05 |
bacitracin
|
Bacitracine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX07 |
gentamicin
|
Gentamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX08 |
tyrothricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX09 |
mupirocin
|
Mupirocine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX10 |
virginiamycin
|
Virginiamycine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX11 |
rifaximin
|
RIFAXIMINE
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX12 |
amikacin
|
Amikacine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX13 |
retapamulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX14 |
ozenoxacin
|
Ozénoxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06AX15 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA |
Sulfonamides
|
Sulfamides
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA01 |
silver sulfadiazine
|
Sulfadiazine d'argent
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA02 |
sulfathiazole
|
Sulfathiazol
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA03 |
mafenide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA04 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA05 |
sulfanilamide
|
Sulfanilamide
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA06 |
sulfamerazine
|
Sulfamérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BA51 |
silver sulfadiazine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB |
Antivirals
|
Antiviraux
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB01 |
idoxuridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB02 |
tromantadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB03 |
aciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB04 |
podophyllotoxin
|
Podophyllotoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB05 |
inosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB06 |
penciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB07 |
lysozyme
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB08 |
ibacitabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB09 |
edoxudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB10 |
imiquimod
|
Imiquimod
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB11 |
docosanol
|
Docosanol
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB12 |
sinecatechins
|
Sinécatéchines
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BB53 |
aciclovir, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BX |
Other chemotherapeutics
|
Autres agents chimiothérapeutiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BX01 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
D06BX02 |
ingenol mebutate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AA |
Corticosteroids, weak (group I)
|
Corticoïdes d'activité faible (groupe I)
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AA01 |
methylprednisolone
|
Méthylprednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AA02 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AA03 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB |
Corticosteroids, moderately potent (group II)
|
Corticoïdes d'activité modérée (groupe II)
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB01 |
clobetasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB02 |
hydrocortisone butyrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB03 |
flumetasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB04 |
fluocortin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB05 |
fluperolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB06 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB07 |
fluprednidene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB08 |
desonide
|
Désonide
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB09 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB10 |
alclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB11 |
hydrocortisone buteprate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB19 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB21 |
clocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AB30 |
combinations of corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC |
Corticosteroids, potent (group III)
|
Corticoïdes d'activité forte (groupe III)
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC01 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC02 |
fluclorolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC03 |
desoximetasone
|
Désoxyméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC04 |
fluocinolone acetonide
|
Acétonide de fluocinolone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC05 |
fluocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC06 |
diflucortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC07 |
fludroxycortide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC08 |
fluocinonide
|
Fluocinonide
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC09 |
budesonide
|
Budésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC10 |
diflorasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC11 |
amcinonide
|
Amcinonide
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC12 |
halometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC13 |
mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC14 |
methylprednisolone aceponate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC15 |
beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC16 |
hydrocortisone aceponate
|
Acéponate d'Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC17 |
fluticasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC18 |
prednicarbate
|
Prednicarbate
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC19 |
difluprednate
|
Difluprednate
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AC21 |
ulobetasol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AD |
Corticosteroids, very potent (group IV)
|
Corticoïdes d'activité très forte (groupe IV)
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AD01 |
clobetasol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07AD02 |
halcinonide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BA |
Corticosteroids, weak, combinations with antiseptics
|
Corticoïdes d'activité faible et antiseptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BA01 |
prednisolone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BA04 |
hydrocortisone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BB |
Corticosteroids, moderately potent, combinations with antiseptics
|
Corticoïdes d'activité modérée et antiseptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BB01 |
flumetasone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BB02 |
desonide and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BB03 |
triamcinolone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BB04 |
hydrocortisone butyrate and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BC |
Corticosteroids, potent, combinations with antiseptics
|
Corticoïdes d'activité forte et antiseptiq
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BC01 |
betamethasone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BC02 |
fluocinolone acetonide and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BC03 |
fluocortolone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07BC04 |
diflucortolone and antiseptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CA |
Corticosteroids, weak, combinations with antibiotics
|
Corticoïdes d'activité faible et antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CA01 |
hydrocortisone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CA02 |
methylprednisolone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CA03 |
prednisolone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB |
Corticosteroids, moderately potent, combinations with antibiotics
|
Corticoïdes d'activité modérée et antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB01 |
triamcinolone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB02 |
fluprednidene and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB03 |
fluorometholone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB04 |
dexamethasone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CB05 |
flumetasone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC |
Corticosteroids, potent, combinations with antibiotics
|
Corticoïdes d'activité forte et antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC01 |
betamethasone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC02 |
fluocinolone acetonide and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC03 |
fludroxycortide and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC04 |
beclometasone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC05 |
fluocinonide and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CC06 |
fluocortolone and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CD |
Corticosteroids, very potent, combinations with antibiotics
|
Corticoïdes d'activité très forte et antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D07CD01 |
clobetasol and antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XA |
Corticosteroids, weak, other combinations
|
Corticoïdes d'activité faible, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XA01 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XA02 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB |
Corticosteroids, moderately potent, other combinations
|
Corticoïdes d'activité modérée, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB01 |
flumetasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB02 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB03 |
fluprednidene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB04 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB05 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XB30 |
combinations of corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC |
Corticosteroids, potent, other combinations
|
Corticoïdes d'activité forte, autres associations
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC01 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC02 |
desoximetasone
|
Désoxyméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC03 |
mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC04 |
diflucortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D07XC05 |
fluocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AA |
Acridine derivatives
|
Dérivés de l'acridine
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AA01 |
ethacridine lactate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AA02 |
aminoacridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AA03 |
euflavine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC |
Biguanides and amidines
|
Biguanides et amidine
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC01 |
dibrompropamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC02 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC03 |
propamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC04 |
hexamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC05 |
polihexanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AC52 |
chlorhexidine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE |
Phenol and derivatives
|
Phénol et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE01 |
hexachlorophene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE02 |
policresulen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE03 |
phenol
|
Phénol
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE04 |
triclosan
|
Triclosan
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE05 |
chloroxylenol
|
Chloroxylénol
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AE06 |
biphenylol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AF |
Nitrofuran derivatives
|
Dérivés du nitrofurane
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AF01 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AG |
Iodine products
|
Dérivés de l'iode
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AG02 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AG03 |
iodine
|
Iode
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AH |
Quinoline derivatives
|
Dérivés de la quinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AH01 |
dequalinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AH02 |
chlorquinaldol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AH03 |
oxyquinoline
|
Oxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AH30 |
clioquinol
|
Clioquinol
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ |
Quaternary ammonium compounds
|
Ammoniums quaternaire
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ01 |
benzalkonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ02 |
cetrimonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ03 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ04 |
cetrimide
|
Cétrimide
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ05 |
benzoxonium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ06 |
didecyldimethylammonium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ08 |
benzethonium chloride
|
Chlorure de benzéthonium
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ10 |
decamethoxine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ57 |
octenidine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ58 |
benzethonium chloride, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AJ59 |
dodeclonium bromide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK |
Mercurial products
|
Dérivés du mercure
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK01 |
mercuric amidochloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK02 |
phenylmercuric borate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK03 |
mercuric chloride
|
Chlorure mercure
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK04 |
mercurochrome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK05 |
mercury, metallic
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK06 |
thiomersal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AK30 |
mercuric iodide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AL |
Silver compounds
|
Dérivés de l'argent
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AL01 |
silver nitrate
|
Nitrate d'argent
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AL30 |
silver
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX |
Other antiseptics and disinfectants
|
Autres antiseptiques et désinfectants
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX01 |
hydrogen peroxide
|
Peroxyde d'hydrogène
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX02 |
eosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX03 |
propanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX04 |
tosylchloramide sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX05 |
isopropanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX06 |
potassium permanganate
|
Permanganate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX07 |
sodium hypochlorite
|
Hypochlorite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX08 |
ethanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D08AX53 |
propanol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA |
Medicated dressings with antiinfectives
|
Pansements avec anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA01 |
framycetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA02 |
fusidic acid
|
Acide fusidique
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA03 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA04 |
phenylmercuric nitrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA05 |
benzododecinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA06 |
triclosan
|
Triclosan
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA07 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA08 |
aluminium chlorohydrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA09 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA10 |
clioquinol
|
Clioquinol
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA11 |
benzalkonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA12 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AA13 |
iodoform
|
Iodoforme
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AB |
Zinc bandages
|
Pansements à base de zinc
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AB01 |
zinc bandage without supplements
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D09AB02 |
zinc bandage with supplements
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AA |
Corticosteroids, combinations for treatment of acne
|
Corticostéroïdes, associations pour traitement de l'acné
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AA01 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AA02 |
methylprednisolone
|
Méthylprednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AA03 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AB |
Preparations containing sulfur
|
Préparations contenant du soufre
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AB01 |
bithionol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AB02 |
sulfur
|
Soufre
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AB03 |
tioxolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AB05 |
mesulfen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD |
Retinoids for topical use in acne
|
Rétinoïdes pour usage topique contre l'acné
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD01 |
tretinoin
|
Trétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD02 |
retinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD03 |
adapalene
|
Adapalène
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD04 |
isotretinoin
|
Isotrétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD05 |
motretinide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD06 |
trifarotene
|
Trifarotène
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD51 |
tretinoin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD53 |
adapalene, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AD54 |
isotretinoin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AE |
Peroxides
|
Peroxydes
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AE01 |
benzoyl peroxide
|
Peroxyde de benzoyle
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AE51 |
benzoyl peroxide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF |
Antiinfectives for treatment of acne
|
Anti-infectieux pour traitement de l'acné
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF01 |
clindamycin
|
Clindamycine
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF02 |
erythromycin
|
Érythromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF03 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF04 |
meclocycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF05 |
nadifloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF06 |
sulfacetamide
|
Sulfacétamide
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF51 |
clindamycin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AF52 |
erythromycin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX |
Other anti-acne preparations for topical use
|
Autres anti-acnéiques pour usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX01 |
aluminium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX02 |
resorcinol
|
Résorcinol
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX03 |
azelaic acid
|
Acide azélaïque
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX04 |
aluminium oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D10AX05 |
dapsone
|
Dapsone
|
WHO |
Active |
2021-06-09 15:34:07 |
D10BA |
Retinoids for treatment of acne
|
Rétinoïdes pour traitement de l'acné
|
WHO |
Active |
2021-06-09 15:34:07 |
D10BA01 |
isotretinoin
|
Isotrétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D10BX |
Other anti-acne preparations for systemic use
|
Autres anti-acnéiques pour usage systémique
|
WHO |
Active |
2021-06-09 15:34:07 |
D10BX01 |
ichtasol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AA |
Antihidrotics
|
Antisudoraux
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AA01 |
glycopyrronium
|
Glycopyrronium
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC |
Medicated shampoos
|
Shampooing médicamenteux
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC01 |
cetrimide
|
Cétrimide
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC02 |
cadmium compounds
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC03 |
selenium compounds
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC06 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC08 |
sulfur compounds
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC09 |
xenysalate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AC30 |
others
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AE |
Androgens for topical use
|
Androgènes à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AE01 |
metandienone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH |
Agents for dermatitis, excluding corticosteroids
|
Agents pour dermatite, excluant les corticostéroïdes
|
WHO |
Active |
2021-10-25 19:07:23 |
D11AH01 |
tacrolimus
|
Tacrolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH02 |
pimecrolimus
|
Pimécrolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH03 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH04 |
alitretinoin
|
Alitrétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH05 |
dupilumab
|
dupilumab
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AH06 |
crisaborole
|
Crisaborile
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX |
Other dermatologicals
|
Autres médicaments dermatologiques
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX01 |
minoxidil
|
Minoxidil
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX02 |
gamolenic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX03 |
calcium gluconate
|
Gluconate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX04 |
lithium succinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX05 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX06 |
mequinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX08 |
tiratricol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX09 |
oxaceprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX10 |
finasteride
|
Finastéride
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX11 |
hydroquinone
|
Hydroquinone
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX12 |
pyrithione zinc
|
Pyrithione zincique
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX13 |
monobenzone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX16 |
eflornithine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX18 |
diclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX21 |
brimonidine
|
BRIMONIDINE
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX22 |
ivermectin
|
Ivermectine
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX23 |
aminobenzoate potassium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX24 |
deoxycholic acid
|
Acide désoxycholique
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX25 |
hydrogen peroxide
|
Peroxyde d'hydrogène
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX52 |
gamolenic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
D11AX57 |
collagen, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA |
Antibiotics
|
Antibiotiques à usage gynécologique
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA01 |
nystatin
|
Nystatine
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA02 |
natamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA03 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA04 |
candicidin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA05 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA06 |
hachimycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA07 |
oxytetracycline
|
Oxytétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA08 |
carfecillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA09 |
mepartricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA10 |
clindamycin
|
Clindamycine
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA11 |
pentamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AA51 |
nystatin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AB |
Arsenic compounds
|
Dérivés arsenicaux
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AB01 |
acetarsol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC |
Quinoline derivatives
|
Dérivés de la quinoléïne
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC01 |
diiodohydroxyquinoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC02 |
clioquinol
|
Clioquinol
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC03 |
chlorquinaldol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC05 |
dequalinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC06 |
broxyquinoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AC30 |
oxyquinoline
|
Oxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AD |
Organic acids
|
Acides organiques
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AD01 |
lactic acid
|
Acide lactique
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AD02 |
acetic acid
|
Acide acétique
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AD03 |
ascorbic acid
|
Acide ascorbique
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AE |
Sulfonamides
|
Sulfamides
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AE01 |
sulfatolamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AE10 |
combinations of sulfonamides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF |
Imidazole derivatives
|
Dérivés imidazolés
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF01 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF02 |
clotrimazole
|
Clotrimazole
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF04 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF05 |
econazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF06 |
ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF07 |
isoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF08 |
tioconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF11 |
ketoconazole
|
Kétoconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF12 |
fenticonazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF13 |
azanidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF14 |
propenidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF15 |
butoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF16 |
omoconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF17 |
oxiconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF18 |
flutrimazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF19 |
sertaconazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF20 |
combinations of imidazole derivatives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AF55 |
econazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AG |
Triazole derivatives
|
Dérivés triazolés
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AG02 |
terconazole
|
Terconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX |
Other antiinfectives and antiseptics
|
Autres anti-infectieux et antiseptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX01 |
clodantoin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX02 |
inosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX03 |
policresulen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX05 |
nifuratel
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX06 |
furazolidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX09 |
methylrosaniline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX11 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX12 |
ciclopirox
|
Ciclopirox
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX13 |
protiofate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX14 |
lactobacillus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX16 |
hexetidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX17 |
dapivirine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G01AX66 |
octenidine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AB |
Ergot alkaloids
|
Alcaloïdes de l'ergot
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AB01 |
methylergometrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AB02 |
ergot alkaloids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AB03 |
ergometrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AC |
Ergot alkaloids and oxytocin incl. analogues, in combination
|
Alcaloïdes de l'ergot et oxytocine et dérivés, en association
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AC01 |
methylergometrine and oxytocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD |
Prostaglandins
|
Prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD01 |
dinoprost
|
Dinoprost
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD02 |
dinoprostone
|
Dinoprostone
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD03 |
gemeprost
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD04 |
carboprost
|
Carboprost
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD05 |
sulprostone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02AD06 |
misoprostol
|
Misoprostol
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BA |
Intrauterine contraceptives
|
Contraceptifs intra-utérins
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BA01 |
plastic IUD
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BA02 |
plastic IUD with copper
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BA03 |
plastic IUD with progestogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BB |
Intravaginal contraceptives
|
Contraceptifs intravaginaux
|
WHO |
Active |
2021-06-09 15:34:07 |
G02BB01 |
vaginal ring with progestogen and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CA |
Sympathomimetics, labour repressants
|
Sympathomimétiques, inhibiteurs du travail
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CA01 |
ritodrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CA02 |
buphenine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CA03 |
fenoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB |
Prolactine inhibitors
|
Inhibiteurs de la prolactine
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB01 |
bromocriptine
|
Bromocriptine
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB02 |
lisuride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB03 |
cabergoline
|
Cabergoline
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB04 |
quinagolide
|
Quinagolide
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB05 |
metergoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CB06 |
terguride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CC |
Antiinflammatory products for vaginal administration
|
Anti-inflammatoires à administration vaginale
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CC01 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CC02 |
naproxen
|
Naproxène
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CC03 |
benzydamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CC04 |
flunoxaprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CX |
Other gynecologicals
|
Autres médicaments gynécologiques
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CX01 |
atosiban
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CX02 |
flibanserin
|
Flibansérine
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CX03 |
Agni casti fructus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G02CX04 |
Cimicifugae rhizoma
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA |
Progestogens and estrogens, fixed combinations
|
Progestatifs et estrogènes en association fixe
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA01 |
etynodiol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA02 |
quingestanol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA03 |
lynestrenol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA04 |
megestrol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA05 |
norethisterone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA06 |
norgestrel and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA07 |
levonorgestrel and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA08 |
medroxyprogesterone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA09 |
desogestrel and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA10 |
gestodene and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA11 |
norgestimate and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA12 |
drospirenone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA13 |
norelgestromin and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA14 |
nomegestrol and estradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA15 |
chlormadinone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA16 |
dienogest and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AA17 |
medroxyprogesterone and estradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB |
Progestogens and estrogens, sequential preparations
|
Progestatifs et estrogènes pour administration séquentielle
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB01 |
megestrol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB02 |
lynestrenol and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB03 |
levonorgestrel and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB04 |
norethisterone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB05 |
desogestrel and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB06 |
gestodene and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB07 |
chlormadinone and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB08 |
dienogest and estradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AB09 |
norgestimate and ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC |
Progestogens
|
Progestatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC01 |
norethisterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC02 |
lynestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC03 |
levonorgestrel
|
Lévonorgestrel
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC04 |
quingestanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC05 |
megestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC06 |
medroxyprogesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC07 |
norgestrienone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC08 |
etonogestrel
|
Étonogestrel
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC09 |
desogestrel
|
Désogestrel
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AC10 |
drospirenone
|
Drospirénone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AD |
Emergency contraceptives
|
Contraception d'urgence
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AD01 |
levonorgestrel
|
Lévonorgestrel
|
WHO |
Active |
2021-06-09 15:34:07 |
G03AD02 |
ulipristal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BA |
3-oxoandrosten (4) derivatives
|
Dérivés du 3-oxoandrostène
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BA01 |
fluoxymesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BA02 |
methyltestosterone
|
Methyltestostérone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BA03 |
testosterone
|
Testostérone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BB |
5-androstanon (3) derivatives
|
Dérivés de la 5-andorstan-3-one
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BB01 |
mesterolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03BB02 |
androstanolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA |
Natural and semisynthetic estrogens, plain
|
Estrogènes naturels et hémisynthétiques non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA01 |
ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA03 |
estradiol
|
Estradiol
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA04 |
estriol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA06 |
chlorotrianisene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA07 |
estrone
|
Estrone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA09 |
promestriene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA53 |
estradiol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CA57 |
conjugated estrogens
|
Oestrogènes conjugués
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CB |
Synthetic estrogens, plain
|
Estrogènes synthétiques non associés
|
WHO |
Active |
2021-10-25 19:07:24 |
G03CB01 |
dienestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CB02 |
diethylstilbestrol
|
Diéthylstilbestrol
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CB03 |
methallenestril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CB04 |
moxestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC |
Estrogens, combinations with other drugs
|
Estrogènes en association avec d'autres substances
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC02 |
dienestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC03 |
methallenestril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC04 |
estrone
|
Estrone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC05 |
diethylstilbestrol
|
Diéthylstilbestrol
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC06 |
estriol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CC07 |
conjugated estrogens and bazedoxifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CX |
Other estrogens
|
Autres estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
G03CX01 |
tibolone
|
TIBOLONE
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DA |
Pregnen (4) derivatives
|
Dérivés pregnène-4
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DA01 |
gestonorone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DA02 |
medroxyprogesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DA03 |
hydroxyprogesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DA04 |
progesterone
|
Progestérone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB |
Pregnadien derivatives
|
Dérivés pregnadiène
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB01 |
dydrogesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB02 |
megestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB03 |
medrogestone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB04 |
nomegestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB05 |
demegestone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB06 |
chlormadinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB07 |
promegestone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DB08 |
dienogest
|
Diénogest
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC |
Estren derivatives
|
Dérivés estrène
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC01 |
allylestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC02 |
norethisterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC03 |
lynestrenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC04 |
ethisterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC06 |
etynodiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03DC31 |
methylestrenolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EA |
Androgens and estrogens
|
Androgènes et estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EA01 |
methyltestosterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EA02 |
testosterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EA03 |
prasterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EK |
Androgens and female sex hormones in combination with other drugs
|
Androgènes et hormones sexuelles femelles en association avec d'autres substances
|
WHO |
Active |
2021-06-09 15:34:07 |
G03EK01 |
methyltestosterone
|
Methyltestostérone
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA |
Progestogens and estrogens, fixed combinations
|
Progestatifs et estrogènes en association
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA01 |
norethisterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA02 |
hydroxyprogesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA03 |
ethisterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA04 |
progesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA05 |
methylnortestosterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA06 |
etynodiol and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA07 |
lynestrenol and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA08 |
megestrol and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA09 |
noretynodrel and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA11 |
levonorgestrel and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA12 |
medroxyprogesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA14 |
dydrogesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA15 |
dienogest and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA16 |
trimegestone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FA17 |
drospirenone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB |
Progestogens and estrogens, sequential preparations
|
Progestatifs et estrogènes pour administration séquentielle
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB01 |
norgestrel and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB03 |
chlormadinone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB04 |
megestrol and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB05 |
norethisterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB06 |
medroxyprogesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB07 |
medrogestone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB08 |
dydrogesterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB09 |
levonorgestrel and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB10 |
desogestrel and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB11 |
trimegestone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03FB12 |
nomegestrol and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA |
Gonadotropins
|
Gonadotrophines
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA01 |
chorionic gonadotrophin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA02 |
human menopausal gonadotrophin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA03 |
serum gonadotrophin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA04 |
urofollitropin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA05 |
follitropin alfa
|
Follitropine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA06 |
follitropin beta
|
Follitropine bêta
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA07 |
lutropin alfa
|
Lutropine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA08 |
choriogonadotropin alfa
|
Choriogonadotropine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA09 |
corifollitropin alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA10 |
follitropin delta
|
Follitropine delta
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GB |
Ovulation stimulants, synthetic
|
Stimulants synthétiques de l'ovulation
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GB01 |
cyclofenil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GB02 |
clomifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03GB03 |
epimestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03HA |
Antiandrogens, plain
|
Anti-androgènes non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
G03HA01 |
cyproterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03HB |
Antiandrogens and estrogens
|
Anti-androgènes et estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
G03HB01 |
cyproterone and estrogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XA |
Antigonadotropins and similar agents
|
Antigonadotrophines et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XA01 |
danazol
|
Danazol
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XA02 |
gestrinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XB |
Progesterone receptor modulators
|
Antiprogestatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XB01 |
mifepristone
|
MIFÉPRISTONE
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XB02 |
ulipristal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XB51 |
mifepristone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC |
Selective estrogen receptor modulators
|
Modulateurs sélectifs des récepteurs aux estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC01 |
raloxifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC02 |
bazedoxifene
|
BAZEDOXIFÈNE
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC03 |
lasofoxifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC04 |
ormeloxifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XC05 |
ospemifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XX |
Other sex hormones and modulators of the genital system
|
Not found
|
WHO |
Active |
2021-06-09 15:34:07 |
G03XX01 |
prasterone
|
Prastérone
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BA |
Acidifiers
|
Acidifiants
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BA01 |
ammonium chloride
|
Chlorure d'ammonium
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BA03 |
calcium chloride
|
Chlorure de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD |
Drugs for urinary frequency and incontinence
|
Antispasmodiques urinaires
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD01 |
emepronium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD02 |
flavoxate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD03 |
meladrazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD04 |
oxybutynin
|
Oxybutynine
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD05 |
terodiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD06 |
propiverine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD07 |
tolterodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD08 |
solifenacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD09 |
trospium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD10 |
darifenacin
|
Darifénacine
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD11 |
fesoterodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD12 |
mirabegron
|
Mirabégron
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BD13 |
desfesoterodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE |
Drugs used in erectile dysfunction
|
Médicaments utilisés dans les troubles de l'érectio
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE01 |
alprostadil
|
Alprostadil
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE02 |
papaverine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE03 |
sildenafil
|
Sildénafil
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE04 |
yohimbine
|
Yohimbine
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE06 |
moxisylyte
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE07 |
apomorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE08 |
tadalafil
|
Tadalafil
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE09 |
vardenafil
|
Vardénafil
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE10 |
avanafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE11 |
udenafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BE30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX |
Other urologicals
|
Autres médicaments urologiques
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX01 |
magnesium hydroxide
|
Hydroxyde de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX03 |
acetohydroxamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX06 |
phenazopyridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX10 |
succinimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX11 |
collagen
|
Collagène
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX12 |
phenyl salicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX13 |
dimethyl sulfoxide
|
Diméthylsulfoxyde
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX14 |
dapoxetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX15 |
pentosan polysulfate sodium
|
Pentosane de polysulfate sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
G04BX16 |
tiopronin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA |
Alpha-adrenoreceptor antagonists
|
Alphabloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA01 |
alfuzosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA02 |
tamsulosin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA03 |
terazosin
|
Térazosine
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA04 |
silodosin
|
Silodosine
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA51 |
alfuzosin and finasteride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA52 |
tamsulosin and dutasteride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA53 |
tamsulosin and solifenacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CA54 |
tamsulosin and tadalafil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CB |
Testosterone-5-alpha reductase inhibitors
|
Inhibiteurs de l'alpha-5-testostérone réductase
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CB01 |
finasteride
|
Finastéride
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CB02 |
dutasteride
|
Dutastéride
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CX |
Other drugs used in benign prostatic hypertrophy
|
Autres médicaments utilisés dans l'hypertrophie bénigne de la prostate
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CX01 |
Prunus africanae cortex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CX02 |
Sabalis serrulatae fructus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CX03 |
mepartricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
G04CX04 |
fexapotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AA |
ACTH
|
ACTH
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AA01 |
corticotropin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AA02 |
tetracosactide
|
Tétracosactide
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AB |
Thyrotropin
|
Thyrotrophine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AB01 |
thyrotropin alfa
|
Thyrotropine alfa
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC |
Somatropin and somatropin agonists
|
Somatotropine et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC01 |
somatropin
|
Somatropine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC02 |
somatrem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC03 |
mecasermin
|
Mécasermine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC04 |
sermorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC05 |
mecasermin rinfabate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AC06 |
tesamorelin
|
Tésamoréline
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AX |
Other anterior pituitary lobe hormones and analogues
|
Autres hormones de l'anté-hypophyse et analogue
|
WHO |
Active |
2021-06-09 15:34:07 |
H01AX01 |
pegvisomant
|
Pegvisomant
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA |
Vasopressin and analogues
|
Vasopressine et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA01 |
vasopressin (argipressin)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA02 |
desmopressin
|
Desmopressine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA03 |
lypressin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA04 |
terlipressin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BA05 |
ornipressin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BB |
Oxytocin and analogues
|
Oxytocine et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BB01 |
demoxytocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BB02 |
oxytocin
|
Oxytocine/Ocytocine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01BB03 |
carbetocin
|
Carbétocine
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CA |
Gonadotropin-releasing hormones
|
Hormones entraînant la libération de gonadotrophines
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CA01 |
gonadorelin
|
Gonadoréline
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CA02 |
nafarelin
|
Nafaréline
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB |
Somatostatin and analogues
|
Somatostatine et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB01 |
somatostatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB02 |
octreotide
|
Octréotide
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB03 |
lanreotide
|
Lanréotide
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB04 |
vapreotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CB05 |
pasireotide
|
PASIRÉOTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CC |
Anti-gonadotropin-releasing hormones
|
Anti-hormones entraînant la libération de gonadotrophine
|
WHO |
Active |
2021-10-25 19:07:26 |
H01CC01 |
ganirelix
|
Ganirélix
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CC02 |
cetrorelix
|
Cétrorélix
|
WHO |
Active |
2021-06-09 15:34:07 |
H01CC03 |
elagolix
|
élagolix
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AA |
Mineralocorticoids
|
Minéralocorticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AA01 |
aldosterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AA02 |
fludrocortisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AA03 |
desoxycortone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB |
Glucocorticoids
|
Glucocorticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB01 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB02 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB03 |
fluocortolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB04 |
methylprednisolone
|
Méthylprednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB05 |
paramethasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB06 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB07 |
prednisone
|
Prednisone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB08 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB09 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB10 |
cortisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB11 |
prednylidene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB12 |
rimexolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB13 |
deflazacort
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB14 |
cloprednol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB15 |
meprednisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02AB17 |
cortivazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02BX |
Corticosteroids for systemic use, combinations
|
Corticoïdes à usage systémique en association
|
WHO |
Active |
2021-06-09 15:34:07 |
H02BX01 |
methylprednisolone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H02CA |
Anticorticosteroids
|
Inhibiteurs de corticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
H02CA01 |
trilostane
|
Trilostane
|
WHO |
Active |
2021-06-09 15:34:07 |
H02CA02 |
osilodrostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA |
Thyroid hormones
|
Hormones thyroïdiennes
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA01 |
levothyroxine sodium
|
Lévothyroxine sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA02 |
liothyronine sodium
|
Liothyronine sodique
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA03 |
combinations of levothyroxine and liothyronine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA04 |
tiratricol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03AA05 |
thyroid gland preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BA |
Thiouracils
|
Thiouraciles
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BA01 |
methylthiouracil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BA02 |
propylthiouracil
|
Propylthiouracile
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BA03 |
benzylthiouracil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BB |
Sulfur-containing imidazole derivatives
|
Dérivés imidazolés soufrés
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BB01 |
carbimazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BB02 |
thiamazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BB52 |
thiamazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BC |
Perchlorates
|
Perchlorates
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BC01 |
potassium perchlorate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BX |
Other antithyroid preparations
|
Autres antithyroïdiens
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BX01 |
diiodotyrosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H03BX02 |
dibromotyrosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H04AA |
Glycogenolytic hormones
|
Hormones glycogénolytiques
|
WHO |
Active |
2021-06-09 15:34:07 |
H04AA01 |
glucagon
|
Glucagon
|
WHO |
Active |
2021-06-09 15:34:07 |
H05AA |
Parathyroid hormones and analogues
|
Hormones parathyroïdiennes
|
WHO |
Active |
2021-06-09 15:34:07 |
H05AA01 |
parathyroid gland extract
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05AA02 |
teriparatide
|
Tériparatide
|
WHO |
Active |
2021-06-09 15:34:07 |
H05AA03 |
parathyroid hormone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BA |
Calcitonin preparations
|
Calcitonines
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BA01 |
calcitonin (salmon synthetic)
|
Calcitonine synthétique de saumon
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BA02 |
calcitonin (pork natural)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BA03 |
calcitonin (human synthetic)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BA04 |
elcatonin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BX |
Other anti-parathyroid agents
|
Autres agents antiparathyroïdiens
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BX01 |
cinacalcet
|
Cinacalcet
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BX02 |
paricalcitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BX03 |
doxercalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
H05BX04 |
etelcalcetide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA |
Tetracyclines
|
Tétracyclines
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA01 |
demeclocycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA02 |
doxycycline
|
Doxycycline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA03 |
chlortetracycline
|
Chlortétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA04 |
lymecycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA05 |
metacycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA06 |
oxytetracycline
|
Oxytétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA07 |
tetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA08 |
minocycline
|
Minocycline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA09 |
rolitetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA10 |
penimepicycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA11 |
clomocycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA12 |
tigecycline
|
Tigécycline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA13 |
eravacycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA14 |
sarecycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA15 |
omadacycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA20 |
combinations of tetracyclines
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01AA56 |
oxytetracycline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01BA |
Amphenicols
|
Phénicols
|
WHO |
Active |
2021-06-09 15:34:07 |
J01BA01 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
J01BA02 |
thiamphenicol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01BA52 |
thiamphenicol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA |
Penicillins with extended spectrum
|
Pénicillines à spectre large
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA01 |
ampicillin
|
Ampicilline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA02 |
pivampicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA03 |
carbenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA04 |
amoxicillin
|
Amoxicilline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA05 |
carindacillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA06 |
bacampicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA07 |
epicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA08 |
pivmecillinam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA09 |
azlocillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA10 |
mezlocillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA11 |
mecillinam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA12 |
piperacillin
|
Pipéracilline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA13 |
ticarcillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA14 |
metampicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA15 |
talampicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA16 |
sulbenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA17 |
temocillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA18 |
hetacillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA19 |
aspoxicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CA51 |
ampicillin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE |
Beta-lactamase sensitive penicillins
|
Pénicillines sensibles aux bêta-lactamases
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE01 |
benzylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE02 |
phenoxymethylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE03 |
propicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE04 |
azidocillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE05 |
pheneticillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE06 |
penamecillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE07 |
clometocillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE08 |
benzathine benzylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE09 |
procaine benzylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE10 |
benzathine phenoxymethylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CE30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF |
Beta-lactamase resistant penicillins
|
Pénicillines résistantes aux bêta-lactamases
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF01 |
dicloxacillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF02 |
cloxacillin
|
Cloxacilline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF03 |
meticillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF04 |
oxacillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF05 |
flucloxacillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CF06 |
nafcillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CG |
Beta-lactamase inhibitors
|
Inhibiteurs des bêta-lactamases
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CG01 |
sulbactam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CG02 |
tazobactam
|
Tazobactam
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR |
Combinations of penicillins, incl. beta-lactamase inhibitors
|
Associations de pénicillines avec un inhibiteur des bêta-lactamases
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR01 |
ampicillin and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR02 |
amoxicillin and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR03 |
ticarcillin and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR04 |
sultamicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR05 |
piperacillin and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01CR50 |
combinations of penicillins
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB |
First-generation cephalosporins
|
Céphalosporines de première génération
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB01 |
cefalexin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB02 |
cefaloridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB03 |
cefalotin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB04 |
cefazolin
|
Céfazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB05 |
cefadroxil
|
Céfadroxil
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB06 |
cefazedone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB07 |
cefatrizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB08 |
cefapirin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB09 |
cefradine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB10 |
cefacetrile
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB11 |
cefroxadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DB12 |
ceftezole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC |
Second-generation cephalosporins
|
Céphalosporines de deuxième génération
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC01 |
cefoxitin
|
Céfoxitine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC02 |
cefuroxime
|
Céfuroxime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC03 |
cefamandole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC04 |
cefaclor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC05 |
cefotetan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC06 |
cefonicid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC07 |
cefotiam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC08 |
loracarbef
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC09 |
cefmetazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC10 |
cefprozil
|
Cefprozil
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC11 |
ceforanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC12 |
cefminox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC13 |
cefbuperazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DC14 |
flomoxef
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD |
Third-generation cephalosporins
|
Céphalosporines de troisième génération
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD01 |
cefotaxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD02 |
ceftazidime
|
Ceftazidime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD03 |
cefsulodin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD04 |
ceftriaxone
|
Ceftriaxone
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD05 |
cefmenoxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD06 |
latamoxef
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD07 |
ceftizoxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD08 |
cefixime
|
Céfixime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD09 |
cefodizime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD10 |
cefetamet
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD11 |
cefpiramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD12 |
cefoperazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD13 |
cefpodoxime
|
Cefpodoxime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD14 |
ceftibuten
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD15 |
cefdinir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD16 |
cefditoren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD17 |
cefcapene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD18 |
cefteram
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD51 |
cefotaxime and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD52 |
ceftazidime and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD54 |
ceftriaxone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD62 |
cefoperazone and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD63 |
ceftriaxone and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DD64 |
cefpodoxime and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DE |
Fourth-generation cephalosporins
|
Céphalosporines de quatrième génération
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DE01 |
cefepime
|
Céfépime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DE02 |
cefpirome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DE03 |
cefozopran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DF |
Monobactams
|
Monobactames
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DF01 |
aztreonam
|
Aztréonam
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DF02 |
carumonam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH |
Carbapenems
|
Carbapénèmes
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH02 |
meropenem
|
Méropénem
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH03 |
ertapenem
|
Ertapénem
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH04 |
doripenem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH05 |
biapenem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH06 |
tebipenem pivoxil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH51 |
imipenem and cilastatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH52 |
meropenem and vaborbactam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH55 |
panipenem and betamipron
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DH56 |
imipenem, cilastatin and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DI |
Other cephalosporins and penems
|
Autres céphalosporines et pénèmes
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DI01 |
ceftobiprole medocaril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DI02 |
ceftaroline fosamil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DI03 |
faropenem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01DI54 |
ceftolozane and beta-lactamase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EA |
Trimethoprim and derivatives
|
Triméthoprime et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EA01 |
trimethoprim
|
Triméthoprime
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EA02 |
brodimoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EA03 |
iclaprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB |
Short-acting sulfonamides
|
Sulfamidés de courte demi-vie
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB01 |
sulfaisodimidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB02 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB03 |
sulfadimidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB04 |
sulfapyridine
|
Sulfapyridine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB05 |
sulfafurazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB06 |
sulfanilamide
|
Sulfanilamide
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB07 |
sulfathiazole
|
Sulfathiazol
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB08 |
sulfathiourea
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EB20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EC |
Intermediate-acting sulfonamides
|
Sulfamidés de demi-vie intermédiaire
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EC01 |
sulfamethoxazole
|
Sulfaméthoxazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EC02 |
sulfadiazine
|
Sulfadiazine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EC03 |
sulfamoxole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EC20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED |
Long-acting sulfonamides
|
Sulfamidés de longue demi-vie
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED01 |
sulfadimethoxine
|
Sulfadiméthoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED02 |
sulfalene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED03 |
sulfametomidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED04 |
sulfametoxydiazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED05 |
sulfamethoxypyridazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED06 |
sulfaperin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED07 |
sulfamerazine
|
Sulfamérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED08 |
sulfaphenazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED09 |
sulfamazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01ED20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE |
Combinations of sulfonamides and trimethoprim, incl. derivatives
|
Associations de sulfamidés et triméthoprime, y compris des dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE01 |
sulfamethoxazole and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE02 |
sulfadiazine and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE03 |
sulfametrole and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE04 |
sulfamoxole and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE05 |
sulfadimidine and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE06 |
sulfadiazine and tetroxoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01EE07 |
sulfamerazine and trimethoprim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA |
Macrolides
|
Macrolides
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA01 |
erythromycin
|
Érythromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA02 |
spiramycin
|
Spiramycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA03 |
midecamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA05 |
oleandomycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA06 |
roxithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA07 |
josamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA08 |
troleandomycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA09 |
clarithromycin
|
Clarithromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA10 |
azithromycin
|
Azithromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA11 |
miocamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA12 |
rokitamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA13 |
dirithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA14 |
flurithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA15 |
telithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FA16 |
solithromycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FF |
Lincosamides
|
Lincosamides
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FF01 |
clindamycin
|
Clindamycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FF02 |
lincomycin
|
Lincomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FG |
Streptogramins
|
Streptogramines
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FG01 |
pristinamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01FG02 |
quinupristin/dalfopristin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GA |
Streptomycins
|
Streptomycines
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GA01 |
streptomycin
|
Streptomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GA02 |
streptoduocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB |
Other aminoglycosides
|
Autres aminosides
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB01 |
tobramycin
|
Tobramycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB03 |
gentamicin
|
Gentamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB04 |
kanamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB05 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB06 |
amikacin
|
Amikacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB07 |
netilmicin
|
Nétilmicine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB08 |
sisomicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB09 |
dibekacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB10 |
ribostamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB11 |
isepamicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB12 |
arbekacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB13 |
bekanamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01GB14 |
plazomicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA |
Fluoroquinolones
|
Fluoroquinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA01 |
ofloxacin
|
Ofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA02 |
ciprofloxacin
|
Ciprofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA03 |
pefloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA04 |
enoxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA05 |
temafloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA06 |
norfloxacin
|
Norfloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA07 |
lomefloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA08 |
fleroxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA09 |
sparfloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA10 |
rufloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA11 |
grepafloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA12 |
levofloxacin
|
Lévofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA13 |
trovafloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA14 |
moxifloxacin
|
Moxifloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA15 |
gemifloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA16 |
gatifloxacin
|
Gatifloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA17 |
prulifloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA18 |
pazufloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA19 |
garenoxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA21 |
sitafloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA22 |
tosufloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MA23 |
delafloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB |
Other quinolones
|
Autres quinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB01 |
rosoxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB02 |
nalidixic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB03 |
piromidic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB04 |
pipemidic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB05 |
oxolinic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB06 |
cinoxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB07 |
flumequine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01MB08 |
nemonoxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA |
Combinations of antibacterials
|
Associations d'antibactériens
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA01 |
penicillins, combinations with other antibacterials
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA02 |
sulfonamides, combinations with other antibacterials (excl. trimethoprim)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA04 |
spiramycin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA05 |
levofloxacin and ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA06 |
cefepime and amikacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA07 |
azithromycin, fluconazole and secnidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA08 |
tetracycline and oleandomycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA09 |
ofloxacin and ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA10 |
ciprofloxacin and metronidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA11 |
ciprofloxacin and tinidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA12 |
ciprofloxacin and ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01RA13 |
norfloxacin and tinidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA |
Glycopeptide antibacterials
|
Antibactériens glycopeptides
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA01 |
vancomycin
|
Vancomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA02 |
teicoplanin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA03 |
telavancin
|
Télavancine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA04 |
dalbavancin
|
DALBAVANCINE
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XA05 |
oritavancin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XB |
Polymyxins
|
Polymyxines
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XB01 |
colistin
|
Colistine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XB02 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XC |
Steroid antibacterials
|
Antibactériens stéroïdiens
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XC01 |
fusidic acid
|
Acide fusidique
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XD |
Imidazole derivatives
|
Dérivés de l'imidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XD01 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XD02 |
tinidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XD03 |
ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XE |
Nitrofuran derivatives
|
Dérivés du nitrofurane
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XE01 |
nitrofurantoin
|
Nitrofurantoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XE02 |
nifurtoinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XE03 |
furazidin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XE51 |
nitrofurantoin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX |
Other antibacterials
|
Autres antibactériens
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX01 |
fosfomycin
|
Fosfomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX02 |
xibornol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX03 |
clofoctol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX04 |
spectinomycin
|
Spectinomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX05 |
methenamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX06 |
mandelic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX07 |
nitroxoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX08 |
linezolid
|
Linézolide
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX09 |
daptomycin
|
Daptomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX10 |
bacitracin
|
Bacitracine
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX11 |
tedizolid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J01XX12 |
lefamulin
|
Léfamuline
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AA |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AA01 |
amphotericin B
|
Amphotéricine b
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AA02 |
hachimycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AB |
Imidazole derivatives
|
Dérivés Imidazoles
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AB01 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AB02 |
ketoconazole
|
Kétoconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC |
Triazole derivatives
|
Dérivés Triazoles
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC01 |
fluconazole
|
Fluconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC02 |
itraconazole
|
Itraconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC03 |
voriconazole
|
Voriconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC04 |
posaconazole
|
Posaconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AC05 |
isavuconazole
|
ISAVUCONAZOLE
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AX |
Other antimycotics for systemic use
|
Autres anti-mycotiques systémiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AX01 |
flucytosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AX04 |
caspofungin
|
Caspofungine
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AX05 |
micafungin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J02AX06 |
anidulafungin
|
Anidulafungine
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AA |
Aminosalicylic acid and derivatives
|
Acide aminosalicylique et ses dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AA01 |
4-aminosalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AA02 |
sodium aminosalicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AA03 |
calcium aminosalicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB01 |
cycloserine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB02 |
rifampicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB03 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB04 |
rifabutin
|
Rifabutine
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB05 |
rifapentine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB06 |
enviomycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AB30 |
capreomycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AC |
Hydrazides
|
Hydrazides
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AC01 |
isoniazid
|
Isoniazide
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AC51 |
isoniazid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AD |
Thiocarbamide derivatives
|
Dérivés du thiocarbamide
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AD01 |
protionamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AD02 |
tiocarlide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AD03 |
ethionamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK |
Other drugs for treatment of tuberculosis
|
Autres médicaments antituberculeux
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK01 |
pyrazinamide
|
Pyrazinamide
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK02 |
ethambutol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK03 |
terizidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK04 |
morinamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK05 |
bedaquiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK06 |
delamanid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AK07 |
thioacetazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM |
Combinations of drugs for treatment of tuberculosis
|
Associations de médicaments antituberculeux
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM02 |
rifampicin and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM03 |
ethambutol and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM04 |
thioacetazone and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM05 |
rifampicin, pyrazinamide and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM06 |
rifampicin, pyrazinamide, ethambutol and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM07 |
rifampicin, ethambutol and isoniazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04AM08 |
isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04BA |
Drugs for treatment of lepra
|
Médicaments pour le traitement de la lèpre
|
WHO |
Active |
2021-06-09 15:34:07 |
J04BA01 |
clofazimine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J04BA02 |
dapsone
|
Dapsone
|
WHO |
Active |
2021-06-09 15:34:07 |
J04BA03 |
aldesulfone sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AA |
Thiosemicarbazones
|
Thiosémicarbazones
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AA01 |
metisazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB |
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
Nucléosides et nucléotides, inhibiteurs de la transcriptase inverse exclus
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB01 |
aciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB02 |
idoxuridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB03 |
vidarabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB06 |
ganciclovir
|
Ganciclovir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB09 |
famciclovir
|
Famciclovir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB11 |
valaciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB12 |
cidofovir
|
Cidofovir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB13 |
penciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB14 |
valganciclovir
|
Valganciclovir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AB15 |
brivudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AC |
Cyclic amines
|
Amines cycliques
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AC02 |
rimantadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AC03 |
tromantadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AD |
Phosphonic acid derivatives
|
Dérivés de l'acide phosphonique
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AD01 |
foscarnet
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE |
Protease inhibitors
|
Inhibiteurs de protéase
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE01 |
saquinavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE02 |
indinavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE03 |
ritonavir
|
Ritonavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE04 |
nelfinavir
|
Nelfinavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE05 |
amprenavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE07 |
fosamprenavir
|
Fosamprénavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE08 |
atazanavir
|
Atazanavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE09 |
tipranavir
|
Tipranavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AE10 |
darunavir
|
Darunavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF |
Nucleoside and nucleotide reverse transcriptase inhibitors
|
Inhibiteurs de la transcriptase inverse nucléosidiques et nucléotidiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF01 |
zidovudine
|
Zidovudine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF02 |
didanosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF03 |
zalcitabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF04 |
stavudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF05 |
lamivudine
|
Lamivudine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF06 |
abacavir
|
Abacavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF07 |
tenofovir disoproxil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF08 |
adefovir dipivoxil
|
Adéfovir dipivoxil
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF09 |
emtricitabine
|
Emtricitabine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF10 |
entecavir
|
Entécavir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF11 |
telbivudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF12 |
clevudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AF13 |
tenofovir alafenamide
|
Ténofovir alafénamide
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG |
Non-nucleoside reverse transcriptase inhibitors
|
Inhibiteurs de la transcriptase inverse non nucléosides
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG01 |
nevirapine
|
Névirapine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG02 |
delavirdine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG03 |
efavirenz
|
Éfavirenz
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG04 |
etravirine
|
Étravirine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG05 |
rilpivirine
|
Rilpivirine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AG06 |
doravirine
|
DORAVIRINE
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AH |
Neuraminidase inhibitors
|
Inhibiteurs de la neuraminidase
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AH01 |
zanamivir
|
Zanamivir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AH02 |
oseltamivir
|
Oséltamivir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AH03 |
peramivir
|
Péramivir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AH04 |
laninamivir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP |
Antivirals for treatment of HCV infections
|
Antiviraux pour le traitement des infections au VHC
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP01 |
ribavirin
|
Ribavirine
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP02 |
telaprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP03 |
boceprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP04 |
faldaprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP05 |
simeprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP06 |
asunaprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP07 |
daclatasvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP08 |
sofosbuvir
|
Sofosbuvir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP09 |
dasabuvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP10 |
elbasvir
|
Elbasvir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP11 |
grazoprevir
|
Grazoprévir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP51 |
sofosbuvir and ledipasvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP52 |
dasabuvir, ombitasvir, paritaprevir and ritonavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP53 |
ombitasvir, paritaprevir and ritonavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP54 |
elbasvir and grazoprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP55 |
sofosbuvir and velpatasvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP56 |
sofosbuvir, velpatasvir and voxilaprevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP57 |
glecaprevir and pibrentasvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AP58 |
daclatasvir, asunaprevir and beclabuvir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR |
Antivirals for treatment of HIV infections, combinations
|
Antiviraux pour le traitement des infections HIV en association
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR01 |
zidovudine and lamivudine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR02 |
lamivudine and abacavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR03 |
tenofovir disoproxil and emtricitabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR04 |
zidovudine, lamivudine and abacavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR05 |
zidovudine, lamivudine and nevirapine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR06 |
emtricitabine, tenofovir disoproxil and efavirenz
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR07 |
stavudine, lamivudine and nevirapine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR08 |
emtricitabine, tenofovir disoproxil and rilpivirine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR09 |
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
Emtricitabine, ténofovir disoproxil, élvitegravir et cobicistat
|
WHO |
Active |
2021-10-01 12:48:43 |
J05AR10 |
lopinavir and ritonavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR11 |
lamivudine, tenofovir disoproxil and efavirenz
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR12 |
lamivudine and tenofovir disoproxil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR13 |
lamivudine, abacavir and dolutegravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR14 |
darunavir and cobicistat
|
darunavir et cobicistat
|
WHO |
Active |
2022-12-08 09:56:29 |
J05AR15 |
atazanavir and cobicistat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR16 |
lamivudine and raltegravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR17 |
emtricitabine and tenofovir alafenamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR18 |
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR19 |
emtricitabine, tenofovir alafenamide and rilpivirine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR20 |
emtricitabine, tenofovir alafenamide and bictegravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR21 |
dolutegravir and rilpivirine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR22 |
emtricitabine, tenofovir alafenamide, darunavir and cobicistat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR23 |
atazanavir and ritonavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR24 |
lamivudine, tenofovir disoproxil and doravirine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR25 |
lamivudine and dolutegravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR26 |
darunavir and ritonavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AR27 |
lamivudine, tenofovir disoproxil and dolutegravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX |
Other antivirals
|
Autres antiviraux
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX01 |
moroxydine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX02 |
lysozyme
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX05 |
inosine pranobex
|
Inosine pranobex
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX06 |
pleconaril
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX07 |
enfuvirtide
|
Enfuvirtide
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX08 |
raltegravir
|
Raltégravir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX09 |
maraviroc
|
Maraviroc
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX10 |
maribavir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX11 |
elvitegravir
|
Elvitegravir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX12 |
dolutegravir
|
DOLUTÉGRAVIR
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX13 |
umifenovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX17 |
enisamium iodide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX18 |
letermovir
|
Létermovir
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX19 |
tilorone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX21 |
pentanedioic acid imidazolyl ethanamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX23 |
ibalizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX24 |
tecovirimat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX25 |
baloxavir marboxil
|
BALOXAVIR MARBOXIL
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX26 |
amenamevir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J05AX27 |
favipiravir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA |
Immune sera
|
Immunsérums
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA01 |
diphtheria antitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA02 |
tetanus antitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA03 |
snake venom antiserum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA04 |
botulinum antitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA05 |
gas-gangrene sera
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06AA06 |
rabies serum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BA |
Immunoglobulins, normal human
|
Immunoglobulines humaines normales
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BA01 |
immunoglobulins, normal human, for extravascular adm.
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BA02 |
immunoglobulins, normal human, for intravascular adm.
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB |
Specific immunoglobulins
|
Immunoglobulines spécifiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB01 |
anti-D (rh) immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB02 |
tetanus immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB03 |
varicella/zoster immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB04 |
hepatitis B immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB05 |
rabies immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB06 |
rubella immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB07 |
vaccinia immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB08 |
staphylococcus immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB09 |
cytomegalovirus immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB11 |
hepatitis A immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB12 |
encephalitis, tick borne immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB13 |
pertussis immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB14 |
measles immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB16 |
palivizumab
|
Palivizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB17 |
motavizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB18 |
raxibacumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB19 |
anthrax immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB21 |
bezlotoxumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB22 |
obiltoxaximab
|
Obiltoxaximab
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BB30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BC |
Other immunoglobulins
|
Autres immunoglobulines
|
WHO |
Active |
2021-06-09 15:34:07 |
J06BC01 |
nebacumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AC |
Anthrax vaccines
|
Vaccins contre le charbon
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AC01 |
anthrax antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AD |
Brucellosis vaccines
|
Vaccins antibrucelliques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AD01 |
brucella antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AE |
Cholera vaccines
|
Vaccins anticholériques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AE01 |
cholera, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AE02 |
cholera, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AE51 |
cholera, combinations with typhoid vaccine, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AF |
Diphtheria vaccines
|
Vaccins antidiphtériques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AF01 |
diphtheria toxoid
|
Anatoxine diphtérique
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AG |
Haemophilus influenzae B vaccines
|
Vaccins anti-Hæmophilus influenzæ B
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AG01 |
hemophilus influenzae B, purified antigen conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AG51 |
hemophilus influenzae B, combinations with toxoids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AG52 |
hemophilus influenzae B, combinations with pertussis and toxoids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AG53 |
hemophilus influenzae B, combinations with meningococcus C, conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH |
Meningococcal vaccines
|
Vaccins antiméningococciques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH01 |
meningococcus A, purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH02 |
other meningococcal monovalent purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH03 |
meningococcus A,C, bivalent purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH04 |
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH05 |
other meningococcal polyvalent purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH06 |
meningococcus B, outer membrane vesicle vaccine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH07 |
meningococcus C, purified polysaccharides antigen conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH08 |
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH09 |
meningococcus B, multicomponent vaccine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AH10 |
meningococcus A, purified polysaccharides antigen conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AJ |
Pertussis vaccines
|
Vaccins contre la coqueluche
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AJ01 |
pertussis, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AJ02 |
pertussis, purified antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AJ51 |
pertussis, inactivated, whole cell, combinations with toxoids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AJ52 |
pertussis, purified antigen, combinations with toxoids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AK |
Plague vaccines
|
Vaccins contre la peste
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AK01 |
plague, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AL |
Pneumococcal vaccines
|
Vaccins antipneumococciques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AL01 |
pneumococcus, purified polysaccharides antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AL02 |
pneumococcus, purified polysaccharides antigen conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AL52 |
pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AM |
Tetanus vaccines
|
Vaccins antitétaniques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AM01 |
tetanus toxoid
|
Anatoxine tétanique
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AM51 |
tetanus toxoid, combinations with diphtheria toxoid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AM52 |
tetanus toxoid, combinations with tetanus immunoglobulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AN |
Tuberculosis vaccines
|
Vaccins antituberculeux
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AN01 |
tuberculosis, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AP |
Typhoid vaccines
|
Vaccins antityphoïdiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AP01 |
typhoid, oral, live attenuated
|
Typhoïde, bactérie vivante atténuée orale
|
WHO |
Active |
2024-11-15 11:39:08 |
J07AP02 |
typhoid, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AP03 |
typhoid, purified polysaccharide antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AP10 |
typhoid, combinations with paratyphi types
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AR |
Typhus (exanthematicus) vaccines
|
Vaccins contre le typhus (exanthématique)
|
WHO |
Active |
2021-06-09 15:34:07 |
J07AR01 |
typhus exanthematicus, inactivated, whole cell
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BA |
Encephalitis vaccines
|
Vaccins contre les encéphalite
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BA01 |
encephalitis, tick borne, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BA02 |
encephalitis, Japanese, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BA03 |
encephalitis, Japanese, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BB |
Influenza vaccines
|
Vaccins antigrippaux
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BB01 |
influenza, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BB02 |
influenza, inactivated, split virus or surface antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BB03 |
influenza, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BC |
Hepatitis vaccines
|
Vaccins contre l'hépatite
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BC01 |
hepatitis B, purified antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BC02 |
hepatitis A, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BC20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD |
Measles vaccines
|
Vaccins contre la rougeole
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD01 |
measles, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD51 |
measles, combinations with mumps, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD52 |
measles, combinations with mumps and rubella, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD53 |
measles, combinations with rubella, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BD54 |
measles, combinations with mumps, rubella and varicella, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BE |
Mumps vaccines
|
Vaccins contre les oreil
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BE01 |
mumps, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BF |
Poliomyelitis vaccines
|
Vaccins contre la poliomyélite
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BF01 |
poliomyelitis oral, monovalent, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BF02 |
poliomyelitis oral, trivalent, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BF03 |
poliomyelitis, trivalent, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BF04 |
poliomyelitis oral, bivalent, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BG |
Rabies vaccines
|
Vaccins antirabiques
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BG01 |
rabies, inactivated, whole virus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BH |
Rota virus diarrhea vaccines
|
Vaccins contre les diarrhées à rotavirus
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BH01 |
rota virus, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BH02 |
rota virus, pentavalent, live, reassorted
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BJ |
Rubella vaccines
|
Vaccins contre la rubéole
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BJ01 |
rubella, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BJ51 |
rubella, combinations with mumps, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BK |
Varicella zoster vaccines
|
Vaccins contre varicelle-zona
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BK01 |
varicella, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BK02 |
zoster, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BK03 |
zoster, purified antigen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BL |
Yellow fever vaccines
|
Vaccins contre la fièvre jaune
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BL01 |
yellow fever, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BM |
Papillomavirus vaccines
|
Vaccin contre Papillomavirus
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BM01 |
papillomavirus (human types 6, 11, 16, 18)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BM02 |
papillomavirus (human types 16, 18)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BM03 |
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BX |
Other viral vaccines
|
Autres vaccins viraux
|
WHO |
Active |
2021-06-09 15:34:07 |
J07BX01 |
smallpox, live attenuated
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA |
Bacterial and viral vaccines, combined
|
Vaccins bactériens et viraux associés
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA01 |
diphtheria-poliomyelitis-tetanus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA02 |
diphtheria-pertussis-poliomyelitis-tetanus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA04 |
hemophilus influenzae B and poliomyelitis
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA05 |
diphtheria-hepatitis B-pertussis-tetanus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA06 |
diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA07 |
diphtheria-hepatitis B-tetanus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA08 |
hemophilus influenzae B and hepatitis B
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA09 |
diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA10 |
typhoid-hepatitis A
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA11 |
diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B
|
|
WHO |
Active |
2021-06-09 15:34:07 |
J07CA12 |
diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA |
Nitrogen mustard analogues
|
Analogues de moutarde azotée
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA01 |
cyclophosphamide
|
Cyclophosphamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA02 |
chlorambucil
|
Chlorambucil
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA03 |
melphalan
|
Melphalan
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA05 |
chlormethine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA06 |
ifosfamide
|
Ifosfamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA07 |
trofosfamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA08 |
prednimustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AA09 |
bendamustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AB |
Alkyl sulfonates
|
Sulfonates d'alkyle
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AB01 |
busulfan
|
Busulfan
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AB02 |
treosulfan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AB03 |
mannosulfan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AC |
Ethylene imines
|
Imines d'éthylène
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AC01 |
thiotepa
|
Thiotépa
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AC02 |
triaziquone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AC03 |
carboquone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD |
Nitrosoureas
|
Nitrosourées
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD01 |
carmustine
|
Carmustine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD02 |
lomustine
|
Lomustine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD03 |
semustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD04 |
streptozocin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD05 |
fotemustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD06 |
nimustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD07 |
ranimustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AD08 |
uramustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AG |
Epoxides
|
Époxydes
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AG01 |
etoglucid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AX |
Other alkylating agents
|
Autre agents alkylants
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AX01 |
mitobronitol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AX02 |
pipobroman
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AX03 |
temozolomide
|
Témozolomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L01AX04 |
dacarbazine
|
Dacarbazine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BA |
Folic acid analogues
|
Analogues de l'acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BA01 |
methotrexate
|
Méthotrexate
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BA03 |
raltitrexed
|
Raltitrexed
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BA04 |
pemetrexed
|
Pémétrexed
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BA05 |
pralatrexate
|
Pralatrexate
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB |
Purine analogues
|
Analogues de la purine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB02 |
mercaptopurine
|
Mercaptopurine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB03 |
tioguanine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB04 |
cladribine
|
Cladribine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB05 |
fludarabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB06 |
clofarabine
|
Clofarabine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BB07 |
nelarabine
|
Nélarabine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC |
Pyrimidine analogues
|
Analogues de la pyrimidine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC01 |
cytarabine
|
Cytarabine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC02 |
fluorouracil
|
Fluorouracil
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC03 |
tegafur
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC04 |
carmofur
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC05 |
gemcitabine
|
Gemcitabine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC06 |
capecitabine
|
Capécitabine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC07 |
azacitidine
|
Azacitidine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC08 |
decitabine
|
DÉCITABINE
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC09 |
floxuridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC52 |
fluorouracil, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC53 |
tegafur, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01BC59 |
trifluridine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA |
Vinca alkaloids and analogues
|
Alcaloïdes de Vinca et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA01 |
vinblastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA02 |
vincristine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA03 |
vindesine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA04 |
vinorelbine
|
Vinorelbine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA05 |
vinflunine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CA06 |
vintafolide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CB |
Podophyllotoxin derivatives
|
Dérivés de la podophyllotoxine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CB01 |
etoposide
|
Étoposide
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CB02 |
teniposide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CC |
Colchicine derivatives
|
Dérivés de la colchicine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CC01 |
demecolcine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CD |
Taxanes
|
Taxanes
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CD01 |
paclitaxel
|
Paclitaxel
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CD02 |
docetaxel
|
Docétaxel
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CD03 |
paclitaxel poliglumex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CD04 |
cabazitaxel
|
Cabazitaxel
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CX |
Other plant alkaloids and natural products
|
Autres alcaloïdes végétaux et produits naturels
|
WHO |
Active |
2021-06-09 15:34:07 |
L01CX01 |
trabectedin
|
Trabectédine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DA |
Actinomycines
|
Actinomycines
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DA01 |
dactinomycin
|
Dactinomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB |
Anthracyclines and related substances
|
Anthracyclines et substances apparentées
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB01 |
doxorubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB02 |
daunorubicin
|
Daunorubicine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB03 |
epirubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB04 |
aclarubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB05 |
zorubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB06 |
idarubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB07 |
mitoxantrone
|
Mitoxantrone
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB08 |
pirarubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB09 |
valrubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB10 |
amrubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DB11 |
pixantrone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DC |
Other cytotoxic antibiotics
|
Autres antibiotiques cytotoxiques
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DC01 |
bleomycin
|
Bléomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DC02 |
plicamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DC03 |
mitomycin
|
Mitomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01DC04 |
ixabepilone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA |
Platinum compounds
|
Composés du platine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA01 |
cisplatin
|
Cisplatine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA02 |
carboplatin
|
Carboplatine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA03 |
oxaliplatin
|
Oxaliplatine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA04 |
satraplatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XA05 |
polyplatillen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XB |
Methylhydrazines
|
Méthylhydrazines
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XB01 |
procarbazine
|
Procarbazine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC |
Monoclonal antibodies
|
Anticorps monoclonaux
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC01 |
edrecolomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01FA01 |
rituximab
|
Rituximab
|
WHO |
Active |
2024-10-04 11:09:28 |
L01XC03 |
trastuzumab
|
Trastuzumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC05 |
gemtuzumab ozogamicin
|
GEMTUZUMAB OZOGAMICINE
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC06 |
cetuximab
|
Cétuximab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC07 |
bevacizumab
|
Bévacizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC08 |
panitumumab
|
Panitumumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC09 |
catumaxomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC10 |
ofatumumab
|
Ofatumumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC11 |
ipilimumab
|
Ipilimumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC12 |
brentuximab vedotin
|
Brentuximab Védotine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC13 |
pertuzumab
|
Pertuzumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC14 |
trastuzumab emtansine
|
TRASTUZUMAB EMTANSINE
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC15 |
obinutuzumab
|
Obinutuzumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC16 |
dinutuximab beta
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC17 |
nivolumab
|
Nivolumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC18 |
pembrolizumab
|
Pembrolizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC19 |
blinatumomab
|
Blinatumomab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC21 |
ramucirumab
|
RAMUCIRUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC22 |
necitumumab
|
Nécitumumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC23 |
elotuzumab
|
Élotuzumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC24 |
daratumumab
|
Daratumumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01FX09 |
mogamulizumab
|
Mogamulizumab
|
WHO |
Active |
2024-08-09 13:23:28 |
L01XC26 |
inotuzumab ozogamicin
|
Inotuzumab ozogamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC27 |
olaratumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC28 |
durvalumab
|
DURVALUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC29 |
ermekumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC31 |
avelumab
|
Avelumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC32 |
atezolizumab
|
ATÉZOLIZUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XC33 |
cemiplimab
|
CÉMIPLIMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD |
Sensitizers used in photodynamic/radiation therapy
|
Sensibilisants utilisés en photochimiothérapie/radiothérapie
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD01 |
porfimer sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD03 |
methyl aminolevulinate
|
Aminolévulinate méthylique
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD04 |
aminolevulinic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD05 |
temoporfin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD06 |
efaproxiral
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XD07 |
padeliporfin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE |
Not found
|
Inhibiteurs de protéine kinase
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE01 |
imatinib
|
Imatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE02 |
gefitinib
|
Géfitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE03 |
erlotinib
|
Erlotinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE04 |
sunitinib
|
Sunitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE05 |
sorafenib
|
Sorafénib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE06 |
dasatinib
|
Dasatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE07 |
lapatinib
|
Lapatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE08 |
nilotinib
|
Nilotinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE09 |
temsirolimus
|
Temsirolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE10 |
everolimus
|
Évérolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE11 |
pazopanib
|
Pazopanib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE12 |
vandetanib
|
Vandétanib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE13 |
afatinib
|
Afatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE14 |
bosutinib
|
Bosutinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE15 |
vemurafenib
|
Vémurafénib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE16 |
crizotinib
|
Crizotinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE17 |
axitinib
|
Axitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE18 |
ruxolitinib
|
Ruxolitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE19 |
ridaforolimus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE21 |
regorafenib
|
Régorafénib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE22 |
masitinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE23 |
dabrafenib
|
Dabrafénib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE24 |
ponatinib
|
Ponatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE25 |
trametinib
|
Tramétinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE26 |
cabozantinib
|
CABOZANTINIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE27 |
ibrutinib
|
Ibrutinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE28 |
ceritinib
|
CÉRITINIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE29 |
lenvatinib
|
Lenvatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE31 |
nintedanib
|
NINTÉDANIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE32 |
cediranib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE33 |
palbociclib
|
PALBOCICLIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE34 |
tivozanib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE35 |
osimertinib
|
Osimertinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE36 |
alectinib
|
Alectinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE37 |
rociletinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE38 |
cobimetinib
|
Cobimetinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE39 |
midostaurin
|
midostaurine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE40 |
olmutinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE41 |
binimetinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE42 |
ribociclib
|
Ribociclib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE43 |
brigatinib
|
Brigatinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE44 |
lorlatinib
|
LORLATINIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE45 |
neratinib
|
NÉRATINIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE46 |
encorafenib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE47 |
dacomitinib
|
Dacomitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE48 |
icotinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE50 |
abemaciclib
|
Abemaciclib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE51 |
acalabrutinib
|
ACALABRUTINIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE52 |
quizartinib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE53 |
larotrectinib
|
Larotrectinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE54 |
gilteritinib
|
Giltéritinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE56 |
entrectinib
|
Entrectinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XE57 |
fedratinib
|
Fédratinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX |
Other antineoplastic agents
|
Autres agents antinéoplasiques
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX01 |
amsacrine
|
Amsacrine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX02 |
asparaginase
|
Asparaginase
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX03 |
altretamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX05 |
hydroxycarbamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX07 |
lonidamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX08 |
pentostatin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX10 |
masoprocol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX11 |
estramustine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX14 |
tretinoin
|
Trétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX16 |
mitoguazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX17 |
topotecan
|
Topotécane
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX18 |
tiazofurine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX19 |
irinotecan
|
Irinotécan
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX22 |
alitretinoin
|
Alitrétinoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX23 |
mitotane
|
Mitotane
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX24 |
pegaspargase
|
Pégaspargase
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX25 |
bexarotene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX27 |
arsenic trioxide
|
Trioxyde d'arsénic
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX29 |
denileukin diftitox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX32 |
bortezomib
|
Bortézomib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX33 |
celecoxib
|
Célécoxib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX35 |
anagrelide
|
Anagrélide
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX36 |
oblimersen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX37 |
sitimagene ceradenovec
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX38 |
vorinostat
|
Vorinostat
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX39 |
romidepsin
|
Romidepsine
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX40 |
omacetaxine mepesuccinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX41 |
eribulin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX42 |
panobinostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX43 |
vismodegib
|
Vismodégib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX44 |
aflibercept
|
Aflibercept
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX45 |
carfilzomib
|
Carfilzomib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX46 |
olaparib
|
Olaparib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX47 |
idelalisib
|
Idélalisib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX48 |
sonidegib
|
Sonidégib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX49 |
belinostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX50 |
ixazomib
|
Ixazomib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX51 |
talimogene laherparepvec
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX52 |
venetoclax
|
Venetoclax
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX53 |
vosaroxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX54 |
niraparib
|
NIRAPARIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX55 |
rucaparib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX56 |
etirinotecan pegol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX57 |
plitidepsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX58 |
epacadostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX59 |
enasidenib
|
ÉNASIDÉNIB
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX60 |
talazoparib
|
Talazoparib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX61 |
copanlisib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX62 |
ivosidenib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX63 |
glasdegib
|
Glasdégib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX64 |
entinostat
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX65 |
alpelisib
|
Alpélisib
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX66 |
selinexor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX67 |
tagraxofusp
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XX68 |
belotecan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XY |
Combinations of antineoplastic agents
|
Associations d'agents antinéoplasiques
|
WHO |
Active |
2021-06-09 15:34:07 |
L01XY01 |
cytarabine and daunorubicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AA |
Estrogens
|
Estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AA01 |
diethylstilbestrol
|
Diéthylstilbestrol
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AA02 |
polyestradiol phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AA03 |
ethinylestradiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AA04 |
fosfestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AB |
Progestogens
|
Progestatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AB01 |
megestrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AB02 |
medroxyprogesterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AB03 |
gestonorone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE |
Gonadotropin releasing hormone analogues
|
Analogues de l'hormone entraînant la libération de gonadotrophines
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE01 |
buserelin
|
Buséréline
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE02 |
leuprorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE03 |
goserelin
|
GosérélinE
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE04 |
triptorelin
|
Triptoréline
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE05 |
histrelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02AE51 |
leuprorelin and bicalutamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BA |
Anti-estrogens
|
Anti-estrogènes
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BA01 |
tamoxifen
|
Tamoxifène
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BA02 |
toremifene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BA03 |
fulvestrant
|
Fulvestrant
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB |
Anti-androgens
|
Anti-androgènes
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB01 |
flutamide
|
Flutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB02 |
nilutamide
|
Nilutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB03 |
bicalutamide
|
Bicalutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB04 |
enzalutamide
|
Enzalutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB05 |
apalutamide
|
APALUTAMIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BB06 |
darolutamide
|
Darolutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG |
Aromatase inhibitors
|
Inhibiteurs de l'aromatase
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG01 |
aminoglutethimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG02 |
formestane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG03 |
anastrozole
|
Anastrozole
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG04 |
letrozole
|
Létrozole
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG05 |
vorozole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BG06 |
exemestane
|
Exémestane
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BX |
Other hormone antagonists and related agents
|
Autres antihormones et apparentés
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BX01 |
abarelix
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BX02 |
degarelix
|
Dégarélix
|
WHO |
Active |
2021-06-09 15:34:07 |
L02BX03 |
abiraterone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA |
Colony stimulating factors
|
Facteurs de croissance
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA02 |
filgrastim
|
FILGRASTIM
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA03 |
molgramostim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA09 |
sargramostim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA10 |
lenograstim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA12 |
ancestim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA13 |
pegfilgrastim
|
Pegfilgastrim
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA14 |
lipegfilgrastim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA15 |
balugrastim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA16 |
empegfilgrastim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AA17 |
pegteograstim
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB |
Interferons
|
Interférons
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB01 |
interferon alfa natural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB02 |
interferon beta natural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB03 |
interferon gamma
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB04 |
interferon alfa-2a
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB05 |
interferon alfa-2b
|
Interféron alfa-2b
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB06 |
interferon alfa-n1
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB07 |
interferon beta-1a
|
Interféron bêta-1A
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB08 |
interferon beta-1b
|
Interféron bêta-1B
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB09 |
interferon alfacon-1
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB10 |
peginterferon alfa-2b
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB11 |
peginterferon alfa-2a
|
Peginterféron alfa-2a
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB12 |
albinterferon alfa-2b
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB13 |
peginterferon beta-1a
|
PEGINTERFÉRON BÊTA-1A
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB14 |
cepeginterferon alfa-2b
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB15 |
ropeginterferon alfa-2b
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB60 |
peginterferon alfa-2b, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AB61 |
peginterferon alfa-2a, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AC |
Interleukins
|
Interleukines
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AC01 |
aldesleukin
|
Aldesleukine
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AC02 |
oprelvekin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX |
Other immunostimulants
|
Autres immunostimulants
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX01 |
lentinan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX02 |
roquinimex
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX03 |
BCG vaccine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX04 |
pegademase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX05 |
pidotimod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX07 |
poly I:C
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX08 |
poly ICLC
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX09 |
thymopentin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX10 |
immunocyanin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX11 |
tasonermin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX12 |
melanoma vaccine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX13 |
glatiramer acetate
|
Acétate de glatiramère
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX14 |
histamine dihydrochloride
|
Dichlorhydrate d'histamine
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX15 |
mifamurtide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX16 |
plerixafor
|
Plérixafor
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX17 |
sipuleucel-T
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX18 |
cridanimod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX19 |
dasiprotimut-T
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L03AX21 |
elapegademase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA |
Selective immunosuppressants
|
Immunosuppresseurs sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA02 |
muromonab-CD3
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA03 |
antilymphocyte immunoglobulin (horse)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA04 |
antithymocyte immunoglobulin (rabbit)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA06 |
mycophenolic acid
|
Acide mycophénolique
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA10 |
sirolimus
|
Sirolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA13 |
leflunomide
|
Léflunomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA15 |
alefacept
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA18 |
everolimus
|
Évérolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA19 |
gusperimus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA21 |
efalizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA22 |
abetimus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA23 |
natalizumab
|
Natalizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA24 |
abatacept
|
Abatacept
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA25 |
eculizumab
|
Éculizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA26 |
belimumab
|
Bélimumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA27 |
fingolimod
|
Fingolimod
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA28 |
belatacept
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA29 |
tofacitinib
|
Tofacitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA31 |
teriflunomide
|
Tériflunomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA32 |
apremilast
|
APREMILAST
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA33 |
vedolizumab
|
Védolizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA34 |
alemtuzumab
|
Alemtuzumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA35 |
begelomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA36 |
ocrelizumab
|
Ocrélizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA37 |
baricitinib
|
Baricitinib
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA38 |
ozanimod
|
Ozanimod
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA39 |
emapalumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA40 |
cladribine
|
Cladribine
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA41 |
imlifidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA42 |
siponimod
|
Siponimod
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AA43 |
ravulizumab
|
Ravulizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AF03 |
upadacitinib
|
Upadacitinib
|
WHO |
Active |
2024-10-04 11:16:16 |
L04AB |
Tumor necrosis factor alpha (TNF-alpha) inhibitors
|
Inhibiteurs du Facteur-alpha Nécrosant des Tumeurs (TNF-alpha)
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB01 |
etanercept
|
Étanercept
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB02 |
infliximab
|
Infliximab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB03 |
afelimomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB04 |
adalimumab
|
Adalimumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB05 |
certolizumab pegol
|
Certolizumab pégol
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB06 |
golimumab
|
Golimumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AB07 |
opinercept
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC |
Interleukin inhibitors
|
Inhibiteurs de l'interleukine
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC01 |
daclizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC02 |
basiliximab
|
Basiliximab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC03 |
anakinra
|
Anakinra
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC04 |
rilonacept
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC05 |
ustekinumab
|
Ustékinumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC07 |
tocilizumab
|
Tocilizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC08 |
canakinumab
|
Canakinumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC09 |
briakinumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC10 |
secukinumab
|
Secukinumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC11 |
siltuximab
|
SILTUXIMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC12 |
brodalumab
|
Brodalumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC13 |
ixekizumab
|
Ixékizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC14 |
sarilumab
|
Sarilumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC15 |
sirukumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC16 |
guselkumab
|
Guselkumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC17 |
tildrakizumab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AC18 |
risankizumab
|
Risankizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AD |
Calcineurin inhibitors
|
Inhibiteurs de la calcineurine
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AD01 |
ciclosporin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AD02 |
tacrolimus
|
Tacrolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AD03 |
voclosporin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX |
Other immunosuppressants
|
Autres immunosuppresseurs
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX01 |
azathioprine
|
Azathioprine
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX02 |
thalidomide
|
Thalidomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX03 |
methotrexate
|
Méthotrexate
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX04 |
lenalidomide
|
Lénalidomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX05 |
pirfenidone
|
Pirfénidone
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX06 |
pomalidomide
|
Pomalidomide
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX07 |
dimethyl fumarate
|
Fumarate de diméthyle
|
WHO |
Active |
2021-06-09 15:34:07 |
L04AX08 |
darvadstrocel
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA |
Butylpyrazolidines
|
Butylpyrazolidines
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA01 |
phenylbutazone
|
Phénylbutazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA02 |
mofebutazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA03 |
oxyphenbutazone
|
Oxyphenbutazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA05 |
clofezone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AA06 |
kebuzone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB |
Acetic acid derivatives and related substances
|
Dérivés de l'acide acétique et apparentés
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB01 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB02 |
sulindac
|
Sulindac
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB03 |
tolmetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB04 |
zomepirac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB05 |
diclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB06 |
alclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB07 |
bumadizone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB08 |
etodolac
|
Étodolac
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB09 |
lonazolac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB10 |
fentiazac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB11 |
acemetacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB12 |
difenpiramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB13 |
oxametacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB14 |
proglumetacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB15 |
ketorolac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB16 |
aceclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB17 |
bufexamac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB51 |
indometacin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AB55 |
diclofenac, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC |
Oxicams
|
Oxicams
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC01 |
piroxicam
|
Piroxicam
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC02 |
tenoxicam
|
Ténoxicam
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC04 |
droxicam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC05 |
lornoxicam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC06 |
meloxicam
|
Méloxicam
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AC56 |
meloxicam, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE |
Propionic acid derivatives
|
Dérivés de l'acide propionique
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE01 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE02 |
naproxen
|
Naproxène
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE03 |
ketoprofen
|
Kétoprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE04 |
fenoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE05 |
fenbufen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE06 |
benoxaprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE07 |
suprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE08 |
pirprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE09 |
flurbiprofen
|
Flurbiprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE10 |
indoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE11 |
tiaprofenic acid
|
Acide tiaprofénique
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE12 |
oxaprozin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE13 |
ibuproxam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE14 |
dexibuprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE15 |
flunoxaprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE16 |
alminoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE17 |
dexketoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE18 |
naproxcinod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE51 |
ibuprofen, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE52 |
naproxen and esomeprazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE53 |
ketoprofen, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AE56 |
naproxen and misoprostol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AG |
Fenamates
|
Fénamates
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AG01 |
mefenamic acid
|
Acide méfénamique
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AG02 |
tolfenamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AG03 |
flufenamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AG04 |
meclofenamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH |
Coxibs
|
Coxibs
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH01 |
celecoxib
|
Célécoxib
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH02 |
rofecoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH03 |
valdecoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH04 |
parecoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH05 |
etoricoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH06 |
lumiracoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AH07 |
polmacoxib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX |
Other antiinflammatory and antirheumatic agents, non-steroids
|
Autres anti-inflammatoires antirhumatismaux non stéroïdiens
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX01 |
nabumetone
|
Nabumétone
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX02 |
niflumic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX04 |
azapropazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX05 |
glucosamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX07 |
benzydamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX12 |
glucosaminoglycan polysulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX13 |
proquazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX14 |
orgotein
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX17 |
nimesulide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX18 |
feprazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX21 |
diacerein
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX22 |
morniflumate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX23 |
tenidap
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX24 |
oxaceprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX25 |
chondroitin sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01AX26 |
avocado and soyabean oil, unsaponifiables
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01BA |
Antiinflammatory/antirheumatic agents in combination with corticosteroids
|
Anti-inflammatoires antirhumatismaux en association avec des corticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
M01BA01 |
phenylbutazone and corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01BA02 |
dipyrocetyl and corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01BA03 |
acetylsalicylic acid and corticosteroids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CA |
Quinolines
|
Quinoléines
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CA03 |
oxycinchophen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB |
Gold preparations
|
Médicaments à base d'or
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB01 |
sodium aurothiomalate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB02 |
sodium aurotiosulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB03 |
auranofin
|
Auranofine
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB04 |
aurothioglucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CB05 |
aurotioprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CC |
Penicillamine and similar agents
|
Pénicillamine et analogues
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CC01 |
penicillamine
|
pénicillamine
|
WHO |
Active |
2021-06-09 15:34:07 |
M01CC02 |
bucillamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA |
Antiinflammatory preparations, non-steroids for topical use
|
Anti-inflammatoires non stéroïdiens à usage topique
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA01 |
phenylbutazone
|
Phénylbutazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA02 |
mofebutazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA03 |
clofezone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA04 |
oxyphenbutazone
|
Oxyphenbutazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA05 |
benzydamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA06 |
etofenamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA07 |
piroxicam
|
Piroxicam
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA08 |
felbinac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA09 |
bufexamac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA10 |
ketoprofen
|
Kétoprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA11 |
bendazac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA12 |
naproxen
|
Naproxène
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA13 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA14 |
fentiazac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA15 |
diclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA16 |
feprazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA17 |
niflumic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA18 |
meclofenamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA19 |
flurbiprofen
|
Flurbiprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA21 |
tolmetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA22 |
suxibuzone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA23 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA24 |
nifenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA25 |
aceclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA26 |
nimesulide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA27 |
dexketoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AA28 |
piketoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AB |
Capsaicin and similar agents
|
Capsaïcine et médicaments similaires
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AB01 |
capsaicin
|
Capsaïcine
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AB02 |
zucapsaicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AX |
Other topical products for joint and muscular pain
|
Autres topiques pour douleurs articulaire et musculaire
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AX02 |
tolazoline
|
Tolazoline
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AX03 |
dimethyl sulfoxide
|
Diméthylsulfoxyde
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AX05 |
idrocilamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M02AX06 |
tolperisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AA |
Curare alkaloids
|
Curares
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AA01 |
alcuronium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AA02 |
tubocurarine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AA04 |
dimethyltubocurarine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AB |
Choline derivatives
|
Dérivés de la choline
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AB01 |
suxamethonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC |
Other quaternary ammonium compounds
|
Autres ammoniums quaternaires
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC01 |
pancuronium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC02 |
gallamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC03 |
vecuronium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC04 |
atracurium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC05 |
hexafluronium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC06 |
pipecuronium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC07 |
doxacurium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC08 |
fazadinium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC09 |
rocuronium bromide
|
Bromure de rocuronium
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC10 |
mivacurium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AC11 |
cisatracurium
|
Cisatracurium
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AX |
Other muscle relaxants, peripherally acting agents
|
Autres myorelaxants à action périphérique
|
WHO |
Active |
2021-06-09 15:34:07 |
M03AX01 |
botulinum toxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA |
Carbamic acid esters
|
Esters de l'acide carbamique
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA01 |
phenprobamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA02 |
carisoprodol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA03 |
methocarbamol
|
Méthocarbamol
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA04 |
styramate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA05 |
febarbamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA51 |
phenprobamate, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA52 |
carisoprodol, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA53 |
methocarbamol, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BA71 |
phenprobamate, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB |
Oxazol, thiazine, and triazine derivatives
|
Dérivés oxazolés, thiaziniques et triaziniques
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB02 |
chlormezanone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB03 |
chlorzoxazone
|
Chlorzoxazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB52 |
chlormezanone, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB53 |
chlorzoxazone, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BB72 |
chlormezanone, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BC |
Ethers, chemically close to antihistamines
|
Éthers chimiquement proches des antihistaminiques
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BC01 |
orphenadrine (citrate)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BC51 |
orphenadrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX |
Other centrally acting agents
|
Autres myorelaxants à action centrale
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX01 |
baclofen
|
Baclofène
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX02 |
tizanidine
|
Tizanidine
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX03 |
pridinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX04 |
tolperisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX05 |
thiocolchicoside
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX06 |
mephenesin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX07 |
tetrazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX08 |
cyclobenzaprine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX09 |
eperisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX30 |
fenyramidol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03BX55 |
thiocolchicoside, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M03CA |
Dantrolene and derivatives
|
Dandrolène et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
M03CA01 |
dantrolene
|
dantrolène
|
WHO |
Active |
2024-03-01 15:06:21 |
M04AA |
Preparations inhibiting uric acid production
|
Inhibiteurs de la synthèse de l'acide urique
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AA01 |
allopurinol
|
Allopurinol
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AA02 |
tisopurine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AA03 |
febuxostat
|
Fébuxostat
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AA51 |
allopurinol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB |
Preparations increasing uric acid excretion
|
Uricosuriques
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB01 |
probenecid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB02 |
sulfinpyrazone
|
Sulfinpyrazone
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB03 |
benzbromarone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB04 |
isobromindione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AB05 |
lesinurad
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AC |
Preparations with no effect on uric acid metabolism
|
Médicaments sans effet sur le métabolisme de l'acide urique
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AC01 |
colchicine
|
Colchicine
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AC02 |
cinchophen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AX |
Other antigout preparations
|
Autres antigoutteux
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AX01 |
urate oxidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M04AX02 |
pegloticase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA |
Bisphosphonates
|
Bisphosphonates
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA01 |
etidronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA02 |
clodronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA03 |
pamidronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA04 |
alendronic acid
|
Acide alendronique
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA05 |
tiludronic acid
|
Acide tiludronique
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA06 |
ibandronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA07 |
risedronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BA08 |
zoledronic acid
|
Acide zolédronique
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB |
Bisphosphonates, combinations
|
Bisphosphonates, associations
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB01 |
etidronic acid and calcium, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB02 |
risedronic acid and calcium, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB03 |
alendronic acid and colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB04 |
risedronic acid, calcium and colecalciferol, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB05 |
alendronic acid, calcium and colecalciferol, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB06 |
alendronic acid and alfacalcidol, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB07 |
risedronic acid and colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB08 |
zoledronic acid, calcium and colecalciferol, sequential
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BB09 |
ibandronic acid and colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BC |
Bone morphogenetic proteins
|
Protéines de la morphogenèse osseuse
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BC01 |
dibotermin alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BC02 |
eptotermin alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX |
Other drugs affecting bone structure and mineralization
|
Autres médicaments agissant sur la minéralisation
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX01 |
ipriflavone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX02 |
aluminium chlorohydrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX03 |
strontium ranelate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX04 |
denosumab
|
Dénosumab
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX05 |
burosumab
|
BUROSUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX06 |
romosozumab
|
Romosozumab
|
WHO |
Active |
2021-06-09 15:34:07 |
M05BX53 |
strontium ranelate and colecalciferol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AA |
Quinine and derivatives
|
Quinines et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AA01 |
hydroquinine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AA72 |
quinine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AB |
Enzymes
|
Enzymes
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AB01 |
chymopapain
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AB02 |
collagenase clostridium histolyticum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AB03 |
bromelains
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AB52 |
trypsin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX |
Other drugs for disorders of the musculo-skeletal system
|
Autres médicaments des désordres musculo-squelettique
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX01 |
hyaluronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX02 |
chondrocytes, autologous
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX03 |
ataluren
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX04 |
drisapersen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX05 |
aceneuramic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX06 |
eteplirsen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
M09AX07 |
nusinersen
|
Nusinersen
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AA |
Ethers
|
Éthers
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AA01 |
diethyl ether
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AA02 |
vinyl ether
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB |
Halogenated hydrocarbons
|
hydrocarbures halogénés
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB01 |
halothane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB02 |
chloroform
|
Chloroforme
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB04 |
enflurane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB05 |
trichloroethylene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB06 |
isoflurane
|
Isoflurane
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB07 |
desflurane
|
Desflurane
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AB08 |
sevoflurane
|
Sévoflurane
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AF |
Barbiturates, plain
|
Barbituriques seuls
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AF01 |
methohexital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AF02 |
hexobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AF03 |
thiopental
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH |
Opioid anesthetics
|
Anesthésiques opiacés
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH01 |
fentanyl
|
Fentanyl
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH02 |
alfentanil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH03 |
sufentanil
|
Sufentanil
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH04 |
phenoperidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH05 |
anileridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH06 |
remifentanil
|
Rémifentanil
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AH51 |
fentanyl, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX |
Other general anesthetics
|
Autres anesthésiques généraux
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX03 |
ketamine
|
Kétamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX04 |
propanidid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX05 |
alfaxalone
|
Alfaxalone
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX07 |
etomidate
|
Étomidate
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX10 |
propofol
|
Propofol
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX11 |
sodium oxybate
|
Oxybate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX13 |
nitrous oxide
|
Oxyde nitreux
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX14 |
esketamine
|
Eskétamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX15 |
xenon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01AX63 |
nitrous oxide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA |
Esters of aminobenzoic acid
|
Esters de l'acide aminobenzoïque
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA01 |
metabutethamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA02 |
procaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA03 |
tetracaine
|
Tétracaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA05 |
benzocaine
|
Benzocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA52 |
procaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BA53 |
tetracaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB |
Amides
|
Amides
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB01 |
bupivacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB02 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB03 |
mepivacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB04 |
prilocaine
|
Prilocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB05 |
butanilicaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB06 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB07 |
etidocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB08 |
articaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB09 |
ropivacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB10 |
levobupivacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB51 |
bupivacaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB52 |
lidocaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB53 |
mepivacaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB54 |
prilocaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB57 |
etidocaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BB58 |
articaine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BC |
Esters of benzoic acid
|
Esters de l'acide benzoïque
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BC01 |
cocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BX |
Other local anesthetics
|
Autres anesthésiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BX01 |
ethyl chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BX02 |
dyclonine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BX03 |
phenol
|
Phénol
|
WHO |
Active |
2021-06-09 15:34:07 |
N01BX04 |
capsaicin
|
Capsaïcine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA |
Natural opium alkaloids
|
Alcaloïdes naturels de l'opium
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA01 |
morphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA02 |
opium
|
Opium
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA03 |
hydromorphone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA04 |
nicomorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA05 |
oxycodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA08 |
dihydrocodeine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA10 |
papaveretum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA51 |
morphine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA53 |
hydromorphone and naloxone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA55 |
oxycodone and naloxone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA56 |
oxycodone and naltrexone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA58 |
dihydrocodeine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA59 |
codeine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AA79 |
codeine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB |
Phenylpiperidine derivatives
|
Dérivés de la phénylpipéridine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB01 |
ketobemidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB02 |
pethidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB03 |
fentanyl
|
Fentanyl
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB52 |
pethidine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AB72 |
pethidine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC |
Diphenylpropylamine derivatives
|
Dérivés de la diphénylpropylamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC01 |
dextromoramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC03 |
piritramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC04 |
dextropropoxyphene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC05 |
bezitramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC54 |
dextropropoxyphene, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AC74 |
dextropropoxyphene, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AD |
Benzomorphan derivatives
|
Dérivés du benzomorphane
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AD01 |
pentazocine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AD02 |
phenazocine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AE |
Oripavine derivatives
|
Dérivés de l'oripavine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AE01 |
buprenorphine
|
Buprénorphine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AF |
Morphinan derivatives
|
Dérivés du morphinane
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AF01 |
butorphanol
|
Butorphanol
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AF02 |
nalbuphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AG |
Opioids in combination with antispasmodics
|
Opiacés en association avec antispasmodiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AG01 |
morphine and antispasmodics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AG02 |
ketobemidone and antispasmodics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AG04 |
hydromorphone and antispasmodics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ |
Opioids in combination with non-opioid analgesics
|
Opiacés en association avec analgésiques non-opioïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ01 |
dihydrocodeine and paracetamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ02 |
dihydrocodeine and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ03 |
dihydrocodeine and other non-opioid analgesics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ06 |
codeine and paracetamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ07 |
codeine and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ08 |
codeine and ibuprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ09 |
codeine and other non-opioid analgesics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ13 |
tramadol and paracetamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ14 |
tramadol and dexketoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ15 |
tramadol and other non-opioid analgesics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ17 |
oxycodone and paracetamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ18 |
oxycodone and acetylsalicylic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AJ19 |
oxycodone and ibuprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX |
Other opioids
|
Autres opiacés
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX01 |
tilidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX02 |
tramadol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX03 |
dezocine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX05 |
meptazinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02AX06 |
tapentadol
|
Tapentadol
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA |
Salicylic acid and derivatives
|
Acide salicylique et dérivés (salicylés
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA01 |
acetylsalicylic acid
|
Acide acétylsalicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA02 |
aloxiprin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA03 |
choline salicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA04 |
sodium salicylate
|
Salicylate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA05 |
salicylamide
|
Salicylamide
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA06 |
salsalate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA07 |
ethenzamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA08 |
morpholine salicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA09 |
dipyrocetyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA10 |
benorilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA11 |
diflunisal
|
Diflunisal
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA12 |
potassium salicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA14 |
guacetisal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA15 |
carbasalate calcium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA16 |
imidazole salicylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA51 |
acetylsalicylic acid, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA55 |
salicylamide, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA57 |
ethenzamide, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA59 |
dipyrocetyl, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA65 |
carbasalate calcium combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA71 |
acetylsalicylic acid, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA75 |
salicylamide, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BA77 |
ethenzamide, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB |
Pyrazolones
|
Pyrazolones
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB01 |
phenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB02 |
metamizole sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB03 |
aminophenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB04 |
propyphenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB05 |
nifenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB51 |
phenazone, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB52 |
metamizole sodium, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB53 |
aminophenazone, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB54 |
propyphenazone, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB71 |
phenazone, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB72 |
metamizole sodium, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB73 |
aminophenazone, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BB74 |
propyphenazone, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE |
Anilides
|
Anilides
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE01 |
acetaminophen (paracetamol)
|
Acétaminophène (paracetamol)
|
WHO |
Active |
2024-11-15 11:35:20 |
N02BE03 |
phenacetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE04 |
bucetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE05 |
propacetamol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE51 |
paracetamol, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE53 |
phenacetin, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE54 |
bucetin, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE71 |
paracetamol, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE73 |
phenacetin, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BE74 |
bucetin, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG |
Other analgesics and antipyretics
|
Autres analgésiques et antipyrétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG02 |
rimazolium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG03 |
glafenine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG04 |
floctafenine
|
Floctafénine
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG05 |
viminol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG06 |
nefopam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG07 |
flupirtine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG08 |
ziconotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG09 |
methoxyflurane
|
Méthoxyflurane
|
WHO |
Active |
2021-06-09 15:34:07 |
N02BG10 |
cannabinoids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA |
Ergot alkaloids
|
Alcaloïdes de l'ergot (du seigle)
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA01 |
dihydroergotamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA02 |
ergotamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA04 |
methysergide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA07 |
lisuride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA51 |
dihydroergotamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA52 |
ergotamine, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CA72 |
ergotamine, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CB |
Corticosteroid derivatives
|
Dérivés des corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CB01 |
flumedroxone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC |
Selective serotonin (5HT1) agonists
|
Agonistes sélectifs de la sérotonine (5-HT1) (« triptans »)
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC01 |
sumatriptan
|
Sumatriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC02 |
naratriptan
|
Naratriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC03 |
zolmitriptan
|
Zolmitriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC04 |
rizatriptan
|
Rizatriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC05 |
almotriptan
|
Almotriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC06 |
eletriptan
|
Élétriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CC07 |
frovatriptan
|
Frovatriptan
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CD01 |
erenumab
|
ÉRÉNUMAB
|
WHO |
Active |
2021-06-14 18:51:56 |
N02CD02 |
galcanezumab
|
GALCANÉZUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CD03 |
fremanezumab
|
Frémanézumab
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX |
Other antimigraine preparations
|
Autres médicaments antimigraineux
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX01 |
pizotifen
|
Pizotifène
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX02 |
clonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX03 |
iprazochrome
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX05 |
dimetotiazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CX06 |
oxetorone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA |
Barbiturates and derivatives
|
Barbituriques et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA01 |
methylphenobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA02 |
phenobarbital
|
Phénobarbital
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA03 |
primidone
|
Primidone
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA04 |
barbexaclone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AA30 |
metharbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB |
Hydantoin derivatives
|
hydantoïne et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB01 |
ethotoin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB02 |
phenytoin
|
Phénytoïne
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB04 |
mephenytoin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB05 |
fosphenytoin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB52 |
phenytoin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AB54 |
mephenytoin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AC |
Oxazolidine derivatives
|
Dérivés de l'oxazolidine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AC01 |
paramethadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AC02 |
trimethadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AC03 |
ethadione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AD |
Succinimide derivatives
|
Dérivés du succinimide
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AD01 |
ethosuximide
|
Éthosuximide
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AD02 |
phensuximide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AD03 |
mesuximide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AD51 |
ethosuximide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AE |
Benzodiazepine derivatives
|
Dérivés des benzodiazépines
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AE01 |
clonazepam
|
Clonazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AF |
Carboxamide derivatives
|
Dérivés du carboxamide
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AF01 |
carbamazepine
|
Carbamazépine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AF02 |
oxcarbazepine
|
Oxcarbazépine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AF03 |
rufinamide
|
Rufinamide
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AF04 |
eslicarbazepine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG |
Fatty acid derivatives
|
Dérivés d'acide gras
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG01 |
valproic acid
|
Acide valproïque
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG02 |
valpromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG03 |
aminobutyric acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG04 |
vigabatrin
|
Vigabatrine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG05 |
progabide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AG06 |
tiagabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX |
Other antiepileptics
|
Autres antiépileptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX03 |
sultiame
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX07 |
phenacemide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX09 |
lamotrigine
|
Lamotrigine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX10 |
felbamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX11 |
topiramate
|
Topiramate
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX12 |
gabapentin
|
Gabapentine
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX13 |
pheneturide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX14 |
levetiracetam
|
Lévétiracétam
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX15 |
zonisamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX16 |
pregabalin
|
Prégabaline
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX17 |
stiripentol
|
Stiripentol
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX18 |
lacosamide
|
Lacosamide
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX19 |
carisbamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX21 |
retigabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX22 |
perampanel
|
Pérampanel
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX23 |
brivaracetam
|
BRIVARACÉTAM
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX24 |
cannabidiol
|
Cannabidiol
|
WHO |
Active |
2021-06-09 15:34:07 |
N03AX30 |
beclamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA |
Tertiary amines
|
Amines tertiaires
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA01 |
trihexyphenidyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA02 |
biperiden
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA03 |
metixene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA04 |
procyclidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA05 |
profenamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA08 |
dexetimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA09 |
phenglutarimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA10 |
mazaticol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA11 |
bornaprine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AA12 |
tropatepine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AB |
Ethers chemically close to antihistamines
|
Éthers chimiquement proches des antihistaminiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AB01 |
etanautine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AB02 |
orphenadrine (chloride)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AC |
Ethers of tropine or tropine derivatives
|
Éthers de la tropine ou dérivés de la tropine
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AC01 |
benzatropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04AC30 |
etybenzatropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BA |
Dopa and dopa derivatives
|
Dopa et dérivés du dopa
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BA01 |
levodopa
|
Lévodopa
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BA02 |
levodopa and decarboxylase inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BA03 |
levodopa, decarboxylase inhibitor and COMT inhibitor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BA04 |
melevodopa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BB |
Adamantane derivatives
|
Dérivés de l'adamantane
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BB01 |
amantadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC |
Dopamine agonists
|
Agonistes de la dopamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC01 |
bromocriptine
|
Bromocriptine
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC02 |
pergolide
|
Pergolide
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC03 |
dihydroergocryptine mesylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC04 |
ropinirole
|
Ropinirole
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC05 |
pramipexole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC06 |
cabergoline
|
Cabergoline
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC07 |
apomorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC08 |
piribedil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BC09 |
rotigotine
|
Rotigotine
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BD |
Monoamine oxidase B inhibitors
|
Inhibiteur de la monoamine oxydase B (IMAOB)
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BD01 |
selegiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BD02 |
rasagiline
|
Rasagiline
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BD03 |
safinamide
|
SAFINAMIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BX |
Other dopaminergic agents
|
Autres agents dopaminergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BX01 |
tolcapone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BX02 |
entacapone
|
Entacapone
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BX03 |
budipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N04BX04 |
opicapone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA |
Phenothiazines with aliphatic side-chain
|
Phénothiazines à chaîne latérale aliphatique
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA01 |
chlorpromazine
|
Chlorpromazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA02 |
levomepromazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA03 |
promazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA04 |
acepromazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA05 |
triflupromazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA06 |
cyamemazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AA07 |
chlorproethazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB |
Phenothiazines with piperazine structure
|
Phénothiazines à structure de pipérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB01 |
dixyrazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB02 |
fluphenazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB03 |
perphenazine
|
Perphénazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB04 |
prochlorperazine
|
Prochlorpérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB05 |
thiopropazate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB06 |
trifluoperazine
|
Trifluopérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB07 |
acetophenazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB08 |
thioproperazine
|
Thiopropérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB09 |
butaperazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AB10 |
perazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AC |
Phenothiazines with piperidine structure
|
Phénothiazines à structure de pipéridine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AC01 |
periciazine
|
Périciazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AC02 |
thioridazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AC03 |
mesoridazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AC04 |
pipotiazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD |
Butyrophenone derivatives
|
Dérivés du butyrophénone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD01 |
haloperidol
|
Halopéridol
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD02 |
trifluperidol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD03 |
melperone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD04 |
moperone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD05 |
pipamperone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD06 |
bromperidol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD07 |
benperidol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD08 |
droperidol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AD09 |
fluanisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE |
Indole derivatives
|
Dérivés de l'indole
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE01 |
oxypertine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE02 |
molindone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE03 |
sertindole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE04 |
ziprasidone
|
Ziprasidone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AE05 |
lurasidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF |
Thioxanthene derivatives
|
Dérivés du thioxanthène
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF01 |
flupentixol
|
Flupentixol
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF02 |
clopenthixol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF03 |
chlorprothixene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF04 |
tiotixene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AF05 |
zuclopenthixol
|
Zuclopenthixol
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AG |
Diphenylbutylpiperidine derivatives
|
Dérivés de la diphénylbutylpipéridine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AG01 |
fluspirilene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AG02 |
pimozide
|
Pimozide
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AG03 |
penfluridol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH |
Diazepines, oxazepines, thiazepines and oxepines
|
Diazépines, oxazépines, thiazépines et oxépines
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH01 |
loxapine
|
Loxapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH02 |
clozapine
|
Clozapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH03 |
olanzapine
|
Olanzapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH04 |
quetiapine
|
Quétiapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH05 |
asenapine
|
Asénapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AH06 |
clotiapine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL |
Benzamides
|
Benzamides
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL01 |
sulpiride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL02 |
sultopride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL03 |
tiapride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL04 |
remoxipride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL05 |
amisulpride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL06 |
veralipride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AL07 |
levosulpiride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AN |
Lithium
|
Lithium
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AN01 |
lithium
|
Lithium
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX |
Other antipsychotics
|
Autres antipsychotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX07 |
prothipendyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX08 |
risperidone
|
Rispéridone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX10 |
mosapramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX11 |
zotepine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX12 |
aripiprazole
|
Aripiprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX13 |
paliperidone
|
Palipéridone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX14 |
iloperidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX15 |
cariprazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX16 |
brexpiprazole
|
Brexpiprazole
|
WHO |
Active |
2021-06-09 15:34:07 |
N05AX17 |
pimavanserin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA |
Benzodiazepine derivatives
|
Dérivés des benzodiazépines
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA01 |
diazepam
|
Diazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA02 |
chlordiazepoxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA03 |
medazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA04 |
oxazepam
|
Oxazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA05 |
potassium clorazepate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA06 |
lorazepam
|
Lorazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA07 |
adinazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA08 |
bromazepam
|
Bromazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA09 |
clobazam
|
Clobazam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA10 |
ketazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA11 |
prazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA12 |
alprazolam
|
Alprazolam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA13 |
halazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA14 |
pinazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA15 |
camazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA16 |
nordazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA17 |
fludiazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA18 |
ethyl loflazepate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA19 |
etizolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA21 |
clotiazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA22 |
cloxazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA23 |
tofisopam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA24 |
bentazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BA56 |
lorazepam, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BB |
Diphenylmethane derivatives
|
Dérivés du diphénylméthane
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BB01 |
hydroxyzine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BB02 |
captodiame
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BC |
Carbamates
|
Carbamates
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BC01 |
meprobamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BC03 |
emylcamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BC04 |
mebutamate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BC51 |
meprobamate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BD |
Dibenzo-bicyclo-octadiene derivatives
|
Dérivés du dibenzo-bicyclo-octadiène
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BD01 |
benzoctamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BE |
Azaspirodecanedione derivatives
|
Dérivés de l'azaspirodécanedion
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BE01 |
buspirone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX |
Other anxiolytics
|
Autres anxiolytiqu
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX01 |
mephenoxalone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX02 |
gedocarnil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX03 |
etifoxine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX04 |
fabomotizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05BX05 |
Lavandulae aetheroleum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA |
Barbiturates, plain
|
Barbituriques, seuls
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA01 |
pentobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA02 |
amobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA03 |
butobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA04 |
barbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA05 |
aprobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA06 |
secobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA07 |
talbutal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA08 |
vinylbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA09 |
vinbarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA10 |
cyclobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA11 |
heptabarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA12 |
reposal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA15 |
methohexital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA16 |
hexobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA19 |
thiopental
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA20 |
etallobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA21 |
allobarbital
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CA22 |
proxibarbal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CB |
Barbiturates, combinations
|
Barbituriques, associations
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CB01 |
combinations of barbiturates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CB02 |
barbiturates in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC |
Aldehydes and derivatives
|
Aldéhydes et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC01 |
chloral hydrate
|
Hydrate de chloral
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC02 |
chloralodol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC03 |
acetylglycinamide chloral hydrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC04 |
dichloralphenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CC05 |
paraldehyde
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD |
Benzodiazepine derivatives
|
Dérivés des benzodiazépin
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD01 |
flurazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD02 |
nitrazepam
|
Nitrazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD03 |
flunitrazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD04 |
estazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD05 |
triazolam
|
Triazolam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD06 |
lormetazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD07 |
temazepam
|
Témazépam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD08 |
midazolam
|
Midazolam
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD09 |
brotizolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD10 |
quazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD11 |
loprazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD12 |
doxefazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD13 |
cinolazepam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CD14 |
remimazolam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CE |
Piperidinedione derivatives
|
Dérivés du pipéridinédione
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CE01 |
glutethimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CE02 |
methyprylon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CE03 |
pyrithyldione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CF |
Benzodiazepine related drugs
|
Médicaments apparentés aux benzodiazépines
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CF01 |
zopiclone
|
Zopiclone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CF02 |
zolpidem
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CF03 |
zaleplon
|
Zaléplone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CF04 |
eszopiclone
|
Eszopiclone
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CH |
Melatonin receptor agonists
|
Récepteurs agonistes de la mélatonine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CH01 |
melatonin
|
Mélatonine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CH02 |
ramelteon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CH03 |
tasimelteon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM |
Other hypnotics and sedatives
|
Autres hypnotiques et sédatifs
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM01 |
methaqualone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM02 |
clomethiazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM03 |
bromisoval
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM04 |
carbromal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM05 |
scopolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM06 |
propiomazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM07 |
triclofos
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM08 |
ethchlorvynol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM09 |
Valerianae radix
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM10 |
hexapropymate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM11 |
bromides
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM12 |
apronal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM13 |
valnoctamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM15 |
methylpentynol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM16 |
niaprazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM18 |
dexmedetomidine
|
Dexmédétomidine
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CM19 |
suvorexant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX |
Hypnotics and sedatives in combination, excl. barbiturates
|
Hypnotiques et sédatifs en associations, sans barbituriques
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX01 |
meprobamate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX02 |
methaqualone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX04 |
clomethiazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX05 |
emepronium, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N05CX06 |
dipiperonylaminoethanol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA |
Non-selective monoamine reuptake inhibitors
|
Inhibiteurs non sélectifs de la recapture des monoamines
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA01 |
desipramine
|
Désipramine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA02 |
imipramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA03 |
imipramine oxide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA04 |
clomipramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA05 |
opipramol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA06 |
trimipramine
|
Trimipramine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA07 |
lofepramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA08 |
dibenzepin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA09 |
amitriptyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA10 |
nortriptyline
|
Nortriptyline
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA11 |
protriptyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA12 |
doxepin
|
Doxépine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA13 |
iprindole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA14 |
melitracen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA15 |
butriptyline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA16 |
dosulepin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA17 |
amoxapine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA18 |
dimetacrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA19 |
amineptine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA21 |
maprotiline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AA23 |
quinupramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB |
Selective serotonin reuptake inhibitors
|
Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS)
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB02 |
zimeldine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB03 |
fluoxetine
|
Fluoxétine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB04 |
citalopram
|
Citalopram
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB05 |
paroxetine
|
Paroxétine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB06 |
sertraline
|
Sertraline
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB07 |
alaproclate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB08 |
fluvoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB09 |
etoperidone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AB10 |
escitalopram
|
Escitalopram
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF |
Monoamine oxidase inhibitors, non-selective
|
Inhibiteurs des monoamines oxydases, non sélectifs
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF01 |
isocarboxazid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF02 |
nialamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF03 |
phenelzine
|
Phénelzine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF04 |
tranylcypromine
|
Tranylcypromine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF05 |
iproniazide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AF06 |
iproclozide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AG |
Monoamine oxidase A inhibitors
|
Inhibiteurs des monoamines oxydases A
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AG02 |
moclobemide
|
Moclobémide
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AG03 |
toloxatone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX |
Other psychostimulants and nootropics
|
Autres antidépresseurs
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX01 |
oxitriptan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX02 |
tryptophan
|
Tryptophane
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX03 |
mianserin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX04 |
nomifensine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX05 |
trazodone
|
Trazodone
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX06 |
nefazodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX07 |
minaprine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX08 |
bifemelane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX09 |
viloxazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX10 |
oxaflozane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX11 |
mirtazapine
|
Mirtazapine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX12 |
bupropion
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX13 |
medifoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX14 |
tianeptine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX15 |
pivagabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX16 |
venlafaxine
|
Venlafaxine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX17 |
milnacipran
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX18 |
reboxetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX19 |
gepirone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX21 |
duloxetine
|
Duloxétine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX22 |
agomelatine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX23 |
desvenlafaxine
|
Desvenlafaxine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX24 |
vilazodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX25 |
Hyperici herba
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX26 |
vortioxetine
|
VORTIOXÉTINE
|
WHO |
Active |
2021-06-09 15:34:07 |
N06AX27 |
esketamine
|
Eskétamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA |
Centrally acting sympathomimetics
|
Sympathicomimétiques centraux
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA01 |
amfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA02 |
dexamfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA03 |
metamfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA04 |
methylphenidate
|
méthylphénidate
|
WHO |
Active |
2024-05-03 15:25:27 |
N06BA05 |
pemoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA06 |
fencamfamin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA07 |
modafinil
|
Modafinil
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA08 |
fenozolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA09 |
atomoxetine
|
Atomoxétine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA10 |
fenetylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA11 |
dexmethylphenidate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA12 |
lisdexamfetamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA13 |
armodafinil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BA14 |
solriamfetol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BC |
Xanthine derivatives
|
Dérivés des xanthines
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BC01 |
caffeine
|
Caféine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BC02 |
propentofylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX |
Other psychostimulants and nootropics
|
Autres psychostimulants et nootropiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX01 |
meclofenoxate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX02 |
pyritinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX03 |
piracetam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX04 |
deanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX05 |
fipexide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX06 |
citicoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX07 |
oxiracetam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX08 |
pirisudanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX09 |
linopirdine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX10 |
nizofenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX11 |
aniracetam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX12 |
acetylcarnitine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX13 |
idebenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX14 |
prolintane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX15 |
pipradrol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX16 |
pramiracetam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX17 |
adrafinil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX18 |
vinpocetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX21 |
mebicar
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06BX22 |
phenibut
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06CA |
Antidepressants in combination with psycholeptics
|
Antidépresseurs associés à des psycholeptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N06CA01 |
amitriptyline and psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06CA02 |
melitracen and psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06CA03 |
fluoxetine and psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA |
Anticholinesterases
|
Anticholinestérases
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA01 |
tacrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA02 |
donepezil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA03 |
rivastigmine
|
Rivastigmine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA04 |
galantamine
|
Galantamine
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA05 |
ipidacrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA52 |
donepezil and memantine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DA53 |
donepezil, memantine and Ginkgo folium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DX |
Other anti-dementia drugs
|
Autres médicaments anti-démence
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DX01 |
memantine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DX02 |
Ginkgo folium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N06DX30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA |
Anticholinesterases
|
Anticholinestérases
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA01 |
neostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA02 |
pyridostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA03 |
distigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA30 |
ambenonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AA51 |
neostigmine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AB |
Choline esters
|
Esters de la choline
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AB01 |
carbachol
|
Carbachol
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AB02 |
bethanechol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AX |
Other parasympathomimetics
|
Autres parasympathicomimétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AX01 |
pilocarpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AX02 |
choline alfoscerate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07AX03 |
cevimeline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BA |
Drugs used in nicotine dependence
|
Médicaments utilisés en cas de dépendance à la nicot
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BA01 |
nicotine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BA03 |
varenicline
|
Varénicline
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BA04 |
cytisine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB |
Drugs used in alcohol dependence
|
Médicaments utilisés en cas de dépendance à l'alcool
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB01 |
disulfiram
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB02 |
calcium carbimide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB03 |
acamprosate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB04 |
naltrexone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BB05 |
nalmefene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC |
Drugs used in opioid dependence
|
Médicaments utilisés en cas de dépendance aux opiacés
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC01 |
buprenorphine
|
Buprénorphine
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC02 |
methadone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC03 |
levacetylmethadol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC04 |
lofexidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC05 |
levomethadone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC06 |
diamorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07BC51 |
buprenorphine, combinations
|
buprénorphine, associations
|
WHO |
Active |
2023-01-24 17:07:42 |
N07CA |
Antivertigo preparations
|
Préparations antivertige
|
WHO |
Active |
2021-06-09 15:34:07 |
N07CA01 |
betahistine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07CA02 |
cinnarizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07CA03 |
flunarizine
|
Flunarizine
|
WHO |
Active |
2021-06-09 15:34:07 |
N07CA04 |
acetylleucine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07CA52 |
cinnarizine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX |
Other nervous system drugs
|
Autres médicaments du système nerveux
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX01 |
tirilazad
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX02 |
riluzole
|
Riluzole
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX03 |
xaliproden
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX04 |
sodium oxybate
|
Oxybate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX05 |
amifampridine
|
Amifampridine
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX06 |
tetrabenazine
|
Tétrabénazine
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX07 |
fampridine
|
Fampridine
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX08 |
tafamidis
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX10 |
laquinimod
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX11 |
pitolisant
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX12 |
patisiran
|
Patisiran
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX13 |
valbenazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX14 |
edaravone
|
Édaravone
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX15 |
inotersen
|
Inotersen
|
WHO |
Active |
2021-06-09 15:34:07 |
N07XX59 |
dextromethorphan, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA |
Hydroxyquinoline derivatives
|
Dérivés de l'hydroxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA01 |
broxyquinoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA02 |
clioquinol
|
Clioquinol
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA04 |
chlorquinaldol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA05 |
tilbroquinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AA52 |
clioquinol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB |
Nitroimidazole derivatives
|
Dérivés nitro-imidazolé
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB01 |
metronidazole
|
Métronidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB02 |
tinidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB03 |
ornidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB04 |
azanidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB05 |
propenidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB06 |
nimorazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB07 |
secnidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AB51 |
metronidazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AC |
Dichloroacetamide derivatives
|
Dérivés du dichloroacétamide
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AC01 |
diloxanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AC02 |
clefamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AC03 |
etofamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AC04 |
teclozan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AR |
Arsenic compounds
|
Médicaments à base d'arsenic
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AR01 |
arsthinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AR02 |
difetarsone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AR03 |
glycobiarsol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AR53 |
glycobiarsol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX |
Other agents against amoebiasis and other protozoal diseases
|
Autres médicaments contre l'amibiase et autres protozooses
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX01 |
chiniofon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX02 |
emetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX04 |
phanquinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX05 |
mepacrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX06 |
atovaquone
|
Atovaquone
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX07 |
trimetrexate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX08 |
tenonitrozole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX09 |
dihydroemetine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX10 |
fumagillin
|
Fumagilline
|
WHO |
Active |
2021-06-09 15:34:07 |
P01AX11 |
nitazoxanide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA |
Aminoquinolines
|
Aminoquinoléïnes
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA01 |
chloroquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA02 |
hydroxychloroquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA03 |
primaquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA06 |
amodiaquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BA07 |
tafenoquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BB |
Biguanides
|
Biguanides
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BB01 |
proguanil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BB02 |
cycloguanil embonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BB51 |
proguanil, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BC |
Methanolquinolines
|
Alcaloïdes de la quinine
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BC01 |
quinine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BC02 |
mefloquine
|
Méfloquine
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BD |
Diaminopyrimidines
|
Diaminopyrimidines
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BD01 |
pyrimethamine
|
Pyriméthamine
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BD51 |
pyrimethamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE |
Artemisinin and derivatives, plain
|
Artémisine et dérivés, seuls
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE01 |
artemisinin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE02 |
artemether
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE03 |
artesunate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE04 |
artemotil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BE05 |
artenimol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF |
Artemisinin and derivatives, combinations
|
Artémisinine et dérivés, combinaisons
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF01 |
artemether and lumefantrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF02 |
artesunate and mefloquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF03 |
artesunate and amodiaquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF04 |
artesunate, sulphamethopyrazine and pyrimethamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF05 |
artenimol and piperaquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BF06 |
artesunate and pyronaridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BX |
Other antimalarials
|
Autres antipaludéens
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BX01 |
halofantrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01BX02 |
arterolane and piperaquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CA |
Nitroimidazole derivatives
|
Dérivés du nitro-imidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CA02 |
benznidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CA03 |
fexinidazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CB |
Antimony compounds
|
Médicaments à base d'antimoine
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CB01 |
meglumine antimonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CB02 |
sodium stibogluconate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CC |
Nitrofuran derivatives
|
Dérivés du nitrofurane
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CC01 |
nifurtimox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CC02 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CD |
Arsenic compounds
|
Médicaments à base d'arsenic
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CD01 |
melarsoprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CD02 |
acetarsol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CX |
Other agents against leishmaniasis and trypanosomiasis
|
Autres antileishmaniens et trypanocides
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CX01 |
pentamidine isethionate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CX02 |
suramin sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CX03 |
eflornithine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P01CX04 |
miltefosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BA |
Quinoline derivatives and related substances
|
Dérivés de la quinoléïne et apparentés
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BA01 |
praziquantel
|
Praziquantel
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BA02 |
oxamniquine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BB |
Organophosphorous compounds
|
Organophosphorés
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BB01 |
metrifonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BX |
Other antitrematodal agents
|
Autres antitrématodes
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BX01 |
bithionol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BX02 |
niridazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BX03 |
stibophen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02BX04 |
triclabendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA |
Benzimidazole derivatives
|
Dérivés du benzimidazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA01 |
mebendazole
|
Mébendazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA02 |
tiabendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA03 |
albendazole
|
Albendazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA04 |
ciclobendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA05 |
flubendazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA06 |
fenbendazole
|
Fenbendazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CA51 |
mebendazole, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CB |
Piperazine and derivatives
|
Pipérazine et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CB01 |
piperazine
|
Pipérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CB02 |
diethylcarbamazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CC |
Tetrahydropyrimidine derivatives
|
Dérivés de la tétrahydropyrimidine
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CC01 |
pyrantel
|
Pyrantel
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CC02 |
oxantel
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CE |
Imidazothiazole derivatives
|
Dérivés de l'imidazothiazole
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CE01 |
levamisole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CF |
Avermectines
|
Avermectines
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CF01 |
ivermectin
|
Ivermectine
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CX |
Other antinematodals
|
Autres antinématodes
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CX01 |
pyrvinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CX02 |
bephenium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02CX03 |
moxidectin
|
Moxidectine
|
WHO |
Active |
2021-06-09 15:34:07 |
P02DA |
Salicylic acid derivatives
|
Dérivés de l'acide salicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
P02DA01 |
niclosamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02DX |
Other anticestodals
|
Autres anticestodes
|
WHO |
Active |
2021-06-09 15:34:07 |
P02DX01 |
desaspidin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P02DX02 |
dichlorophen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA |
Sulfur containing products
|
Dérivés soufrés
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA01 |
dixanthogen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA03 |
mesulfen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA04 |
disulfiram
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA05 |
thiram
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AA54 |
disulfiram, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AB |
Chlorine containing products
|
Dérivés chlorés
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AB01 |
clofenotane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AB02 |
lindane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AB51 |
clofenotane, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC |
Pyrethrines, incl. synthetic compounds
|
Pyréthrines, dérivés de synthèse inclus
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC01 |
pyrethrum
|
Pyrèthre
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC02 |
bioallethrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC03 |
phenothrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC04 |
permethrin
|
Perméthrine
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC51 |
pyrethrum, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC52 |
bioallethrin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC53 |
phenothrin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AC54 |
permethrin, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX |
Other ectoparasiticides, incl. scabicides
|
Autres antiparasitaires externes, scabicides inclus
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX01 |
benzyl benzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX03 |
malathion
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX04 |
quassia
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX05 |
dimeticone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03AX06 |
benzyl alcohol
|
Alcool benzylique
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BA |
Pyrethrines
|
Pyréthrines
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BA02 |
cypermethrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BA03 |
decamethrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BA04 |
tetramethrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BX |
Other insecticides and repellents
|
Autres insecticides
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BX01 |
diethyltoluamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BX02 |
dimethylphthalate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BX03 |
dibutylphthalate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
P03BX06 |
etohexadiol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA |
Sympathomimetics, plain
|
Sympathomimétiques, seuls
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA02 |
cyclopentamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA03 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA04 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA05 |
oxymetazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA06 |
tetryzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA07 |
xylometazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA08 |
naphazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA09 |
tramazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA10 |
metizoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA11 |
tuaminoheptane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA12 |
fenoxazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA13 |
tymazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA14 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AA15 |
indanazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB |
Sympathomimetics, combinations excl. corticosteroids
|
Sympathomimétiques, associations sans corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB01 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB02 |
naphazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB03 |
tetryzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB05 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB06 |
xylometazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB07 |
oxymetazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AB08 |
tuaminoheptane
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC |
Antiallergic agents, excl. corticosteroids
|
Agents antiallergiques, corticostéroïdes exclus
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC01 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC02 |
levocabastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC03 |
azelastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC04 |
antazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC05 |
spaglumic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC06 |
thonzylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC07 |
nedocromil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC08 |
olopatadine
|
Olopatadine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AC51 |
cromoglicic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD |
Corticosteroids
|
Corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD01 |
beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD02 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD03 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD04 |
flunisolide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD05 |
budesonide
|
Budésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD06 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD07 |
tixocortol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD08 |
fluticasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD09 |
mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD11 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD12 |
fluticasone furoate
|
Furoate de fluticasone
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD13 |
ciclesonide
|
Ciclésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD52 |
prednisolone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD53 |
dexamethasone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD57 |
tixocortol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD58 |
fluticasone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AD60 |
hydrocortisone, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX |
Other nasal preparations
|
Autres préparations nasales
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX02 |
retinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX03 |
ipratropium bromide
|
Bromure d'ipratropium
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX05 |
ritiometan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX06 |
mupirocin
|
Mupirocine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX07 |
hexamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX08 |
framycetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX09 |
hyaluronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01AX30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA |
Sympathomimetics
|
Sympathomimétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA01 |
phenylpropanolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA02 |
pseudoephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA03 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA51 |
phenylpropanolamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA52 |
pseudoephedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R01BA53 |
phenylephrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA |
Antiseptics
|
Antiseptiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA01 |
ambazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA02 |
dequalinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA03 |
dichlorobenzyl alcohol
|
Alcool dichlorobenzylique
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA05 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA06 |
cetylpyridinium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA09 |
benzethonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA10 |
myristyl-benzalkonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA11 |
chlorquinaldol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA12 |
hexylresorcinol
|
Hexylrésorcinol
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA13 |
acriflavinium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA14 |
oxyquinoline
|
Oxyquinoline
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA15 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA16 |
benzalkonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA17 |
cetrimonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA18 |
hexamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA19 |
phenol
|
Phénol
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AA21 |
octenidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB01 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB02 |
tyrothricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB03 |
fusafungine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB04 |
bacitracin
|
Bacitracine
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AB30 |
gramicidin
|
Gramicidine
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AD |
Anesthetics, local
|
Anesthésiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AD01 |
benzocaine
|
Benzocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AD02 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AD03 |
cocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AD04 |
dyclonine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AX |
Other throat preparations
|
Autres produits de soin pour la gorge
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AX01 |
flurbiprofen
|
Flurbiprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AX02 |
ibuprofen
|
Ibuprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
R02AX03 |
benzydamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AA |
Alpha- and beta-adrenoreceptor agonists
|
Agonistes des alpha- et bêta-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AA01 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AB |
Non-selective beta-adrenoreceptor agonists
|
Agonistes non-sélectifs des bêta-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AB02 |
isoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AB03 |
orciprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC |
Selective beta-2-adrenoreceptor agonists
|
Agonistes sélectifs des bêta2-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC02 |
salbutamol
|
Salbutamol
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC03 |
terbutaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC04 |
fenoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC05 |
rimiterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC06 |
hexoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC07 |
isoetarine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC08 |
pirbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC09 |
tretoquinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC10 |
carbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC11 |
tulobuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC12 |
salmeterol
|
Salmétérol
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC13 |
formoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC14 |
clenbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC15 |
reproterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC16 |
procaterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC17 |
bitolterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC18 |
indacaterol
|
Indacatérol
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AC19 |
olodaterol
|
Olodatérol
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK |
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
|
Adrénergiques en association avec des corticostéroïdes et d'autres principes actifs, à l'exclusion des anticholinergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK02 |
isoprenaline and other drugs for obstructive airway diseases
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK04 |
salbutamol and sodium cromoglicate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK05 |
reproterol and sodium cromoglicate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK06 |
salmeterol and fluticasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK07 |
formoterol and budesonide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK08 |
formoterol and beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK09 |
formoterol and mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK10 |
vilanterol and fluticasone furoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK11 |
formoterol and fluticasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK12 |
salmeterol and budesonide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK13 |
salbutamol and beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AK14 |
indacaterol and mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL |
Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
|
Adrénergiques en association avec un anticholinergique incluant les triple-associations avec des corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL01 |
fenoterol and ipratropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL02 |
salbutamol and ipratropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL03 |
vilanterol and umeclidinium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL04 |
indacaterol and glycopyrronium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL05 |
formoterol and aclidinium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL06 |
olodaterol and tiotropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL07 |
formoterol and glycopyrronium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL08 |
vilanterol, umeclidinium bromide and fluticasone furoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL09 |
formoterol, glycopyrronium bromide and beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL10 |
formoterol and tiotropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL11 |
formoterol, glycopyrronium bromide and budesonide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03AL12 |
indacaterol, glycopyrroinium bromide and mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA |
Glucocorticoids
|
Glucocorticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA01 |
beclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA02 |
budesonide
|
Budésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA03 |
flunisolide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA04 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA05 |
fluticasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA06 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA07 |
mometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA08 |
ciclesonide
|
Ciclésonide
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BA09 |
fluticasone furoate
|
Furoate de fluticasone
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB |
Anticholinergics
|
Anticholinergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB01 |
ipratropium bromide
|
Bromure d'ipratropium
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB02 |
oxitropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB03 |
stramoni preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB04 |
tiotropium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB05 |
aclidinium bromide
|
Bromure d'aclidinium
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB06 |
glycopyrronium bromide
|
Bromure de Glycopyrronium
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB07 |
umeclidinium bromide
|
Bromure d'uméclidinium
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB08 |
revefenacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BB54 |
tiotropium bromide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BC |
Antiallergic agents, excl. corticosteroids
|
Agents antiallergiques, à l'exclusion des corticostéroïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BC01 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BC03 |
nedocromil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BX |
Other drugs for obstructive airway diseases, inhalants
|
Autres médicaments en inhalation pour les maladies obstructives des voies respiratoires
|
WHO |
Active |
2021-06-09 15:34:07 |
R03BX01 |
fenspiride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CA |
Alpha- and beta-adrenoreceptor agonists
|
Agonistes des alpha- et bêta-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CA02 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB |
Non-selective beta-adrenoreceptor agonists
|
Agonistes non-sélectifs des bêta-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB01 |
isoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB02 |
methoxyphenamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB03 |
orciprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB51 |
isoprenaline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CB53 |
orciprenaline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC |
Selective beta-2-adrenoreceptor agonists
|
Agonistes sélectifs des bêta-2-adrénorécepteurs
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC02 |
salbutamol
|
Salbutamol
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC03 |
terbutaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC04 |
fenoterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC05 |
hexoprenaline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC06 |
isoetarine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC07 |
pirbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC08 |
procaterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC09 |
tretoquinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC10 |
carbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC11 |
tulobuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC12 |
bambuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC13 |
clenbuterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC14 |
reproterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC53 |
terbutaline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03CC63 |
clenbuterol and ambroxol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA |
Xanthines
|
Xanthines
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA01 |
diprophylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA02 |
choline theophyllinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA03 |
proxyphylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA04 |
theophylline
|
Théophylline
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA05 |
aminophylline
|
Aminophylline
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA06 |
etamiphylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA07 |
theobromine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA08 |
bamifylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA09 |
acefylline piperazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA10 |
bufylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA11 |
doxofylline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA12 |
mepyramine theophyllinacetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA20 |
combinations of xanthines
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA51 |
diprophylline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA54 |
theophylline, combinations excl. psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA55 |
aminophylline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DA74 |
theophylline, combinations with psycholeptics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DB |
Xanthines and adrenergics
|
Xanthines et adrénergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DB01 |
diprophylline and adrenergics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DB02 |
choline theophyllinate and adrenergics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DB04 |
theophylline and adrenergics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DB05 |
aminophylline and adrenergics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC |
Leukotriene receptor antagonists
|
Antagonistes des récepteurs des leucotriènes
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC01 |
zafirlukast
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC02 |
pranlukast
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC03 |
montelukast
|
Montélukast
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC04 |
ibudilast
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DC53 |
montelukast, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX |
Other systemic drugs for obstructive airway diseases
|
Autres médicaments systémiques pour les maladies obstructives des voies respiratoires
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX01 |
amlexanox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX02 |
eprozinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX03 |
fenspiride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX05 |
omalizumab
|
Omalizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX06 |
seratrodast
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX07 |
roflumilast
|
Roflumilast
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX08 |
reslizumab
|
Reslizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX09 |
mepolizumab
|
Mépolizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
R03DX10 |
benralizumab
|
BENRALIZUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA |
Expectorants
|
Expectorants
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA01 |
tyloxapol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA02 |
potassium iodide
|
Iodure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA03 |
guaifenesin
|
Guaïfénésine
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA04 |
ipecacuanha
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA05 |
althea root
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA06 |
senega
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA07 |
antimony pentasulfide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA08 |
creosote
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA09 |
guaiacolsulfonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA11 |
levoverbenone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA12 |
Hederae helicis folium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CA13 |
cineole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB |
Mucolytics
|
Mucolytiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB01 |
acetylcysteine
|
Acétylcystéine
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB02 |
bromhexine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB03 |
carbocisteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB04 |
eprazinone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB05 |
mesna
|
Mesna
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB06 |
ambroxol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB07 |
sobrerol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB08 |
domiodol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB09 |
letosteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB10 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB11 |
stepronin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB13 |
dornase alfa (desoxyribonuclease)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB14 |
neltenexine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB15 |
erdosteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05CB16 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA |
Opium alkaloids and derivatives
|
Alcaloïdes de l'opium et dérivés
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA01 |
ethylmorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA03 |
hydrocodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA04 |
codeine
|
Codéine
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA06 |
normethadone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA07 |
noscapine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA08 |
pholcodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA09 |
dextromethorphan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA10 |
thebacon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA11 |
dimemorfan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA12 |
acetyldihydrocodeine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DA20 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB |
Other cough suppressants
|
Autres antitussifs
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB01 |
benzonatate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB02 |
benproperine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB03 |
clobutinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB04 |
isoaminile
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB05 |
pentoxyverine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB07 |
oxolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB09 |
oxeladin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB10 |
clofedanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB11 |
pipazetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB12 |
bibenzonium bromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB13 |
butamirate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB14 |
fedrilate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB15 |
zipeprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB16 |
dibunate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB17 |
droxypropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB18 |
prenoxdiazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB19 |
dropropizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB21 |
cloperastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB22 |
meprotixol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB23 |
piperidione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB24 |
tipepidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB25 |
morclofone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB26 |
nepinalone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB27 |
levodropropizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05DB28 |
dimethoxanate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FA |
Opium derivatives and expectorants
|
Dérivés de l'opium et expectorants
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FA01 |
opium derivatives and mucolytics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FA02 |
opium derivatives and expectorants
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FB |
Other cough suppressants and expectorants
|
Autres antitussifs et expectorants
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FB01 |
cough suppressants and mucolytics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R05FB02 |
cough suppressants and expectorants
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA |
Aminoalkyl ethers
|
Aminoalkyl éthers
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA01 |
bromazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA02 |
diphenhydramine
|
Diphénhydramine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA04 |
clemastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA06 |
chlorphenoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA07 |
diphenylpyraline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA08 |
carbinoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA09 |
doxylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA10 |
trimethobenzamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA52 |
diphenhydramine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA56 |
chlorphenoxamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA57 |
diphenylpyraline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AA59 |
doxylamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB |
Substituted alkylamines
|
Alkylamines substituées
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB01 |
brompheniramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB02 |
dexchlorpheniramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB03 |
dimetindene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB04 |
chlorphenamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB05 |
pheniramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB06 |
dexbrompheniramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB07 |
talastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB51 |
brompheniramine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB52 |
dexchlorpheniramine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AB54 |
chlorphenamine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC |
Substituted ethylene diamines
|
Éthylène diamines substituées
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC01 |
mepyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC02 |
histapyrrodine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC03 |
chloropyramine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC04 |
tripelennamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC05 |
methapyrilene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC06 |
thonzylamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC52 |
histapyrrodine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AC53 |
chloropyramine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD |
Phenothiazine derivatives
|
Dérivés de la phénothiazine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD01 |
alimemazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD02 |
promethazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD03 |
thiethylperazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD04 |
methdilazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD05 |
hydroxyethylpromethazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD06 |
thiazinam
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD07 |
mequitazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD08 |
oxomemazine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD09 |
isothipendyl
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD52 |
promethazine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AD55 |
hydroxyethylpromethazine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE |
Piperazine derivatives
|
Dérivés de la pipérazine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE01 |
buclizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE03 |
cyclizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE04 |
chlorcyclizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE05 |
meclozine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE06 |
oxatomide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE07 |
cetirizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE09 |
levocetirizine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE51 |
buclizine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE53 |
cyclizine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AE55 |
meclozine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX |
Other antihistamines for systemic use
|
Associations d'antihistaminiques
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX01 |
bamipine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX02 |
cyproheptadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX03 |
thenalidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX04 |
phenindamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX05 |
antazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX07 |
triprolidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX08 |
pyrrobutamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX09 |
azatadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX11 |
astemizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX12 |
terfenadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX13 |
loratadine
|
Loratadine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX15 |
mebhydrolin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX16 |
deptropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX17 |
ketotifen
|
Kétotifène
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX18 |
acrivastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX19 |
azelastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX21 |
tritoqualine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX22 |
ebastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX23 |
pimethixene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX24 |
epinastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX25 |
mizolastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX26 |
fexofenadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX27 |
desloratadine
|
Desloratadine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX28 |
rupatadine
|
Rupatadine
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX29 |
bilastine
|
BILASTINE
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX31 |
quifenadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX32 |
sequifenadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R06AX53 |
thenalidine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AA |
Lung surfactants
|
surfactants pulmonaires
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AA01 |
colfosceril palmitate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AA02 |
natural phospholipids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB |
Respiratory stimulants
|
Stimulants respiratoires
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB01 |
doxapram
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB02 |
nikethamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB03 |
pentetrazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB04 |
etamivan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB05 |
bemegride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB06 |
prethcamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB07 |
almitrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB08 |
dimefline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB09 |
mepixanox
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB52 |
nikethamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AB53 |
pentetrazol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AX |
Other respiratory system products
|
Autres produits pour le système respiratoire
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AX01 |
nitric oxide
|
Monoxyde d'azote
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AX02 |
ivacaftor
|
IVACAFTOR
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AX30 |
ivacaftor and lumacaftor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
R07AX31 |
ivacaftor and tezacaftor
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA |
Antibiotics
|
Antibiotiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA01 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA02 |
chlortetracycline
|
Chlortétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA03 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA04 |
oxytetracycline
|
Oxytétracycline
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA05 |
tyrothricin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA07 |
framycetin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA09 |
tetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA10 |
natamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA11 |
gentamicin
|
Gentamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA12 |
tobramycin
|
Tobramycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA13 |
fusidic acid
|
Acide fusidique
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA14 |
benzylpenicillin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA15 |
dihydrostreptomycin
|
Dihydrostreptomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA16 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA17 |
erythromycin
|
Érythromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA18 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA19 |
ampicillin
|
Ampicilline
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA20 |
antibiotics in combination with other drugs
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA21 |
amikacin
|
Amikacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA22 |
micronomicin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA23 |
netilmicin
|
Nétilmicine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA24 |
kanamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA25 |
azidamfenicol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA26 |
azithromycin
|
Azithromycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA27 |
cefuroxime
|
Céfuroxime
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA28 |
vancomycin
|
Vancomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AA30 |
combinations of different antibiotics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB |
Sulfonamides
|
Sulfamides
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB01 |
sulfamethizole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB02 |
sulfafurazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB03 |
sulfadicramide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB04 |
sulfacetamide
|
Sulfacétamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AB05 |
sulfafenazol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD |
Antivirals
|
Antiviraux
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD01 |
idoxuridine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD02 |
trifluridine
|
Trifluridine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD03 |
aciclovir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD05 |
interferon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD06 |
vidarabine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD07 |
famciclovir
|
Famciclovir
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD08 |
fomivirsen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AD09 |
ganciclovir
|
Ganciclovir
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE |
Fluoroquinolones
|
Fluoroquinolones
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE01 |
ofloxacin
|
Ofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE02 |
norfloxacin
|
Norfloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE03 |
ciprofloxacin
|
Ciprofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE04 |
lomefloxacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE05 |
levofloxacin
|
Lévofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE06 |
gatifloxacin
|
Gatifloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE07 |
moxifloxacin
|
Moxifloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AE08 |
besifloxacin
|
Bésifloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX |
Other antiinfectives
|
Autres anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX01 |
mercury compounds
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX02 |
silver compounds
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX04 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX05 |
bibrocathol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX06 |
resorcinol
|
Résorcinol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX07 |
sodium borate
|
Borate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX08 |
hexamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX09 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX10 |
sodium propionate
|
Propionate de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX14 |
dibrompropamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX15 |
propamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX16 |
picloxydine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01AX18 |
povidone-iodine
|
Iode-povidone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA |
Corticosteroids, plain
|
Corticoïdes non associés
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA01 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA02 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA03 |
cortisone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA04 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA05 |
triamcinolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA06 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA07 |
fluorometholone
|
Fluorométholone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA08 |
medrysone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA09 |
clobetasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA10 |
alclometasone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA11 |
desonide
|
Désonide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA12 |
formocortal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA13 |
rimexolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA14 |
loteprednol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BA15 |
fluocinolone acetonide
|
Acétonide de fluocinolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BB |
Corticosteroids and mydriatics in combination
|
Corticoïdes et mydriatiques en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BB01 |
hydrocortisone and mydriatics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BB02 |
prednisolone and mydriatics
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC |
Antiinflammatory agents, non-steroids
|
Anti-inflammatoires non stéroïdiens
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC01 |
indometacin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC02 |
oxyphenbutazone
|
Oxyphenbutazone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC03 |
diclofenac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC04 |
flurbiprofen
|
Flurbiprofène
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC05 |
ketorolac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC06 |
piroxicam
|
Piroxicam
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC07 |
bendazac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC08 |
salicylic acid
|
Acide salicylique
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC09 |
pranoprofen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC10 |
nepafenac
|
Népafénac
|
WHO |
Active |
2021-06-09 15:34:07 |
S01BC11 |
bromfenac
|
Bromfénac
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA |
Corticosteroids and antiinfectives in combination
|
Corticoïdes et anti-infectieux en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA01 |
dexamethasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA02 |
prednisolone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA03 |
hydrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA04 |
fluocortolone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA05 |
betamethasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA06 |
fludrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA07 |
fluorometholone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA10 |
fluocinolone acetonide and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CA11 |
clobetasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CB |
Corticosteroids/antiinfectives/mydriatics in combination
|
Corticoïdes, anti-infectieux et mydriatiques en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CB01 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CB02 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CC |
Antiinflammatory agents, non-steroids and antiinfectives in combination
|
Anti-inflammatoires et anti-infectieux en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CC01 |
diclofenac and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01CC02 |
indometacin and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA |
Sympathomimetics in glaucoma therapy
|
Sympathomimétiques antiglaucomateux
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA01 |
epinephrine
|
Épinéphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA02 |
dipivefrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA03 |
apraclonidine
|
ApraclonidinE
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA04 |
clonidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA05 |
brimonidine
|
BRIMONIDINE
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EA51 |
epinephrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB |
Parasympathomimetics
|
Parasympathomimétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB01 |
pilocarpine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB02 |
carbachol
|
Carbachol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB03 |
ecothiopate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB04 |
demecarium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB05 |
physostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB06 |
neostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB07 |
fluostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB08 |
aceclidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB09 |
acetylcholine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB10 |
paraoxon
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB51 |
pilocarpine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EB58 |
aceclidine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC |
Carbonic anhydrase inhibitors
|
Inhibiteurs de l'anhydrase carbonique
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC01 |
acetazolamide
|
Acétazolamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC02 |
diclofenamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC03 |
dorzolamide
|
Dorzolamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC04 |
brinzolamide
|
Brinzolamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC05 |
methazolamide
|
Méthazolamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EC54 |
brinzolamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED |
Beta blocking agents
|
Bêtabloquants
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED01 |
timolol
|
Timolol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED02 |
betaxolol
|
Bétaxolol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED03 |
levobunolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED04 |
metipranolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED05 |
carteolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED06 |
befunolol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED51 |
timolol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED52 |
betaxolol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED54 |
metipranolol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01ED55 |
carteolol, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE |
Prostaglandin analogues
|
Analogues des prostaglandines
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE01 |
latanoprost
|
Latanoprost
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE02 |
unoprostone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE03 |
bimatoprost
|
Bimatoprost
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE04 |
travoprost
|
Travoprost
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE05 |
tafluprost
|
Tafluprost
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE06 |
latanoprostene bunod
|
Latanoprostène BUNOD
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EE51 |
latanoprost and netarsudil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EX |
Other antiglaucoma preparations
|
Autres antiglaucomateux
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EX01 |
guanethidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EX02 |
dapiprazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EX05 |
netarsudil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01EX06 |
omidenepag
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA |
Anticholinergics
|
Anticholinergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA01 |
atropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA02 |
scopolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA03 |
methylscopolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA04 |
cyclopentolate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA05 |
homatropine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA06 |
tropicamide
|
Tropicamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA54 |
cyclopentolate, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FA56 |
tropicamide, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FB |
Sympathomimetics excl. antiglaucoma preparations
|
Sympathomimétiques, antiglaucomateux exclus
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FB01 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FB02 |
ephedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FB03 |
ibopamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01FB51 |
phenylephrine and ketorolac
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA |
Sympathomimetics used as decongestants
|
Sympathomimétiques utilisés comme décongestionnants
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA01 |
naphazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA02 |
tetryzoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA03 |
xylometazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA04 |
oxymetazoline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA05 |
phenylephrine
|
Phényléphrine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA06 |
oxedrine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA51 |
naphazoline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA52 |
tetryzoline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA53 |
xylometazoline, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA55 |
phenylephrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GA56 |
oxedrine, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX |
Other antiallergics
|
Autres anti-allergiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX01 |
cromoglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX02 |
levocabastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX03 |
spaglumic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX04 |
nedocromil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX05 |
lodoxamide
|
Lodoxamide
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX06 |
emedastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX07 |
azelastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX08 |
ketotifen
|
Kétotifène
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX09 |
olopatadine
|
Olopatadine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX10 |
epinastine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX11 |
alcaftadine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01GX51 |
cromoglicic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA |
Local anesthetics
|
Anesthésiques locaux
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA01 |
cocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA02 |
oxybuprocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA03 |
tetracaine
|
Tétracaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA04 |
proxymetacaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA05 |
procaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA06 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01HA07 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
S01JA |
Colouring agents
|
Colorants
|
WHO |
Active |
2021-06-09 15:34:07 |
S01JA01 |
fluorescein
|
Fluorescéine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01JA02 |
rose bengal sodium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01JA51 |
fluorescein, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KA |
Viscoelastic substances
|
Médicaments viscoélastiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KA01 |
hyaluronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KA02 |
hypromellose
|
Hypromellose
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KA51 |
hyaluronic acid, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KX |
Other surgical aids
|
Autres adjuvants en chirurgie ophtalmique
|
WHO |
Active |
2021-06-09 15:34:07 |
S01KX01 |
chymotrypsin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA |
Antineovascularisation agents
|
Agents antinéovascularisation
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA01 |
verteporfin
|
Vertéporfine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA02 |
anecortave
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA03 |
pegaptanib
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA04 |
ranibizumab
|
Ranibizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA05 |
aflibercept
|
Aflibercept
|
WHO |
Active |
2021-06-09 15:34:07 |
S01LA06 |
brolucizumab
|
Brolucizumab
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA |
Other ophthalmologicals
|
Autres médicaments ophtalmologiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA01 |
guaiazulen
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA02 |
retinol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA03 |
sodium chloride, hypertonic
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA04 |
potassium iodide
|
Iodure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA05 |
sodium edetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA06 |
ethylmorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA07 |
alum
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA08 |
acetylcysteine
|
Acétylcystéine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA09 |
iodoheparinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA10 |
inosine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA11 |
nandrolone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA12 |
dexpanthenol
|
Dexpanthénol
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA13 |
alteplase
|
Altéplase
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA14 |
heparin
|
Héparine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA15 |
ascorbic acid
|
Acide ascorbique
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA18 |
ciclosporin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA19 |
limbal stems cells, autologous
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA20 |
artificial tears and other indifferent preparations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA21 |
mercaptamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA22 |
ocriplasmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA23 |
sirolimus
|
Sirolimus
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA24 |
cenegermin
|
Cénégermine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA25 |
lifitegrast
|
Lifitegrast
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA26 |
riboflavin
|
Riboflavine
|
WHO |
Active |
2021-06-09 15:34:07 |
S01XA27 |
voretigene neparvovec
|
Voretigène néparvovec
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA |
Antiinfectives
|
Anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA01 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA02 |
nitrofural
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA03 |
boric acid
|
Acide borique
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA04 |
aluminium acetotartrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA05 |
clioquinol
|
Clioquinol
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA06 |
hydrogen peroxide
|
Peroxyde d'hydrogène
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA07 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA08 |
tetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA09 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA10 |
acetic acid
|
Acide acétique
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA11 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA12 |
rifamycin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA13 |
miconazole
|
Miconazole
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA14 |
gentamicin
|
Gentamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA15 |
ciprofloxacin
|
Ciprofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA16 |
ofloxacin
|
Ofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S02AA30 |
antiinfectives, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA |
Corticosteroids
|
Corticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA01 |
hydrocortisone
|
Hydrocortisone
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA03 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA06 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA07 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S02BA08 |
fluocinolone acetonide
|
Acétonide de fluocinolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA |
Corticosteroids and antiinfectives in combination
|
Corticoïdes et anti-infectieux en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA01 |
prednisolone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA02 |
flumetasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA03 |
hydrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA04 |
triamcinolone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA05 |
fluocinolone acetonide and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA06 |
dexamethasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02CA07 |
fludrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA |
Analgesics and anesthetics
|
Analgésiques et anesthésiques
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA01 |
lidocaine
|
Lidocaïne
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA02 |
cocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA03 |
phenazone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA04 |
cinchocaine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S02DA30 |
combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA |
Antiinfectives
|
Anti-infectieux
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA01 |
neomycin
|
Néomycine
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA02 |
tetracycline
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA03 |
polymyxin B
|
Polymyxine B
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA04 |
chlorhexidine
|
Chlorhexidine
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA05 |
hexamidine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA06 |
gentamicin
|
Gentamicine
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA07 |
ciprofloxacin
|
Ciprofloxacine
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA08 |
chloramphenicol
|
Chloramphénicol
|
WHO |
Active |
2021-06-09 15:34:07 |
S03AA30 |
antiinfectives, combinations
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03BA |
Corticosteroids
|
Corticoïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
S03BA01 |
dexamethasone
|
Dexaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S03BA02 |
prednisolone
|
Prednisolone
|
WHO |
Active |
2021-06-09 15:34:07 |
S03BA03 |
betamethasone
|
Bétaméthasone
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA |
Corticosteroids and antiinfectives in combination
|
Corticoïdes et anti-infectieux en association
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA01 |
dexamethasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA02 |
prednisolone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA04 |
hydrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA05 |
fludrocortisone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
S03CA06 |
betamethasone and antiinfectives
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA |
Allergen extracts
|
Extraits d'allergènes
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA01 |
feather
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA03 |
house dust mites
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA04 |
mould fungus and yeast fungus
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA07 |
insects
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA08 |
food
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V01AA11 |
animals
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB |
Antidotes
|
Antidotes
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB02 |
nalorphine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB03 |
edetates
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB04 |
pralidoxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB06 |
thiosulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB08 |
sodium nitrite
|
Nitrite de sodium
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB09 |
dimercaprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB13 |
obidoxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB14 |
protamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB15 |
naloxone
|
Naloxone
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB16 |
ethanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB17 |
methylthioninium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB18 |
potassium permanganate
|
Permanganate de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB19 |
physostigmine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB20 |
copper sulfate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB21 |
potassium iodide
|
Iodure de potassium
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB22 |
amyl nitrite
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB23 |
acetylcysteine
|
Acétylcystéine
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB24 |
digitalis antitoxin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB25 |
flumazenil
|
Flumazénil
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB26 |
methionine
|
Méhionine
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB27 |
4-dimethylaminophenol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB31 |
prussian blue
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB32 |
glutathione
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB33 |
hydroxocobalamin
|
Hydroxocobalamine
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB34 |
fomepizole
|
Fomépizole
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB35 |
sugammadex
|
Sugammadex
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB36 |
phentolamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB37 |
idarucizumab
|
IDARUCIZUMAB
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AB38 |
andexanet alfa
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AC |
Iron chelating agents
|
Chélateurs du fer
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AC01 |
deferoxamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AC02 |
deferiprone
|
Défériprone
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AC03 |
deferasirox
|
Déférasirox
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE |
Drugs for treatment of hyperkalemia and hyperphosphatemia
|
Médicaments de l'hyperkaliémie et de l'hyperphosphatémie
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE01 |
polystyrene sulfonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE02 |
sevelamer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE03 |
lanthanum carbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE04 |
calcium acetate and magnesium carbonate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE05 |
sucroferric oxyhydroxide
|
Oxyhydroxyde sucro-ferrique
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE06 |
colestilan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE07 |
calcium acetate
|
Acétate de calcium
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE08 |
ferric citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AE09 |
patiromer calcium
|
patiromer de calcium
|
WHO |
Active |
2023-09-25 09:46:22 |
V03AE10 |
sodium zirconium cyclosilicate
|
CYCLOSILICATE DE ZIRCONIUM SODIQUE
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF |
Detoxifying agents for antineoplastic treatment
|
Médicaments détoxifiants dans un traitement cytostatiqu
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF01 |
mesna
|
Mesna
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF02 |
dexrazoxane
|
Dexrazoxane
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF03 |
calcium folinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF04 |
calcium levofolinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF05 |
amifostine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF06 |
sodium folinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF07 |
rasburicase
|
Rasburicase
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF08 |
palifermin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF09 |
glucarpidase
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF10 |
sodium levofolinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AF11 |
arginine and lysine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AG |
Drugs for treatment of hypercalcemia
|
Médicaments de l'hypercalcémie
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AG01 |
sodium cellulose phosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AH |
Drugs for treatment of hypoglycemia
|
Médicaments de l'hypoglycémie
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AH01 |
diazoxide
|
Diazoxide
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AN |
Medical gases
|
Gaz médicaux
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AN01 |
oxygen
|
Oxygène
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AN02 |
carbon dioxide
|
Dioxyde de carbone
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AN03 |
helium
|
Hélium
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AN04 |
nitrogen
|
Azote
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AX |
Other therapeutic products
|
Autres médicaments
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AX02 |
nalfurafine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AX03 |
cobicistat
|
Cobicistat
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AZ |
Nerve depressants
|
Dépresseurs du système nerveux
|
WHO |
Active |
2021-06-09 15:34:07 |
V03AZ01 |
ethanol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CA |
Tests for diabetes
|
Tests pour le diabète
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CA01 |
tolbutamide
|
Tolbutamide
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CA02 |
glucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CC |
Tests for bile duct patency
|
Tests pour la fonction biliaire
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CC01 |
sorbitol
|
Sorbitol
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CC02 |
magnesium sulfate
|
Sulfate de magnésium
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CC03 |
sincalide
|
Sincalide
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CC04 |
ceruletide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD |
Tests for pituitary function
|
Tests pour la fonction hypophysaire
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD01 |
metyrapone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD03 |
sermorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD04 |
corticorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD05 |
somatorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CD06 |
macimorelin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CE |
Tests for liver functional capacity
|
Tests pour la fonction hépatique
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CE01 |
galactose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CE02 |
sulfobromophthalein
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CE03 |
methacetin (13C)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CF |
Tuberculosis diagnostics
|
Diagnostic de la tuberculose
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CF01 |
tuberculin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG |
Tests for gastric secretion
|
Tests pour la sécrétion gastrique
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG01 |
cation exchange resins
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG02 |
betazole
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG03 |
histamine phosphate
|
Phosphate d'histamine
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG04 |
pentagastrin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG05 |
methylthioninium chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CG30 |
caffeine and sodium benzoate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH |
Tests for renal function and ureteral injuries
|
Tests pour la fonction rénale
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH01 |
inulin and other polyfructosans
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH02 |
indigo carmine
|
Bleu indigo
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH03 |
phenolsulfonphthalein
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH04 |
alsactide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CH30 |
aminohippuric acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CJ |
Tests for thyreoidea function
|
Tests pour la fonction thyroïdienne
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CJ01 |
thyrotropin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CJ02 |
protirelin
|
Protiréline
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CK |
Tests for pancreatic function
|
Tests pour la fonction pancréatique
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CK01 |
secretin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CK02 |
pancreozymin (cholecystokinin)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CK03 |
bentiromide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CM |
Tests for fertility disturbances
|
Tests pour les troubles de la fertilité
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CM01 |
gonadorelin
|
Gonadoréline
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX |
Other diagnostic agents
|
Autres médicaments pour diagnostic
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX01 |
indocyanine green
|
Vert d'indocyanine
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX02 |
folic acid
|
Acide folique
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX03 |
methacholine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX04 |
mannitol
|
Mannitol
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX05 |
13C-urea
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX06 |
hexaminolevulinate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX07 |
edrophonium
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX08 |
carbon monoxide
|
Monoxyde de carbone
|
WHO |
Active |
2021-06-09 15:34:07 |
V04CX09 |
patent blue
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V06DC |
Carbohydrates
|
Hydrates de carbon
|
WHO |
Active |
2021-06-09 15:34:07 |
V06DC01 |
glucose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V06DC02 |
fructose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA |
Watersoluble, nephrotropic, high osmolar X-ray contrast media
|
Produits de contraste de haute osmolarité, hydrosolubles
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA01 |
diatrizoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA02 |
metrizoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA03 |
iodamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA04 |
iotalamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA05 |
ioxitalamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA06 |
ioglicic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA07 |
acetrizoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA08 |
iocarmic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA09 |
methiodal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AA10 |
diodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB |
Watersoluble, nephrotropic, low osmolar X-ray contrast media
|
Produits de contraste de basse osmolarité, hydrosolubles, à tropisme rénal
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB01 |
metrizamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB02 |
iohexol
|
Iohexol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB03 |
ioxaglic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB04 |
iopamidol
|
Iopamidol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB05 |
iopromide
|
Iopromide
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB06 |
iotrolan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB07 |
ioversol
|
Ioversol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB08 |
iopentol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB09 |
iodixanol
|
Iodixanol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB10 |
iomeprol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB11 |
iobitridol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AB12 |
ioxilan
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC |
Watersoluble, hepatotropic X-ray contrast media
|
Produits de contraste hydrosolubles, à tropisme hépatique
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC01 |
iodoxamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC02 |
iotroxic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC03 |
ioglycamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC04 |
adipiodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC05 |
iobenzamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC06 |
iopanoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC07 |
iocetamic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC08 |
sodium iopodate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC09 |
tyropanoic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AC10 |
calcium iopodate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AD |
Non-watersoluble X-ray contrast media
|
Produits de contraste non hydrosolubles
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AD01 |
ethyl esters of iodised fatty acids
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AD02 |
iopydol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AD03 |
propyliodone
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08AD04 |
iofendylate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08BA |
Barium sulfate containing X-ray contrast media
|
Produits de contraste barytés
|
WHO |
Active |
2021-06-09 15:34:07 |
V08BA01 |
barium sulfate with suspending agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08BA02 |
barium sulfate without suspending agents
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA |
Paramagnetic contrast media
|
Produits de contraste paramagnétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA01 |
gadopentetic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA02 |
gadoteric acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA03 |
gadodiamide
|
Gadodiamide
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA04 |
gadoteridol
|
Gadotéridol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA05 |
mangafodipir
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA06 |
gadoversetamide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA07 |
ferric ammonium citrate
|
Citrate ferrique d'ammonium
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA08 |
gadobenic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA09 |
gadobutrol
|
Gadobutrol
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA10 |
gadoxetic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CA11 |
gadofosveset
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CB |
Superparamagnetic contrast media
|
Produits de contraste superparamagnétiques
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CB01 |
ferumoxsil
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CB02 |
ferristene
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CB03 |
iron oxide, nanoparticles
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CX |
Other magnetic resonance imaging contrast media
|
Autres produits de contraste pour imagerie par résonance
|
WHO |
Active |
2021-06-09 15:34:07 |
V08CX01 |
perflubron
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA |
Ultrasound contrast media
|
Produits pour échographie
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA01 |
perflutren, human albumin microspheres
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA02 |
microparticles of galactose
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA03 |
perflenapent
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA04 |
perflutren, phospholipid microspheres
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA05 |
sulfur hexafluoride, phospholipid microspheres
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V08DA06 |
perflubutane, phospholipid microspheres
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AA01 |
technetium (99mTc) exametazime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AA02 |
technetium (99mTc) bicisate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AX |
Other central nervous system diagnostic radiopharmaceuticals
|
Autres produits radiopharmaceutiques à usage diagnostique pour le système nerveux central
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AX04 |
flutemetamol (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AX05 |
florbetapir (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09AX06 |
florbetaben (18F)
|
FLORBÉTABÈNE (18F)
|
WHO |
Active |
2021-06-09 15:34:07 |
V09BA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09BA01 |
technetium (99mTc) oxidronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09BA02 |
technetium (99mTc) medronic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09BA03 |
technetium (99mTc) pyrophosphate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA01 |
technetium (99mTc) pentetic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA02 |
technetium (99mTc) succimer
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA03 |
technetium (99mTc) mertiatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA04 |
technetium (99mTc) gluceptate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CA06 |
technetium (99mTc) ethylenedicysteine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CX |
Other renal system diagnostic radiopharmaceuticals
|
Autres produits radiopharmaceutiques à usage diagnostique pour la fonction rénale
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CX01 |
sodium iodohippurate (123I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CX02 |
sodium iodohippurate (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09CX04 |
chromium (51Cr) edetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DA01 |
technetium (99mTc) disofenin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DA02 |
technetium (99mTc) etifenin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DA04 |
technetium (99mTc) mebrofenin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB |
Technetium (99mTc), particles and colloids
|
99mTc-Technétium, particules et colloïdes
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB01 |
technetium (99mTc) nanocolloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB04 |
technetium (99mTc) tin colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB05 |
technetium (99mTc) sulfur colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB06 |
technetium (99mTc) rheniumsulfide colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DB07 |
technetium (99mTc) phytate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DX |
Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals
|
Autres produits radiopharmaceutiques à usage diagnostique pour la fonction hépatique ou le système réticulo-endothélial
|
WHO |
Active |
2021-06-09 15:34:07 |
V09DX01 |
selenium (75Se) tauroselcholic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EA |
Technetium (99mTc), inhalants
|
99mTc-Technétium, pour inhalation
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EA01 |
technetium (99mTc) pentetic acid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EB |
Technetium (99mTc), particles for injection
|
99mTc-Technétium, particules pour injection
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EB01 |
technetium (99mTc) macrosalb
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EX |
Other respiratory system diagnostic radiopharmaceuticals
|
Autres produits radiopharmaceutiques à usage diagnostique pour l'appareil respiratoire
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EX01 |
krypton (81mKr) gas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09EX03 |
xenon (133Xe) gas
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09FX |
Various thyroid diagnostic radiopharmaceuticals
|
Divers radiopharmaceutiques à usage diagnostique pour la thyroïde
|
WHO |
Active |
2021-06-09 15:34:07 |
V09FX01 |
technetium (99mTc) pertechnetate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09FX02 |
sodium iodide (123I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09FX03 |
sodium iodide (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2024-05-17 08:52:54 |
V09GA01 |
technetium (99mTc) sestamibi
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GA02 |
technetium (99mTc) tetrofosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GA03 |
technetium (99mTc) teboroxime
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GA05 |
technetium (99mTc) furifosmin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GA07 |
technetium (99mTc) apcitide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GX |
Other cardiovascular system diagnostic radiopharmaceuticals
|
Autres produits radiopharmaceutiques à usage diagnostique pour l'appareil cardiovasculaire
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GX01 |
thallium (201Tl) chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GX03 |
chromium (51Cr) chromate labelled cells
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09GX04 |
rubidium (82Rb) chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09HA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09HA02 |
technetium (99mTc) exametazime labelled cells
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09HA04 |
technetium (99mTc) sulesomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09HX |
Other diagnostic radiopharmaceuticals for inflammation and infection detection
|
Autres produits radiopharmaceutiques à usage diagnostique
|
WHO |
Active |
2021-06-09 15:34:07 |
V09HX01 |
gallium (67Ga) citrate
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA |
Technetium (99mTc) compounds
|
Dérivés du 99mTc-Technétium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA05 |
technetium (99mTc) depreotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA06 |
technetium (99mTc) arcitumomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA07 |
technetium (99mTc) hynic-octreotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA08 |
technetium (99mTc) etarfolatide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IA09 |
technetium (99mTc) tilmanocept
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IB |
Indium (111In) compounds
|
Dérivés du 111In-Indium
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IB01 |
indium (111In) pentetreotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX |
Other diagnostic radiopharmaceuticals for tumour detection
|
Autres produits radiopharmaceutiques à usage diagnostique
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX01 |
iobenguane (123I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX02 |
iobenguane (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX04 |
fludeoxyglucose (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX05 |
fluorodopa (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX06 |
sodium fluoride (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX07 |
fluorocholine (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX08 |
fluoroethylcholine (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX09 |
gallium (68Ga) edotreotide
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX10 |
fluoroethyl-L-tyrosine (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX11 |
fluoroestradiol (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX12 |
Fluciclovine (18F)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09IX13 |
methionine (11C)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XA |
Iodine (131I) compounds
|
Dérivés de l'131I-Iode
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XA01 |
iodine (131I) norcholesterol
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XA02 |
iodocholesterol (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XA03 |
iodine (131I) human albumin
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XX |
Various diagnostic radiopharmaceuticals
|
Divers produits radiopharmaceutiques à usage diagnostique
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XX01 |
cobalt (57Co) cyanocobalamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V09XX02 |
cobalt (58Co) cyanocobalamine
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AA |
Yttrium (90Y) compounds
|
Dérivés de 90Y-Yttrium
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AA01 |
yttrium (90Y) citrate colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AA03 |
yttrium (90Y) silicate colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AX |
Other antiinflammatory therapeutic radiopharmaceuticals
|
Autres produits radiopharmaceutiques anti-inflammatoires
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AX04 |
erbium (169Er) citrate colloid
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10AX06 |
gold (198Au) colloidal
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10BX |
Various pain palliation radiopharmaceuticals
|
Divers produits radiopharmaceutiques pour la palliation de la douleur
|
WHO |
Active |
2021-06-09 15:34:07 |
V10BX01 |
strontium (89Sr) chloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10BX02 |
samarium (153Sm) lexidronam
|
Samarium (153SM) lexidronam
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XA |
Iodine (131I) compounds
|
Dérivés de l'131I-Iode
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XA01 |
sodium iodide (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XA02 |
iobenguane (131I)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XA53 |
tositumomab/iodine (131I) tositumomab
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XX |
Various therapeutic radiopharmaceuticals
|
Divers produits radiopharmaceutiques à usage thérapeutique
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XX01 |
sodium phosphate (32P)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XX02 |
ibritumomab tiuxetan (90Y)
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XX03 |
radium (223Ra) dichloride
|
|
WHO |
Active |
2021-06-09 15:34:07 |
V10XX04 |
lutetium (177Lu) oxodotreotide
|
LUTÉCIUM (177LU) OXODOTRÉOTIDE
|
WHO |
Active |
2021-06-09 15:34:07 |
N02CD |
Calcitonin gene-related peptide (CGRP) antagonists
|
|
WHO |
Active |
2021-06-15 19:46:48 |
D10AX06 |
Clascoterone
|
|
WHO |
Active |
2022-06-02 15:18:06 |
B03AC |
Iron, parenteral preparations
|
Fer trivalent, préparations parentérales
|
WHO |
Active |
2022-06-07 15:56:57 |
L01FC01 |
Daratumumab
|
|
WHO |
Active |
2022-07-05 18:08:36 |
L01FC02 |
Isatuximab
|
|
WHO |
Active |
2022-07-05 18:10:51 |
L01EN01 |
erdafitinib
|
erdafitinib
|
WHO |
Active |
2023-09-22 13:25:38 |
L01EB09 |
lazertinib
|
lazertinib
|
WHO |
Active |
2024-03-08 14:41:00 |
C01EB24 |
mavacamten
|
Mavacamten
|
WHO |
Active |
2024-05-17 10:29:35 |
L04AF07 |
deucravacitinib
|
Deucravacitinib
|
WHO |
Active |
2024-05-17 10:31:43 |
L01XL08 |
lisocabtagene maraleucel
|
Lisocabtagène maraleucel
|
WHO |
Active |
2024-05-17 10:33:46 |
L01EX28 |
repotrectinib
|
Répotrectinib
|
WHO |
Active |
2024-05-24 14:02:08 |
L01FY02 |
nivolumab and relatlimab
|
Nivolumab et rélatlimab
|
WHO |
Active |
2024-05-24 14:04:33 |
L01EX11 |
quizartinib
|
Quizartinib
|
WHO |
Active |
2024-06-07 13:35:10 |
L01XK52 |
niraparib and abiraterone
|
Niraparib et abiratérone
|
WHO |
Active |
2024-06-07 13:31:33 |
N04BA07 |
foslevodopa and decarboxylase
|
Foslévodopa et décarboxylase
|
WHO |
Active |
2024-10-07 10:13:19 |
L01FX26 |
mirvetuximab soravtansine
|
Mirvétuximab soravtansine
|
WHO |
Active |
2024-11-15 11:26:48 |